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SUMMARY
Three attempts at developing a radioimmunoassay
for prostaglandin were made. Two of these attempts
resulted in the production of anti-sera directed mainly
to prostaglandin B2« The third attempt was designed
to produce anti-sera specific to prostaglandin F2yp» a
prostaglandin readily formed from prostaglandin E2 by
reduction with sodium borohydride. Antibodies were
successfully raised to prostaglandin F^ with a low cross-
reactivity to the majority of potentially interfering
prostaglandins, including prostaglandin otl*er
epimer produced by sodium borohydride reduction of
prostaglandin EThe anti-sera tested were unable to
distinguish between prostaglandins F and F„_.
If 2f
Attempts were made to explain why rabbits
immunised with prostaglandin E^ - bovine serum albumin
conjugates produced anti-sera primarily directed to
prostaglandin . No evidence for the conversion of
prostaglandin to prostaglandin B2 during the synthesis
of the immunising conjugate was obtained. Although
prostaglandins of the A series have been extracted from
a variety of sources and these are readily isomerised
to the corresponding prostaglandin B, the nature of
their biological synthesis remains to be elucidated.
The possibility that the prostaglandin E2 conjugated
to the bovine serum albumin was being dehydrated
enzymatically to the corresponding prostaglandin
by the immunised rabbits and then isomerised to the
corresponding prostaglandin B was investigated. No
iii
evidence for a prostaglandin E dehydrase was obtained
in either rabbit blood or lymph nodal tissue.
In experiments designed to evaluate the sheep
as a possible alternative animal suitable for raising
prostaglandin E2 anti-sera, an enzyme was discovered
in the blood that reduced prostaglandin E2 specifically
to prostaglandin The enzyme has been quantitatively
assayed by radiochemical and combined gas chromatography-
mass spectroraetric methods. The pH and temperature
characteristics of the enzyme system were determined
by the first assay method. Both assay methods have
been used for substrate specificity studies. This
enzyme system is active within a narrow pH range with
optimum activity at around pH 7. At temperatures
o
above 50 C the enzyme reaction rate is greatly reduced
0
with optimum activity being around 40-45 C. The
enzyme has been detected in rabbit, horse, guinea-pig
and chicken liver and horse heart and chicken brain
homogenates. The richest source is rabbit liver.
The enzyme was not detectable by the methods employed
in blood samples from cat, chicken, dog, guinea-pig,
horse, man, rabbit and rat. Preliminary results
suggest that a similar enzyme may be present in human
liver. The enzyme system was not detectable in liver,
kidney or heart samples from the cat, dog, cow and rat.
The influence of age, sex and hormonal state
have been studied with reference to the reduction of
prostaglandin E2 to prostaglandin enzyme
systems present in sheep blood and liver samples from
chicken, rabbit and guinea-pig. Ovarian steroid
iv
hormones have been found to influence the enzyme activity
and preliminary evidence would suggest a link between
these hormones and prostaglandin metabolism.
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The presence of smooth muscle stimulating
factors in human semen and tissues of the reproductive
tract has been reported since the beginning of the
century ( see von Euler, 1936, for references )•
Independently Goldblatt (1935) and von Euler (1936)
attributed this activity to a new pharmacologically
active substance that von Euler termed "prostaglandin"•
Although the early work of von Euler suggested that
"prostaglandin" had a structure compatible with it
being a lipid soluble fatty acid, it was not until
1960 that Bergstrom and Sjovall (1960 a; 1960 b.)
were able to assign the empirical formulae C_ , w ,,q20 3& 5
and ^20H36°5 to Prostaglandins E and F respectively
that had been extracted from ram seminal vesicles.
The first structural elucidation followed in 1963
(Bergstrom, Ryhage, Samuelsson and Sjovall, 1963 )
when the structures of prostaglandins E^, and p
were deduced. Since this initial structural elucidation
was performed a wide spectrum of prostaglandins and
their metabolites have been discovered. Much of this
isolation and structural elucidation work was carried
out on extracts of human semen ( Bergstrom and
Samuelsson, 1962? Samuelsson, 1963? Bygderaan, 1964?
Haniberg and Samuelsson, 1965; Bygdeman and Samuelsson,
1966 a? 1966 b; Haraberg and Samuelsson, 1966 a?
Kelly and Taylor, 1974 ).
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Natural primary" prostaglandins belong to a
series o£ compounds with certain common features. In
their non-metabolised form they are 20 carbon unsaturated
fatty acids, containing a 13,14-trans double bond and a
15(S) hydroxy1 group that belong to either the A, B, C,
D, E or P series. The series differ from each other
in the substituents on the cyclopentane ring as shown
by structural formulae of some prostaglandins in figure 1.
The degree of unsaturation of the side chains is denoted
by the subscript 1, 2 or 3 after the letter, although
when the 13, 14-trans double bond is saturated the
name is prefixed with 13, 14-dihydro. The 1 subscript
indicates the presence of only the 13, 14-trans double
bond ( unless prefixed with 13, 14-dihydro ) whilst the
2 and 3 subscripts refer to the presence of a 5, 6 cis
plus a 17, 18 cis double bonds respectively. The
prefix 19-0H refers to the presence of a hydroxyl group
at C-19.
The past decade has witnessed an ever-increasing
interest in prostaglandins, particularly by the various
national and international drug houses. Much of this
interest stems from the high biological activity that
various prostaglandins have on a variety of biological
systems. Consequently, numerous reports are appearing
that describe ( or confirm ) the routes of biological
synthesis and metabolism, the pharmacological, bio¬
chemical and physiological effects and the analysis of













13, 14 - dihydro PGE,
COOH OH
(9 - deoxy - 6. 9i - epoxy - a 5 - PGF, )
OH OH
OH OH OH OH
19 - hydroxy PGE-
Figure 1. Comparison of the cyclopentane ring
substituents in prostaglandins A - F and the
side chain substituents in PGG2, PGI2»
13»14-dihydro PGE2, PGE2, PGE1, PGE,, and
19 hydroxy PGE2.
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The discovery of prostaglandin-like substances
in a variety of biological situations often leads to
the suggestion that a particular prostaglandin may have
an important physiological role in that system. An
example of this is the suggestion that prostaglandin
A^ ( or a metabolite of this prostaglandin ) may be
the natriuretic hormone produced in response to the
increased in the extracellular fluid volume ( Lee,
19697 Horton, 1972; Lee, 1975 ). Evidence has been
accumulating for the presence of a circulating hormone
produced in response to an increased extracellular
volume ( de Wardener, Mills, Claphara and Hayter, 1961f
Lichardus and Pearce, 19661 Johnston, Herzog and Lauler,
1967 )• It has been suggested that the origin of this
hormone is the kidney ( Johnston, Davis, Howards and
Wright, 1967 ) and that it has a short half life in
the systemic circulation ( de Wardener; Mils, Clapham
and Hayter, 1961 )• This hormone also induces
natriuresis in response to saline loading without
altering the glomerular filtration rate or the systemic
blood pressure ( de Wardener et al., 1961 ) physiological
effects also claimed for prostaglandins e2 and A2
( Herzog, Johnston and Lauler, 1968 )• Further
circumstantial evidence supporting the suggestion that
a prostaglandin A may be the hormone was derived from
the fact that both prostaglandins E and A_ could be
« a
detected in renal venous blood after renal nerve
stimulation ( Davis and Horton, 1972 ) or during ischaemia
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( McGiff, Crowshaw, Terragno and Lonigro, 1970 ).
Certainly prostaglandins E2, a, and F^have been
conclusively identified in renal medullary tissue
( Lee, Crowshaw, Takman, Attrep and Gougoutas, 1967 )•
The origin of the prostaglandin A^ present in the medullary
samples, however, has seriously been questioned by the
work of Larsson and Anggard (1975) who have conclusively
shown that in their experiments the entire prostaglandin
A2 that was detectable had originated entirely from
chemical degradation during extraction and purification
procedures. It is » fact that prostaglandin Aj has a
longer half life in the systemic circulation of the
cat and dog than prostaglandin E due to it not being
inactivated by the lungs ( Horton and Jones, 1969;
McGiff, Terragno, Strand, Lee, Lonigro and Ng., 1969 ).
Thus A series prostaglandins could be thought of as
potential circulating hormones, although it must be
remembered that the hepatic circulation can decrease
the activity of prostaglandins A^ and A2 ( Horton and
Jones, 1969 )•
The analysis of prostaglandins and their metabolites
The low concentrations of prostaglandins either
present in or produced by the majority of biological
systems generally prevents their full rigorous
identification by physico-chemical analysis. Consequently
the past decade has witnessed the development of a
variety of extraction, chromatographic and analytical
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procedures that allow an "identification" of
prostaglandins to be made. These techniques have
been thoroughly reviewed (Shaw and Ramwell, 1969;
Horton, 1972; Hensby, in press ).
The first step in the successful analysis for
prostaglandins of biological origin usually involves a
preliminary purification by organic solvent extraction
( Horton, 1972 ). This step produces several problems
particularly associated with stability and recovery.
The E series prostaglandins in particular are prone to
dehydration in the acidic aqueous media associated
with extraction procedure ( Daniels, Hinraan, Johnson,
Kupiecki, Nelson and Pike, 1965; Nugteren, Beerthuis
and van Dorp, 1966; Larsson and Anggard, 1975 ).
Consequently, the origin of the A series prostaglandins
identified in biological systems must remain in doubt
until rigorously proven by methods similar to those of
Larsson and Anggard ( 1975 ). Recently, Taylor and
Kelly ( 1974) have perfected a method for the extraction
of E series prostaglandins from semen samples without
the problems of dehydration into the corresponding A
prostaglandins occurring. This method involves
conversion of the E prostaglandins into the corresponding
O-alkyl oximes which are more resistant to dehydration
during extraction or purification procedures. Using
this technique the major prostaglandins present in human
semen have been identified as the E series prostaglandins,
particularly in the 19-OH prostaglandins and (Taylor
and Kelly, 1974; Jonsson, Middleditch, Desiderio and
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Schexnayder, 1975 ). Consequently, the previous reports
that 19-OH prostaglandins A and B and not the corresponding
E analogues ( Hamberg and Samuelsson, 1966 ) were
present in human semen may be explained as extraction
artifacts.
The problem associated with the recovery in high
yields of the small amounts of prostaglandins has been
studied in great detail ( Morton, 1972 ). The most
efficient and quantitative results are obtained when d< u er: urn
isotope dilution techniques are employed. The
development of deuterium and tritium labelled prostaglandins
and their metabolites has certainly enhanced their
qualitative and quantitative analysis. The use of
deuterium labelled carrier prostaglandins for the
quantitative analysis of prostaglandin was originally
proposed by Samuelsson, Hamberg and Sweeley (1970).
However, this method relied on the addition of the deuterium
labelled compound after the derivatisation procedures
were complete and thus only quantitated the final analysis
by gas chromatography-mass spectrometry. The development
of high isotope purity tetra deuterated prostaglandins,
particularly when used in combination with the corresponding
tritium labelled prostaglandins, has proved to be one of
the better developments in the quantitative analysis of
prostaglandins and their metabolites by combined gas
chromatography-mass spectrometry ( Axen, Horlin and
Samuelsson, 1971; Green, 1973; Green, Granstrora,
Samuelsson and Axen 1973; Kelly, 1973; Granstrom,
Green, Bygdeman, Toppozada and Wiqvist, 1973; Hensby
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and Naylor, 1974 ). Not all prostaglandin metabolites
are available in the corresponding deuterium form,
however, methods that are generally applicable for the
production of deuterated forms of the derivatised
prostaglandins have been described ( Samuelsson et al.,
1970? Hamberg, 1972? 1974 ).
Although combined gas chromatography-mass
spectrometry has proved to be the most conclusive method
for identifying and quantifying prostaglandins and their
metabolites, this method entails considerable preparative
procedures. These methods must be performed if any
useful information is to be obtained from any form of
gas chromatography. One of the major problems associated
with gas chromatography of prostaglandins is their inherent
instability at the high temperatures employed. Consequently
a series of derivatives fcas- evolved that stabilise
prostaglandins sufficiently to enable them to be subjected
to gas chromatography. The most routinely employed
derivatives have been reviewed ( Green, 1969? Middleditch
and Desiderio, 1975 ). In all cases the carboxylic acid
has to be esterified, usually as either the methyl, ethyl
or trimethylsilyl derivative, although the pentafluorobenzyl
ester has recently been described for the specific use in
gas chromatography with electron capture detection
( Wickramasinghe, Morozowich, Hamlin and Shaw, 1973?
Wickramasinghe and Shaw, 1974 ). For prostaglandins
containing a ketonic function, the corresponding 0-alkyl
oxime derivative usually has to be prepared. The most
commonly employed are the 0-methyl and 0-benzyl oxime
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analogues ( Green, 1969? Granstrom, 1972? Baczynskyi,
Duchamp, Zieserl and Axen, 1973 ). Prostaglandins of the
A and B series can be subjected to gas chromatography
with the ketonic function underivatised. The B
prostaglandins when remaining as the free ketone contain
a conjugated dienone that has been successfully employed
for the electron capture detection of tetranor prostaglandin
B (Green and Samuelsson, 1971 ). The hydroxyl functions
of prostaglandins are usually protected for gas
chromatography as either the trimethylsilyl ether
( Thompson, Los and Horton, 1970 ), the acetate ( Green,
1969 ), trifluoroacetate (Thompson et al, 1970 ) or the
heptafluorobutyrate ( Levitt and Josimivich, 1971 )•
This latter derivative has proved particularly useful
for electron capture detection although the choice of
derivatising reagent may determine the success with which
the derivative is formed ( Sugiura and Hirano, 1974 ).
The ring structure of the F prostaglandins enables the
choice of derivatives that selectively form when both
the ring hydroxly groups are in the cis configuration to
be made. Such a derivative is the n-butyl first described
for prostaglandin Fn^hy Pace-Asciak and Wolfe (1971) •
This derivative has been successfully used for the
qualitative and quantitative analysis of prostaglandin
P2oi (Kelly, 1973? Hensby, 1974 ).
Another problem associated with the gas
chromatography of prostaglandins is that many other lipid-
like compounds are also extracted from the majority of
biological systems. Thus if meaningful results are
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to be obtained by gas chromatography or, indeed, most
other analytical procedures, some further purification
of the organic extract residue must be performed. The
most routinely employed preparative purification
procedures include thin layer chromatography ( Green and
Samuelsson, 1964? Andersen, 1969? Miller, 1974? Horton,
1972 ), silicic acid and silica gel column chromatography
( Daniels and Pike, 1968? Hamberg and Jonsson, 1973?
Hamberg, Svensson, Wakabayashi and Samuelsson, 1973 ),
reversed phase partition chromatography ( Anggard and
Samuelsson, 1964? Granstrom and Samuelsson, 1969? 1971?
Hamberg and Wilson, 1973? Nystrom and Sjovall, 1973 ),
and straight phase partition chromatography ( Anggard
and Bergvist, 1970? Sun and Stafford, 1974? Brash and
Jones, 1974? Sun, 1974? Hensby, 1974 ). The latter two
methods in particular have proved to be highly reproduceable
and efficient chromatography systems for the small
quantities of prostaglandins usually involved.
Although the use of gas chromatography particularly
in conjunction with mass spectrometry may provide the most
reliable results, the expense and complexity of the
operation are limiting factors for this technique.
Consequently, many other less conclusive techniques are
used for the analysis of prostaglandins. These assays
include various bioassay procedures ( Horton and Main,
1963? 1965? Vane, 1969? Horton and Jones, 1969 ),
ultraviolet spectroscopy ( Bygdeman, Fredricsson, Svanborg
and Samuelsson, 1970? Andersen, 1969 ), enzymatic assay
( Anggard, 1968 ) and radio-immunoassays ( Caldwell,
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Burstein, Brock and Spero££, 1971; Gershman, Powers,
Levine and Van Vunakis, 1972; Ja££e, Smith, Newton and
Parker, 1971; Levine, Gutierrez-Cernosek and Van Vunakia,
1971; Kirton, Cornette and Barr, 1972; Levine, Gutierrez-
Cernosek and Van Vunakis, 1973 )•
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Biosynthesis, metabolism and interconversion of
prostaglandins
The biosynthesis of prostaglandins E and F^has
been extensively studied, particularly with acetone dried
aggregates of the prostaglandin synthetase from bovine and
ovine seminal vesicles. This enzyme complex is widely
distributed ( see Horton, 1972 )• The conversion of all
cis-5,8,ll,14-eicosatetraenoic acid ( arachidonic acid )
into prostaglandin E^ was described independently by van
Dorp et al, and Bergstrom et al. ( van Dorp, Beerthuls,
Nugteren and Vonkeman, 1964? Bergstrom, Danielsson and
Samuelsson, 1964), Prostaglandin is also enzymatically
synthesised from this acid ( Anggard and Samuelsson, 1965 ).
The enzymatic conversion of all-cis-8,ll,14-eicosatrienoic
acid ( dihomo-$-linolenic ) into prostaglandins E^ and
Bergstrom, Danielsson, Klenberg and Sarauelsson, 1964?
van Dorp, Beerthuis, Nugteren and Vonkeman, 1964? Kupiecki,
1965 ) and all cis-5,8,ll,14,17-eicosapentaenoic acid into
prost ^glandin ( Bergatrom, Danielsson and Samuelsson,
1964 ) have also been described. The synthesis of
prostaglandin A^ from arachadonic acid by an enzyme present
in the sea whip Plexaura Homomalla is the only report that
describes the biosynthesis of prostaglandin A^ directly from
arachidonic acid ( Corey, Washburn and Chen, 1973 ). The
enzymatic synthesis of prostaglandins was postulated to
proceed via a common cyclic endoperoxide intermediate
( Samuelsson, Granstrom and Hamberg, 1967? Samuelsson, 1971 )
that was subsequently identified ( Hamberg and Samuelsson,
1973 ) and shown to be converted to E and D series
prostaglandins by distinct isomerases and F prostaglandins
by a reductase ( Hamberg and Samuelsson, 1973? Nugteren and
Hazelhof, 1973 ). The metabolism of arachidonic acid by
human blood platelets has been shown to produce compounds
other than prostaglandins ( Hamberg and Samuelsson, 1974 ).
One compound, 12L-hydroxy-5,3,lO,14-eicosatetraenoic acid
is produced by a different enzyme system to the prostaglandin
synthetase, namely the lipoxygenase enzyme system. The other
major products identified were 12L-hydroxy-5,8,10~
heptadecatrienoic acid and 8-(1-hydroxy-3-oxopropyl)-9,12L-
dihydroxy-5,10-heptadecadienoic acid. This latter
compound originally named PHD, has been re-named thromboxane
B it has been shown to be a derivative of thromboxane
( Hamberg, Svensson and Samuelsson, 1975 ), previously
known as Rabbit Aorta Contracting Substance and hought to
be a prostaglandin intermediate ( Piper and Vane, 1969 ).
The major products produced from arachidonic acid that
have been identified are shown in figure 2,
Prostaglandins of the E and ^series formed from
endogenous or radioactively labelled precursors have!been
demonstrated in a wide range of biological systems ( Horton,
197i ). These areas include renal medullary tissue of
rabbits, cats and dogs ( Hamberg, 1969? Muirhead, Germain,
Leach, Pitcock, Stephenson, Brooks, Brosius, Daniels and
Hinman, 1972? Crowshaw, McBiff, Strand, Lonigro and Terragno
1970? Daniels, Hinman, Leach and Muirhead, 1967? Lee,
Crowshaw, Takman, Attrep and Gougoutas, 1967? Crowshaw, 1971 )
the reproductive organs and fluids of man and animals
( Bergstrom and Samuelsson, 1962? Taylor and Kelly, 1974?
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Figure 2. Somw of the major transformations of
arachidonic acid that have been identified.
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Eglinton, Raphael, Smith, Hall and Pickles, 1963y Karim,
1967; Karim and Hillier, 1970; Karim and Devlin, 1967;
Horton, Jones, Thompson and Poyser, 1971; Poyser, 1971;
Bland, Horton and Poyser, 1971 ); lung tissue ( Anggard,
1965; Bergstrom, Dressier, Krabisch, Ryhage and Sjovall,
1962; Samuelsson, 1964a)y the spleen ( Davies, Horton and
Withrington, 1968; Gilmore, Vane and Wyllie, 1968; Gilmore,
Vane and Wyllie, 1969 )y the central nervous system (Coceani
and Wolfe, 1965; Ramwell and Shaw, 1966; Holmes, 1970;
Samuelsson, 1964; Horton and Main, 1967; Feldberg, Gupta,
Milton and Wendlandt, 1972 ) and inflamatory exudates and
skin ( Willis, 1969; Jonsson and Hamberg, 1973; Greaves,
Sondergaard and McDonald-Gibson, 1971; Mathur and Gandhi,
1972 ).
A variety of enzymes that metabolise prostaglandins
of the A,C,D,E and ^series has: been described, some of
them in great detail. The wide range of metabolic pathways
that have been described, particularly for the E and F^
type prostaglandins explain the often short h] oIo^i.cq! h.q]!1-
these prostaglandins have. In addition these enzymes may in ir
influence either site of action or the physiological, bio¬
chemical or pathological function of endogenous prostaglandins.
The enzyme that has been most widely reported to
metabolise 15 (S) prostaglandin is the 15-hydroxyprostag-
landin dehydrogenase ( Anggard and Samuelsson, 1966 )
which converts 15(S) prostaglandins into their 15-oxo
analogues. These metabolites were originally thought to be
considerably less active ( Anggard, 1966; Kloez:e, 1969;
Pike, Kupiecki and Weeks, 1967 ), however, recent reports
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would indicate that in some biological systems they may
have an equal or greater activity than the parent prostaglandin
( Dawson, Lewis, McMahon and Sweatman, 1974; Jones, 1975 ).
Detailed studies of the biochemical properties (Nakano,
Anggard and Samuelsson, 1969; Shio, Andersen, Corey and
Ramwell, I970 ) and distribution ( Anggard, Larsson and
Samuelsson, 1971; Samuelsson, Granstrom, Green and Hamberg,
1971 ) have been made. Recently reports have appeared that
indicate that two distinct types of 15-hydroxy-prostaglandin
dehydrogenase may be present in many systems ( Lee and
Levine, 1974; 1975 ). The type I dehydrogenase has a
requirement of NAD+ as cofactor whilst the type II
requires NADP+ as cofactor ( Lee and Levine, 1975 ). The
majority of reports, however, have only differentiated one
type of 15(S)-hydroxyprostaglandin dehydrogenase This
enzyme appears to be specific for 15(S)-hydroxyprostaglandins
with a variety of ring structures, although prostaglandins
and do not appear to be subtrates and V-dinor,
tetranor and 13,-4-dihydro prostaglandins are only poor
substrates ( Nakano et al., 1969; Sun, Armour and Bockstanz,
1975 ). This enzyme present in lung tissue is thought to
play a principal role in the inactivation of circulating E
and F prostaglandins ( Vane, 1969 ). It has been demonstrated
that during a single passage through the lungs of a cat, dog
and rabbit both prostaglandins E2 and F2 lose most of their
biological activity ( Ferreira and Vane, 1967 ).
Prostaglandins A^ and A2, which are good substrates for
this enzyme ( Nakano et at., 1969 ) are not, however,
inactivated by the pulmonary circulation of either the dog
or the cat ( Horton and Jones 1969; McGiff, Terragno, Strand,
Lee and Lonigro, 1969 ) although the guinea-pig lung perfused
with Krebs solution will metabolise them ( Piper, Vane and
Wyllie, 1969 ). These results may indicate that the A type
prostaglandins are either bound to a plasma protein or are
not substrates for lung uptake mechanisms. The 15(S)
hydroxyprostaglandin dehydrogenase does not accept the
corresponding 15(R) hydroxyprostaglandins which, with the
7-oxa-15(R) prostaglandins, are competitive inhibitors of
the enzyme (Shio et al., 1970; Marrazziand Matschinsky,
1972 ). A variety of chemically synthesised analogues of
the 15 (S) prostaglandins are currently being investigated
for biological activity. Many of these contain alkyl
functional groups at either C-15 or C-16 which protect
them from the action of this enzyme yet retain their
biological activity ( Bundy, Lincoln, Nelson, Pike and
Schneider, 1971; Bundy, Yankee, Weeks and Miller, 1973;
Robert and Magerlein, 1973; Karim, Carter, Bhana and
Ganer-n, 1973 ).
Another enzyme which tends to be ubiquitous in the
tissues containing the 15(S) hydroxyprostaglandin dehyd¬
rogenase is the^-13 prostaglandin reductase. This enzyme
reduces the C-13,14 double bond of the 15-oxo prostaglandins
and was first reported in the guinea-pig lung ( Anggard and
Samuelsson, 1964 ). Although the 13,14-dihydro
prostaglandin E has been identified in the particle-free
fraction of guinea-pig lung homogenates ( Anggard and
Samuelsson, 1964; 1965 ) and liver ( Kamberg and
Samuelsson, 1971 ) it has been shown that reduction of
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the C-13,14 double bond in vivo must proceed via oxidation
of the 15 (S) hydroxyl group ( Hamberg and Samuelsson, 1971).
The in vivo metabolism of the E and type prostaglandins
is thought to initially proceed, therefore, via the 15(S)
hydroxyprostaglandin dehydrogenase and the<Al3,14 reductase.
Both prostaglandins E1 and E2 are rapidly metabolised by
these processes in vivo in man (Hamberg and Samuelsson,
1971 ). When H-labelled prostaglandins or Ej are
administered intravenously in man their half-life is
approximately two minutes with the resulting 15-keto-13,14-
dihydro metabolites that are produced having a much longer
half-life ( Hamberg and Samuels3on, 1971 )•
One of the major problems related to the metabolism
of E series prostaglandins concerns the possibility that
there may be enzyme systems capable of dehydrati tg E to A
prostaglandins• The E series prostaglandins are known to
dehydrate under the extraction conditions usually used
( Schneider, Pike and Kupiecki, 1966 ). Recently, however,
several reports of enzymes present in blood or tissue
homogenates which will metabolise E series prostaglandins
to less polar compounds which behave as the corresponding
A prostaglandins have appeared ( Levine, Gutierrez-Cernosek
and Van Vunakis, 1973; Ramwell and Shaw, 1967; Shaw and
Ramwell, 1969; McDonald-Gibson, McDonald-Gibson and Greaves,
1972; Cammock, 1973; Russel, Alam and Clary, 1973; Polet
and Levine, 1975 ). In addition, several reports of A series
prostaglandins being identified in seminal fluid samples
(Hamberg and Samuelsson, 1966; Hamberg, 1968 ) and tissue
extracts ( Lee, Crowshaw, Takman Attrep and Gougoutas,
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1967; Presyna, Attallah, Vance, Schodman and Lee, 1973 )
have appeared. However, as discussed on page 18 unless
strict precautions are taken it must always remain debatable
as to the origin of A series prostaglandins. There are
reports of enzymes that will metabolise A prostaglandins in
preference to either E or F^prostaglandins. For example,
guinea-pig liver microsomes are reported to contain enzymes
that will convert prostaglandin A^ into the corresponding
19 and 20 hydroxylated derivatives (Israelsson, Hamberg and
Samuelsson, 1969 ). Under identical conditions little (3%
or less ) of the corresponding compounds were produced when
prostaglandin was used as a substrate. Similarly, the
plasma of several mammalian species have been shown to
contain an enzyme which induces a single shift of the 10,
11 double bond of PGA^ to produce the corresponding 9-oxo-
11,13-diene isomer, PGC^ ( Jones, 1972; Jones and Cammock,
1973; Jones, Cammock and Horton, 1972; Horton, Jones,
Thompson and Poyser, 1971; Polet and Levine, 1971; 1975 )•
In addition, human and rabbit serum is claimed to contain
another enzyme that isomerises the PGC to PGB ( Polet and
Levine, 1975 ), although, because of the low levels of
enzyme activity, these reports require confirmation that it
is not a chemically-induced isomerisation. Prostaglandin
A^ and also A^ are also substrates for the 15(S)
hydroxyprostaglandin dehydrogenase ( Nakano et at., 1969 ).
A,B,E and F^series prostaglandins isp-oxidation of both
the and tO-s ide chains. Rat liver mitochondria were
found to -oxidise the (X -side chains of these prostaglandins
One route of metabolism that appears to apply to
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in vitro ( Hamberg, 1968 ). This route of metabolism may
be of particular importance for the in vivo inactivation of
prostaglandin analogues that are not substrates for the 15(S)
hydroxyprostaglandin dehydrogenase ( Granstrom, 1975 ).
Although little published information relating to the
biological activity of -dinor and oc -tetranor
prostaglandins is available it is known that -nor
prostaglandin E^ has approximately 10}6 of the activity of
prostaglandin E^ on several smooth muscle preparations
( Horton and Main, 1966 ) .
The E and F 5^ prostaglandins are not interconverted
during their biosynthesis from a common precursor fatty
acid ( Anggard and Samuelsson, 1965; Hamberg and Samuelsson,
1967 ). Recently, several repeats have indicated that many
biological systems including man ( Hamberg and ^lson, 1973;
Ziboh, Lord and Penneys, 1975 ); guinea-pig ( Hamberg and
Israelsson, 1970; Hensby, 1974; 1975 ), actively fermenting
Baker's yeast ( Schneider and Murray, 1973 ) and a variety
of mammalian tissues ( Lee and Levine, 1974; 1975; Lee,
Pong, Katzen, Wu and Levine, 1975; Hensby, 1974; 1975 )
may possess enzymes capable of interconverting E and F^C
prostaglandins. This type of metabolism could be of
importance because many of the pharmacological actions of
prostaglandins E and differ both qualitatively and
quantitatively; an example being that prostaglandin E^
is a bronchodilator whereas prostaglandin F^ ^ is a
bronchoconstrictor ( Sweatman and Collier, 1968 ). Indeed,
the possibility that there may be at least two distinct
receptors, one being more selective for E type prostaglandins
I
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and the other being more selective for F(^ prostaglandins
has been suggested ( Horton and Main, 1965? Eakins and
Sanner, 1972 ). The possibility that three or more
prostaglandin receptor types may exist was suggested by
Pickles (1967). Recently Jones (1975) has provided
pharmacological evidence for the presence of E, D and
FO< receptors.
The in vivo metabolism of prostaglandins E and
F by a variety of mammals has been studied and all of the
above metabolic transformations have been detected. One
interesting metabolic route not described is the reduction
of the 9-keto group of the E series prostaglandins into
the corresponding ^8-hydroxyl configuration. In the
guinea-pig in vivo prostaglandin E^ is metabolised to
7 O^-dihydroxyl-ll-oxo-tetranor-prostaroic acid as determined
by the major urinary metabolite ( Hamberg and Samuelsson,
1969 ). This is in contrast to the metabolism of
prostaglandin E^ in vitro by guinea-pig liver homogenates
where the 9-keto group is reduced to the corresponding -
f
hydroxyl configuration { Hamberg and Israelsson, 1970;
Hensby, 1974; 1975 ). Prostaglandin is metabolised
in vivo by the guinea-pig to the major urinary metabolite
with the 5&<, 70< -dihydroxy-ll-oxo-tetranor-prostanoic acid
structure ( Granstrom and Samuelsson, 1969; Samuelsson,
Granstrom, Green and Hamberg, 1971 ). Consequently, the
major urinary metabolite of prostaglandins E and F in
* 2 W.
the guinea-pig differ only in the stereochemical configuration
of the hydroxyl group at the C-5 position. The rat has also
been shown to metabolise prostaglandin to 5V »7o^~
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dihydroxy-11-oxo-tetranor-prostanoic acid as determined by
urinary metabolite studies ( Samuelsson, Granstrom, Green,
and Hamberg, 1971; Green, 1971 ). Another interesting
feature of the in vivo metabolism of prostaglandin E^ by
the rat is that four of the excreted urinary metabolites
contained a B ring structure. This may indicate that the
rat has enzyme systems capable of dehydrating E prostaglandins
to the corresponding A prostaglandins which are then
isomerised to the corresponding B prostaglandins. It is
known that rat plasma contains a prostaglandin A isomerase
( Jones and Cammock, 1973 ). Prostaglandin F^^ and Fj ^
are also metabolised in vivo by the rat to a variety of
metabolites some of which appear to have only undergone one
step of -oxidation prior to excretion ( Granstrom, Inger
and Samuelsson, 1965; Green and Samuelsson, 1968 Green,
1971 ). Recently however, 5,7,11-trihydroxy-tetranor-
prostanoic acis has been detected as a rat urinary metabolite
of prostaglandin ^ Sun, 1974 ) . This compound obviously
was oxidised at d-15 and reduced at C-13,14 to produce the
15-keto-13,14-dihydro derivative prior to being stereo-
select ively reduced at the C-15. This may indicate that
the <x -dinor and the Of -tetranor prostaglandins F which
x
are excreted may have undergone other routes of metabolism
although their structures would not indicate this. The
biological inactivation of either prostaglandins E^ or
in vivo by rabbit and human subjects has also been studied
( Svanborg and Bygdeman, 1972; Hamberg and Samuelsson, 1969;
Granstrom and Samuelsson, 1969; Samuelsson, Granstrom, Green
and Hamberg, 1971; Hamberg and Wilson, 1973; Granstrom,
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1973 ). The major urinary metabolite of man was
found to be 7 -hydroxy-5,11-diketotetranor-prostane-1,
16-diocic acid ( Hamberg and Samuelsson, 1969,1971 ),
whilst the corresponding major human urinary metabolite
of prostaglandin F^^was found to be 5#, 7|f-dihydroxy-ll-
oxo-tetranorprosta-1,16-diocic acid ( Granstrom and
Samuelsson, 1969 ). Thus in both man and guinea-pig the
major urinary metabolites of E2 and F2 ^differ only in the
substituent at C-5. However, it is apparent from these
results that there are species differences in the
metabolism of prostaglandins. A particularly interesting
urinary metabolite for prostaglandin F2^has recently been
discovered in man ( Granstrom, 1973? Granstrom and
Samuelsson, 1972 ). This metabolite has been identified as
7<*' 9 tt^-dihydroxy ( (X -dinor, O-tetranor )-prost -3-ene-
1,14-dioic acid. The route by which this metabolite is
of fhi's focHifeotite
formed remains unknown. However, yields^are obtained in
urine after the intravenous injection of either 9fc<,ll0i(
dihydroxy-15-ketoprost-5-enoic acid of 9 11 (X, 15 K -
trihydroxyprost-5-enoic acid but not 7o£ # 9©^ -dihydroxy-
13-oxo-( -dinor, CO -dinor )-prost-1,16-diocic acid. The
structures of these metabolites are shown in figure 3 •
The Pharmacology and Physiology of Prostaglandins
The entire pharmacology and physiology of prosta¬
glandins that has been reported to date obviously cannot
be reviewed? however, areas that are relevant to this thesis,
namely cardiovascular and reproductive aspects, will be
dealt with in some detail.





5a, 7a - dihydroxy -11 - keto
tetranor - prostanic acid
56, 7a - dihydroxy -11 - keto




5a, 7a - dihydroxy -11 - keto
tetranor - prosta - 1, 16 - dioic acid
COOH
OH u
7a hydroxy - 5, 11 - di - keto
tetranor - prosta -1, 16 - dioic acid
Figure 5. The structures of the major urinary
metabolites of PGE^ and PGF2^in guinea
pig (upper) and man (lower) respectively.
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muscle preparations have been described ( Bergstrom,
Carlsson and Weeks, 1968; Horton, 1969; Jones, 1970 ).
In general the majority of reports deal with the E and F ^
series prostaglandins, although the actions of A, B and
D series prostaglandins have been described. The responses
of most smooth muscle are generally thought to be due to a
direct action of prostaglandins on the cell. However, a
variety of neuronal antagonists including procaine ( Harry,
*£
1968 ), atropine ( Horton, 1965; Harry, 1968 ) and hyoscine
( Bennett, Eley and Scholes, 1968; 1969 ) have been shown
to depress the responses of human and guinea-pig ileum to
prostaglandins. This, in conjunction with the fact that
the responses of aneuronal smooth muscle such as the
umbilical blood vessels appears to be unaffected by a
variety of pharmacological antagonists ( Hillier, 1970 ),
might suggest that on certain smooth muscle preparations
prostaglandins may have a direct and indirect mode of action.
The fact that many pharmacological antagonists do not appear
to block the actions of prostaglandins on a variety of
smooth muscle preparations ( Bennett, Eley and Scholes,
1968a 1968b; Horton, 1965; Strong and Bohr, 1967; 1967b )
indicates that prostaglandins probably have different
receptors from those of other agonists. Similarly
although E and F^ prostaglandins are known to contract
isolated segments of gastro-intestinal longitudinal from
all species tested ( Bergstrom, Elliasson, von Euler, and
Sjovall, 1959; Horton and Main, 1963; 1965; Bennett et al.,
1968 a; 1968 b ) results from the actions of E and F ^
prostaglandins on other types of smooth muscle would suggest
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that discrete receptor sites for each of these prostaglandins
exist. For example, isolated human bronchiolar smooth muscle
is relaxed by E series prostaglandins whilst prostaglandin
^ is spasmogenic on this preparation ( Collier and
Sweatman, 1968? Sweatman and Collier, 1968? Sheard, 1968?
Rosenthale, Dervinis, Begany, Lapidus and Gluckman, 1970?
Smith and Cuthbert, 1973 ). Similarly, evidence from the
in vivo actions of various prostaglandins on the sheep
cardiovascular system would suggest the presence of at
least two distinct receptors ( Jones, 1975 ). Activation of
one type results in vasoconstriction and a rise in blood
pressure whilst activation of the other results in
vasodilation and a fall in blood pressure. Although
prostaglandins and E2 are the most potent agonists
respectively on these two receptor systems, it has been
suggested that 15-keto prostaglandin and 13, 14-dihydro
prostaglandin E^ may respectively be the most selective
agonists ( R.L. Jones, personal communication ). The
relative non-selectivity of certain prostaglandin receptors
is exemplified by the responses of isolated gastro-intestinal
longitudinal smooth muscle preparations which contract to
both E and prostaglandins. This could be due to the
presence of two distinct systems both of which activate
the contractile response? however, this would appear not to
be the case (R.L. Jones, personal communication ). This
problem would obviously be resolved by a combination of
totally selective E and prostaglandins agonists and
antagonists.
The central nervous system has been shown to
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produce or contain biologically active prostaglandin-like
substances ( Horton and Main, 1967; Ramwell and Shaw, 1966;
Bradley, Samuels and Shaw, 1969 ). Similarly, a variety of
prostaglandins have been found to have marked pharmacological
actions on the central nervous system. Prostaglandin E
injected into the lateral ventricle of the unaneasthetised
cat or intravenously into chicks produced prolonged stupour
and sedation ( Horton, 1964 ), whereas prostaglandin F ,
2
has no observable effects in cats but induced an immediate
extension of the limbs and dorsiflexion of the chick ( Horton
and Main, 1965 ). The sedative actions of A series
prostaglandins on the central nervous system of the two
animals is qualitatively very similar ( Jones, 1970 ).
Detailed reviews of the many pharmacological actions
of prostaglandins in the central nervous system have been
published recently ( Horton, 1972; Karim, 1972 ).
The analysis of human semen led to the
identification and isolation of 13 different prostaglandins
( Bercrstrom and Samuelsson, 1962; Samuelsson, 1963; Bygdeman,
1964; Hamberg and Samuelsson, 1965; Bygdeman and Samuelsson,
1966 a; 1966 b; Hamberg and Samuelsson, 1966 ). Recently
the 19-hydroxy derivatives of prostaglandin E e_, F
~L _L
and F^^have also been conclusively identified and 8-iso-19-
prostaglandin F?^tentatively identified ( Taylor and Kelly,
1974; Kelly and Taylor, 1975; Jonsson, Middleditch,
Desidero and Schexnayder, 1975 ). The high concentrations
present were postulated as being important for normal
fertility ( Hawkins and Labrum, 1961; Bygdeman, Fredricsson,
Svanborg and Samuelsson, 1970 ). Seminal prostaglandins
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have been implicated in ejaculation, sperm transport, ovum
transport or retention and uterine activity for a variety
of species ( Horton, 1972; Karim, 1972; Poyser, 1973;
Labhsetwar, 1973; Chang, Hunt and Polge, 1973; Eskin, Sepic,
Azarbol and Slate, 1972; Horton and Main, 1965; Levy and
Linder, 1971 ).
Prostaglandins have been implicated in the ovulatory
mechanism since it is known that non-steroidal anti¬
inflammatory prostaglandin synthetase inhibitors ( Vane,
1971 ) will block ovulation ( Orc*yk and Behrman, 1972;
Armstrong and Grinwich, 1972; Grinwich, Kennedy and
Armstrong, 1972; O'Grady, Caldwell, Auletta and Speroff,
1972 ). The mechanism appears to be related to follicular
rupture and not ovum maturation and thus it was concluded
that the actions of LH on the ovary are independent of
prostaglandins although a modulatory role may be implicated
( Linder, Zor, Bauminger, Tsafriri, Lamprecht, Koch, Antebi
and Schwarts, 1974 ).
Other areas of reproduction where prostaglandin
production and release have been implicated as having a
role are menstruation in women and luteolysis in many
animals. The presence of smooth muscle stimulants in
menstrual fluid was shown by Pickles ( 1957 ) and in the
early 1960's these were identified as several substances
of lipid origin including prostaglandins and F„
( Clitheroe and Pickles, 1961; Clitheroe, 1961; Pickles
and Hall, 1963; Pickles and Ward, 1965; Eglinton, Raphael,
Smith, Hall and Pickles, 1963 ). From the analysis of
human endometrial curettings it would appear that the
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levels of prostaglandins E2 and F2^ remain low in the
proliferative phase prior to ovulation, although
levels may rise slightly in the late proliferative phase.
Following ovulation rise but the PGE levels
remain low and thus the ratio of PGF to PGE produced during
the luteal phase may be important for the menstrual process
(Downie, Poyser and Wunderlich, 1974; Pickles, Hall, Best
and Smith, 1965 ).
In many animal species including guinea-pig, sheep
and cow, pseudo-pregnant rabbit, rat and hamster but not
woman, the presence of the uterus is essential if normal
luteal regression is to occur. It has thus been postulated
that many animal species release a luteolytic hormone
which acts on the ovary to stimulate luteal regression
( Poyser, 1973 )• The release of this hormone by the sheep
in luteolytic concentrations occurs only at the end of
the oestrous cycle ( McCracken, Carlson, Glew, Goding,
Baird, Green and Samuelsson, 1972 ). The evidence to date
sugge ts that in the sheep and guinea-pig prostaglandin
F2^ is the uterine luteolyic hormone ( Bland, Horton and
Poyser, 1971; Poyser, 1971; Blatchley, Donovan, Horton
and Poyser, 1972; Earthy, Bishop and Flack, 1975; Poyser,
1975; McCracken, Baird and Goding, 1971; Thorburn, Cox,
Currie, Restall and Schneider, 1972; Horton, 1972; Poyser,
1974 ).
Prostaglandins have been implicated in the
parturition process of many animals and also women ( Poyser,
1974; Karim, 1972 ). Sharp increases of the prostaglandin
F2 (x present in the uterine venous blood of pregnant <*heep
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were recorded in the final day of gestation ( Thorburn,
Nicol, Bassett, Shutt and Cox, 1972; Liggins, Grieves,
Kendall and Knox, 1972; Challis, Harrison, Heap, Horton
and Poyser, 1972 )• In women, prostaglandins have been
reported to be present in the venous blood during labour
( Karim, 1968 ) or spontaneous abortion ( Karim and Hillier,
1970 )• This evidence, in conjunction with the fact that
prostaglandins are only detectable in the amniotic fluid
during spontaneous labour or abortion {Karim, 1966; Karim
and Devlin, 1967 ) and prostaglandin ^ released during
labour is maximal at the time of peak uterine activity
{ Bruraraer and Craft, 1973; Craft, Scrivener and Dewhurst,
1973 ), would suggest that prostaglandins may have a
functional role in parturition. Certainly indomethacin
and aspirin, known prostaglandin synthetase inhibitors,
will prolong gestation and delay parturition in rats
( Aiken, 1972; Chester, Dukes, Slater and Walpole, 1972 )
and women ( Lewis and Schulroan, 1973 ).
A direct consequence of the many physiological
pharmacological and biochemical actions of prostaglandins
is the requirement for more selective and sensitive
qualitative assay procedures. It was with this background
that I began ray attempt to develop a sensitive radio¬
immunoassay specific for prostaglandin E^ •
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SECTION I




Preparation of prostaglandin E^ solutions for use in
prostaglandin radiommunoassays and metabolism studies
Solid samples of prostaglandin E2 were generously
supplied by Dr. D.R. Maxwell and Dr. K. Crowshaw of May &
Baker Ltd. These were transferred to 50ml pear-shaped
flasks, dissolved in a small volume (5-10 ml) of Analar
methanol and taken to dryness under reduced pressure at
40*c. Analar methanol was used throughout for the stock-
prostaglandin solutions. After desiccation under vacuum
of the residue until a constant weight was obtained, a
calculated volume of methanol was added to give a nominal
-I
concentration for prostaglandin E^ of 10 mg ml . From
this stock solution 2 ml was transferred to another 50 ml
pear shaped flask and the volume adjusted to 20 ml with
methanol. After thorough mixing an aliquot (2(^ul)
was removed and added to 1.98 ml of methanol in a silica
cell of 3 ml volume and 1 cm pathlength. The spectrum
! . -
between 350 nm and 200 nm was recorded against a cell
containing 2.0 ml of analar methanol using a Pye Unicam
SP 800 ultraviolet spectrophotometer equipped with a
SP825 programme controller. The concentration of prosta^
glandin E^ was then calculated by estimation of the
prostaglandin B produced on treatment with freshly
(Molar)
prepared methanolic potassium hydroxide (Andersen
1969). To each cell in rapid succession 0.2 ml of Molar
KOH was added and the contents thoroughly mixed with a
battery operated electrical Teflon stirring rod. A
spectra was recorded immediately after the mixing and
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then a plot of the abaorbance at a fixed wavelength of
273 nra ( M«O0 max) prostaglandin B ■ 278 nm ) against
time was obtained. After approximately 25 minutes, the
plot plateaued and following a further 5 minute incubation
the spectra between 350 nm and 200 nm was recorded. At
this time the maximum conversion of prostaglandin Eto
prostaglandin B2 (■& 99.8% ) was complete. The
concentration of prostaglandin B2 was then calculated as
follows s
OD278 for 10/*** 1111 ^ prostaglandin B2 81 0.81 (in
methanol)
But prostaglandin B2 present in 2,2 ml MeOH
» prostaglandin E2 in 20 yul MeOH » X yug.
wh,ere X = OD278 X 10 X 2,2
0.81
Therefore prostaglandin E2 present in 1 ml of
diluted stock solution = X x lOOOyug
20
Samples of ^H-labelled prostaglandin E2 ( 1 to 5
mCi 5,6,8,11,12,14, 15-^h PGE2 sP» Ac 145-167 Ci m mole-1.
Radiochemical Centre, Amersham, England) were transferred
to 50 ml pear-shaped flasks, taken to dryness under reduced
pressure at 40'c and desiccated at room temperature under
vacuum until dry. The residue was then dissolved in
10-20 ml of methanol and an aliquot ( 5-20 jil ) was
mixed with 10-20jxq of the diluted ( cold ) prostaglandin
E2 solution in an Eppendorf tube. This mixture was then
subjected to thin layer chromatography on neutral silica
gel ( 50 mm x 200 mm x 0.25 mm; E. Merck A.G. ) on glass.
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Marker standards containing approximately 10 to 20 yug
each of cold prostaglandins E and A_ ( or B, ) were
w fr mm
spotted on the plate at the side of the sample being
chromatographed. The plates were then developed in
either the FVI ( Andersen 1969 ) or the GCM ( Miller
described
1974 ) solvent systems y^ The plates were developed
until the solvent was approximately 2 cm from the top of
the plate after which the plates were dried under a stream
of air until no scent of solvent residue was detected.
The radioactive containing plates were then automatically
scanned using a Panax radio thin layer chromatographic
plate scanner. Prom the resulting scans it was possible
to determine whether the 3H~labelled prostaglandin E2
required purification before use. The remaining
prostaglandins were then detected by spraying the plates
with a saturated solution of phosphomolybdic acid in
ethanol and heating at 115'c for 15-20 minutes. This
method of detection produced green/blue spots on a yellow
background.
Purification of 3H-labelled prostaglandin E„
The high specific activity 3h labelled prosta¬
glandin was found to undergo radiochemical breakdown
even when stored as a methanol solution at -20*c ( as
determined by radiochemical purity of thin layer chroraa-
tographyj. Consequently it was desirable to check the
radiochemical purity at frequent intervals 1 month ).
This decay did not always result in material being
produced that co-chromatographed ( on t.l.c ) with
authentic prostaglandin ( or B2 ). In certain cases
»_ 1 ..
has been reduced by the addition of cold prostaglandin E
mm
and this has been found to prolong the stability of the
radio-actively labelled prostaglandin E2»
When a batch of the 3h-labelled prostaglandin E2
has been found to be contaminated it has usually been
purified by reversed phase partition chromatography (R.P.P.C)
on Sephadex LH-20. An example of this is shown in figure If. .
In this example a glass column ( 300 x 10 mm ) was packed
with graded Sephadex LH-20 ( SO + 5yuM diameter particle
size ) previously equilibrated in the solvent mixture
( methanol - water - chloroform butanol - acetic acid 50:
5025:5:0.1 by vol. ) and allowed to flow at a constant
pressure head overnight prior to use. The column bed
volume was 20 ml. the flow rate 7-8 ml hr™5 and the room
temperature 23+ l'c. The sample of 3H PGE2 ( 1.5 ra Ci^
3.5yug ) was applied to the column in 0.5 ml of eluting
solvent ( + 2 x 0.2 ml washings ) and fractions of 2.0 ml
collected on an LKB Ultrorac fraction collector. From
each fraction 5yul was removed and estimated for radio¬
activity by liquid scintillation counting. This enabled
the elution profile to be plotted and the fractions
corresponding with authentic prostaglandin to be determined.
These fractions were then pooled in a 100 ml pear-shaped
flask, taken to dryness under reduced pressure at 40*c and
redissolved in 10 ml of methanol. This material was then
subjected to t.l.c. using the G.C.M. solvent ( Miller 1974 )
and found to be greater than 99% pure.
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Figure-4. The purification by reversed phase gel
partition chromatography on graded Sephadex
LH-20 (50 £ 5 uM particle size) of




Preparation of prostaglandin - bovin ; serum conjugate
All glassware was thoroughly washed with methanol
and distilled water before being dried.
Into a 3 dram capped vial ( 5 ml vol ) 6.762 mg
of prostaglandin E2 and 55400 dpm of 3H-labelled prostaglandin
( Sp. Ac. 167 Ci ra .mole"*". Ameraham ) was pipetted
( methanol solutions? total vol. 1.0 ml )• The methanol
was evaporated under a stream of dry air and the dry residue
redissolved in 0.5 ml of redistilled l,4-dioxane. This
solution was cooled by partially immersing the vial in a
petri dish containing an ice-water mixture and continually
stirring with the aid of a magnetic stirrer. To the vial
tri-n-butylamine ( 10yul ) was added and after 5 minutes
iso-butylchloroformate ( 2.5yal ). The reaction was left
for 30 minutes and then the reaction mixture was added to
another capped 3 dram vial containing a cool solution of
British bovine serum albumin { 22.41 mg ), NaOH (23yil? IN)
and distilled water ( 0.6 ml ). The original reaction vial
was rinsed with 1,4 dioxane( 0.6 ml ) and the contents
added to the second vial. The resulting reaction mixture
was kept cool and thoroughly mixed ( magnetic stirrer) for
a further 4 hours.
The volume of the reaction mixture was then measured
( 1.6 ml ) and 10ji1 was transferred to a cellophane dialysis
bag containing 5 ml distilled water. This was then sealed
with double knots and dialysed for 48 hours against 250 ml
of distilled water in a measuring cylinder. The bag was
agitated with a fine stream of nitrogen bubbles to ensure
maximum efficiency of the dialysis system. The residual
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reaction mixture was placed in another dialysis bag and
dialysed for 48 hours against running tap water (25-50
litres hr""1 ) .
After 48 hours the dialysis bag containing 10yul
of the reaction mixture was washed externally into a beaker
and pooled with the contents of the measuring cylinder.
The pooled contents were then acidified to pH 5.0 with lO%
aqueous acetic acid and extracted twice with an equal volume
of redistilled ethyl acetate. The pooled ethyl acetate was
washed twice with 20 ml of distilled water then taken to
dryness under reduced pressure at 40*c and vacuum desiccated
at room temperature. The residue was redissolved in 5.0 ml
of methanol and 2.0 ml transferred to a silica cell of 3 ml
volume and 1 cm pathlength. The spectrum between 350 nm and
200 nm was recorded against a cell containing 2.0 ml of
methanol using a Pye Unicam SP800 ultraviolet spectrophoto¬
meter equipped with a SP825 programme controller. The
residual 3 .0 ml of methanol was reduced t?o, a volume of 0.2
ml
. at reduced pressure and applied as a thin band ( 0.2
mm x 20 ram ) 3 cm from the base of a neutral silica gel
thin layer chromatography plate { 50 mm x 200 mm x 0.1 mm
on glass ) . The plate was then developed to a height of
16 cm in the AI solvent system of Green and Samuelsson
( 1965 ) ( benzene? 1,4-dioxane? glacial acetic acid,
20:20:1 by vol. ). Marker prostaglandins E and A ( 10
^ug each ) were applied at the side of this methanol residue.
After development the plate was scanned for radioactivity
using a Panax radio thin layer chromatographic plate scanner.
The plate was then sprayed with a solution of 10%
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phosphomolybdic acid in ethanol and heaced at 110 *C for
IS minutes. The spots that developed were outlined in
pencil.
The contents of the dialysis bag containing the
majority of the reaction mixture after 43 hours was
transferred to polypropylene centrifuge tubes and then
centrifuged at 5000 x g ( at 4'c ) for 20 minutes. The
supernatant was carefully transferred to a 250 ml round
bottomed flask and frozen by external application of dry
ice ( solid C02 )-acetone mixture. The frozen contents
were then lyophilised overnight under vacuum.
The dry contents were carefully transferred to an
8 dram vial of known weight for the estimation of the
recovered P<3E2-bsa conjugate.
Three scintillation vials containing 10 ml of a
toluene scintillant mixture ( toluene, ethoxyethanol,
2#5-diphenyloxazole (PPO), 1,4-di-(2-(4-methyl-5~
phenyloxazolyl ))-benzene ( dimethyl POPOP ) (2000? 400?
8.52; 0.22 v/v/w/w )), 2 ml of Nuclear Chicago Solubiliser
and 0.2 ml of distilled water were prepared. To one vial
780 jxg and another 529^ug of the PGE2~bsa conjugate was
added and the contents thoroughly solubilised and mixed.
The vials were then counted several times on a Nuclear
Chicago Mark ZI scintillation counter and the d.p.m.
computed on a Pop 8 I digital computer by the external
standard channels ratio method.
The number of prostaglandin E2 molecules conjugated
per molecule of bovine serum albumin was then calculated as
follows ;
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i) Assume molecular weight of British BSA =»
66,500
ii) 780 yug and 590 jxq of conjugate contained 894
dpm and 582 dpm respectively.
iii) 6.762 mg of pGE2 contained 55,4oo dpm .*. amount
of pge2 ^5°und in o.78 mg of conjugate
™ 894 x 6.762 mg
55,400
= 0.10911963 mg
• • amount of BSA conjugated with O.10911963 mg of PGE^
- o.78-0.10911963
« 0.6708804 mg
• . 1 mg of BSA is conjugated with 0.1Q911963
0.6708804
« 0.1626514 mg of PGE2
• • 66,500 g ( 1 mole ) of BSA is conjugated with 10816.318 g
Of PGE
2
But molecular weight of PGE2 o 352




By analogy with the d.p.m. value obtained from 590 jxg of
the PGE2~bsa conjugate it can be calculated that 1 mole of
BSA is conjugated with 25.86 moles of PGE2.
• • on average 28.30 moles of PGE^ are conjugated per mole
of BSA
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Preparation of PGE^-BSA conjugate for use in immunisation
procedures
Samples of the PGE^-BSA conjugate ( 3-4 mg ) were
weighed, transferred to glass bottles ( 25 ml ) and
dissolved in sterile isotonic saline (6-8 ml; 0,9% w/v ).
An equal volume of Freund's complete adjuvant was added
and the resulting suspension thoroughly mixed with a Polytron
homogeniser at maximum speed for 3O-60 seconds to produce
a water-in-oil mixture.
For 'booster samples' of the PGE^-BSA conjugate the same
procedure was employed with the exception that Freund's
incomplete was substituded as the emulsifying agent.
Immunisation procedures
a) Multiple intradermal
The method of Vaitukaitis, Robbins, Nieschlag and
Ross (1971) was used. Six female New Zealand white rabbits
( 1.8-2.4 kg ) were shaved along the back and given 25-40
injections intradermally ( total volume 2 ml ) of the
Freund's emulsified PGE^-BSA conjugate. The rabbits were
caged and fed water and food ad libid^m .
b) Intranodal
The method of Boyd and Peart ( 1968 ) was used.
Six female New Zealand white rabbits ( 2.1-2.6 kg ) were
shaved along the back of each hind limb and subcutaneously
injected with lignocaine until pain responses could not be
elicited. The popliteal lymph nodes of each leg were exposed
under sterile conditions and injected with 100-200^il of the
PGE^-BSA emulsion. The lymph nodes from two further rabbits
were removed for histological examination. After the wounds
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had been stitched, each rabbit was injected intra¬
muscularly with benzyl-penicillin ( 5 rag/kg ) .
Preparation of anti-sera for evaluation
At four weekly intervals after the primary
immunisation procedure the rabbets were bled from the
shin covering hit
marginal ear vein. The^ear vein was shaved, coated in a
fine film of petroleum jelly and an incision made
approximately half-way between the tip and base of the ear.
Blood was collected in SO ml glass tubes and the flow
enhanced by covering the remaining area of the ear with
xylene. After collection of 25-50 ml of blood during a
15-30 minute period the blood containers were sealed with
parafilm and stored at 4*c for a minimum of 16 hours to
enable the clotting process to occur.
The resulting serum ( anti-serum ) was transferred
to 35 ml test tubes and centrifuged at 25GO x g ( at 4*c )
for 20 minutes to remove traces of the blood clot. The
resulting supernatant was transferred to clean 35 ml tubes
and heated at 55*c for 30 minutes to ensure maximum de-
complimentat ion had occurred. The resulting antisera was
then treated with aqueous sodium azide ( 10 mg/ml ) ( 100
i10 ml antisera ) and stored in 2-5 ml aliquots at -20*c.
Buffers and solutions
a) Diluent
Tris-HCl buffer ( 50 mM, pH8 ) containing gelatin
( 100 mg/1 ) was used as the standard buffer for radio¬
immunoassay incubations unless otherwise specified.
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b) Normal rabbit serum (NRS)
Female New Zealand white rabbits were bled from
the marginal ear vein and the serum harvested as described
for the immunised rabbits. The serum was diluted with
the diluent to a concentration of 1% (v/v) unless otherwise
stated.
c) Donkey anti-rabbit gamma globulin serum (PARS)
This was supplied by Dr. W. Hunter of the MRC
Radioimmunoassay Unit, Edinburgh. The DARS was diluted
with the diluent buffer to 20% (v/v) unless otherwise stated.
Liquid Scintillation Counting and Analysis of Results
Liquid scintillation counting was performed with a Mark II
Nuclear Chicago liquid scintillation counter.
Individual radioimmunoassay samples (600yul) were
counted in 14 ml of a toluene, ethoxyethanol based
scintillant mixture. ( toluene-ethoxyethanol 1500? 900
v/v napthalene; 2,5-diphenloxazole (PPO) and 1,4-di-
(2-(4-methyl-5-phenyloxazolyl ))-benzene (dimethyl POPOP )
112.5; 10.5;0.9 by weight ). Quench-calibration curves
constructed for the scintillant mixture and the automatic
external standard channels ratio method were used to
convert c.p.ra. into d.p.m. A PDP8I computer was used for these
calculations.
Each batch of radioimmunoassay samples were counted
in the following sequence s
Vial No. 1 - Background ( scintillant and 600^il
diluent )
2 -)Counting standards ( scintillant +
)
3 -) 600 ul of diluent containing
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3H labelled PGE2 only)
4)
5)
6+ - Samples. (scintillant + 600 jal
sample)
Th« values for d.p.m. were then used to calculate
the percentage of the -label bound to the antieera in
each sample by the following calculations ;
Average d.p.m. added « 2+3*4+5-1 * X
4
d.p.m. in sample » y
% bound « lOO - x 100
The effect of diluting the anti-sera on the binding of
either 3H~labeiled PGE^, PGA^ or PGB^
An initial dilution of the antiserum ( )
100
produced by each rabbit was prepared and 1 ml added to a
glass tube containing 1 ml of diluent. The sample was
vortexed to give 2 ml of a 1 dilution of the anfcisera.
200
From this sample 1 ml was transferred to another tube
containing 1 ml of diluent and vortexed. This dilution
procedure was used to produce tubes containing 1 ml of
diluted antisera at the following dilutions i 1»200;
400r 800; 1600; 3200; 6400 and 12800. in addition 8 tubes
containing 1 mi of diluent only were prepared.
To each tube 50yul of 3a p«E2 ( 400,000 d.p.m.
, ~i -1*al 8 p .Ac 167 Ci m mole ) was added and the samples
vortexed. Four of the tubes containing diluent only
were then sealed with parafilm ( counting standards ).
After incubating the samples at room temperature for 1 hour
45
50yul of NRS (1:100) was added to the four remaining
tubes containing diluent only and the sample tubes
containing dilutions of 1:3200 or greater. After a
further incubation of 10 minutes at room temperature 50
jil of diluted DARS (1:5) was added to all tubes
containing a dilution of 1:1600 or greater and two of
the blank tubes. To the remaining tubes 100jxl of the
diluted DARS was added. The samples were thoroughly
mixed and after an overnight incubation at 4*c# centrifuged
at 20Q0 x g for 30 minutes. From the supernatant 60O^al
was transferred to 14 ml of toluene scintillation
mixture for liquid scintillation counting.
This experiment was also repeated for 3h PGA2
and 3h PGB2.
3
Factors influencing the binding of H to antisera
Dilution curves for antisera obtained from two
rabbits ( nos. 25 and 26 ) were set up as described above.
In each dilution curve the incubation time with NRS and












b) Concentration of NRS and PARS
Dilution curves were set up with incubation
times for NRS and DARS of 10 minutes and 16 hours
respectively. The initial concentration of NRS and










Preparation and purification of 3h-labelled PGF^jgfree acid
Approximately 5m Ci 3H-labelled PGE2 ( 167 Ci
m mole-1 ) was taken to dryness under reduced pressure in
a 50 ml pear-shaped flask. The vacuum dried residue was
redissolved in 1.0 ml of analar methanol and cooled to
-10*c with an ice/acetone mixture. A small aliquot of
sodium borohydride was added and the reaction vessel
stoppered. After 60 minutes at 0 to 10*c the reaction
mixture was diluted to approximately 50 ml with distilled
water, acidified to pH4 with 10% aqueous acetic acid and
extracted twice with an equal volume of diethyl ether.
The pooled ether fractions were washed twice with 20 ml
of distilled water and then taken to dryness under reduced
pressure. The residue was vacuum desiccated and re-
dissolved in 0.5 ml of a mixture containing methanol.
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water, chloroform, butanol, glacial acetic acid ( 40? 60;
4x 6* 0.1 by vol. ) This was applied to a column { 35
ml bed volume ) of Lipidex lOOO and eluted with the solvent
mixture at a flow rate of 6-8 ml hr~\ Fractions { 2.5 ml )
were collected in glass test tubes on an LKB Ultrorac
fraction collecter and aliguots (10yul ) from alternate
fractions assayed for radioactivity by liquid scintillation
counting. From the elution profile it was possible to
pool several fractions containing prostaglandins F ^and
f2y3respectively. These were found to be greater than
98% pure with respect to each other when subjected to
thin layer chromatography in the F VI solvent system
( Andersen 1969 ).
3
Preparation and purification of H-labelled PG£^^methyl
ester
Approximately 500jiQi. of the purified ^H-labelled
FGF2^free acid was dissolved in 0.5 ml of methanol and
treated with excess freshly prepared diazomethane for 10
minutes at room temperature. The sample was then taken
to dryness under reduced pressure and vacuum desiccated
before being redissolved in 150yul of redistilled
chloroform. This was then made up to 500^Jtl with n-heptane
and applied to a column of Lipidex 5000 ( 30 ml bed volume )
previously equilibrated in this solvent. The column was
eluted at 6-8 ml hr~^ and fractions of 3 ml were collected
on an LKB Ultrorac fraction collecter. The elution profile
of the column was determined by assaying alternate fractions
( 10yul aliquots ) for radioactivity by liquid scintillation
3
counting. The fractions containing the H-labelled PGF «,
7
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were pooled, taken to dryness under reduced pressure and
vacuum desiccated. The residue was dissolved in 5.0 ml
of methanol and approximately 0.5 ^tCi wag applied to a
thin layer chromatography plate. Marker standards of
PGF2 0<and I>G£'2^8me"thy1 esters(0.5 yuCi each ) were applied
at the side of the sample and the plate was then developed
in the FVI solvent system. After development the plate
was scanned for radioactivity on a Panax thin layer
chromatography plate scanner. The resulting scans revealed
the purified 3H~labelled PGFj ^nethyl esters to be greater
than 99% radiochemically pure.
Preparation and purification of PGF^^m® ester
Prostaglandin F2o<^ ^ m9 ) dissolved in methanol
( 1.0 ml ) was converted to methyl ester by treatment with
excess ethereal diazomethane as described on page 6
The sample was then taken to dryness, vacuum desiccated
and purified by straight phase gel partition chromatography
on Lipidex 5000. The column ( 30 ml bed volume ) used was
equilibrated in an n-heptane-chloroform mixture ( 70s30
v/v ) and fractions of 3.0 ml were collected. Aliquots
( 30 yal ) from alternate fractions were ( starting at
fraction 20 ) taken to dryness and redissolved in an equal
volume of BSTFA. These were heated at 60'c for 15 minutes
and then 5 yul aliquots were subjected to gas chromatography
on a Pye Unicam Series 104 gas chromatograph. The
instrument was equipped with a glass column ( 1.5 x 2mm
i.d ), packed with 3% 07-1 on Supelcoport. The carrier
gas { nitrogen ) flow rate was 25-30 mlmin""3, and the oven
temperature 195*c. The fractions containing the PGF2(^
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methyl ester were pooled, taken to dryness and vacuum
desiccated. The residue was redissolved in lO ml and
the concentration of PGF2^me ester present calculated
by gas chromatography with PGF -me ester as an internal
standard. r
Preparation and purification of 15(s)PGF^<y ; 15(s)PGF]L^r
15 (R) PGF^ PCand 15(R)PGF2
Samples ( 1 mg ) of 15(S)PGE^ and 15(R)PGE2 were
transferred in methanol to 25 ml pear-shaped flasks. These
were then cooled to -10*c with ice-acetone mixture after
which solid sodium borohydride ( Ca lOOmg ) was added to
each sample. The samples were incubated at this temperature
for 60 minutes and then distilled water ( 50 ml ) was added
to each followed by glacial acetic acid until pH4 was reached.
The samples were then extracted twice with an equal volume
of ethyl acetate. The pooled ethyl acetate was washed
twice with 10 ml of distilled water, taken to dryness and
vacuum desiccated. The samples were then dissolved in
0.5 ml methanol and converted to methyl esters by treatment
with ethereal diazomethane as described on page 61 . The
individual samples were subjected to straight phase gel
partition chromatography as described on page 47 to
yield the pure epimers.
Preparation of PGF^ft -BSA conjugatef
The method described on page 37 was employed.
Pure PGF2^( 10.5 mg ) was conjugated with British Bovine
Serum Albumin ( BSA ) ( 17 mg ) to yield 17 mg of the PGF^g
BSA conjugate that was calculated to have an average
composition of 32 PGF molecules per molecule of BSA.
T
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In an identical procedure 50 mg of PGF2gWas conjugated
conjugate/
with 90 rag of BSA and the resulting^was found to have a
composition of 29 PGF^^molecules per molecule of BSA.
Immunisation procedures
a) Multiple intradermal
Twelve female New Zealand White rabbits ( 2.2-
2.9 kg ) were immunised by the method of Vaitukaitis,
Bobbins, Nieschlag and Ross (1971) as described on page , .
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b) Intramuscular
The above twelve rabbits were given booster
injections of the PGF BSA conjugate starting approximately
r
four months after the initial immunisation procedure.
The PGF _ - BSA conjugate was prepared as a water in oil
emulsion as described previously with the exception being
that incomplete Freund's adjuvant was substituted as the
emulsifying agent. The rabbits were injected { intra¬
muscularly ) with 0.5 ml at each shoulder and upper thigh
region. The booster procedure was repeated at six-weekly
intervals.
Preparation of anti-sera for evaluation
The details of this method are described on page , .
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Blood samples were collected at four -weekly intervals after
the primary immunisation procedure. Following booster
immunisation procedures the rabbits were bled one week after
each booster immunisation. In all cases the blood was
collected from the marginal ear vein, allowed to clot at
4*c and the anti-serum withdrawn. After centrifugation to
remove blood clot fragments the anti-sera were
decorapleraentated by heating at 55*c for 30 minutes and then
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treated with sodium azide ( 10 mg ml • 100 ul i 10 ml
anti-sera ) before being stored at -20*c in 2-5 ml aliquots
Buffers and solutions
The diluent ( tris-HCl buffer 50 nM pH8 ), normal
rabbit serum and donkey anti-rabbit serum are as described
on page 42 • Stock prostaglandin solutions were prepared
from methanol solutions containing known amounts of the
given prostaglandin. Aliquots of the methanol solutions
were taken to dryness under a stream of dry air and then
redissolved in a calculated volume of diluent to give the
required concentration of prostaglandin. From these stock
solutions the desired dilutions of the prostaglandins could
be made by mixing known volumes of stock solutions with
calculated volumes of diluent. All samples were stored at
-20*c and thawed immediately before use.
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Liquid Scintillation Counting and the Analysis of Results
The liquid scintillation counting was performed
with a Mark II Nuclear Chicago liquid scintillation counter
using the scintillant described previously on page 43 .
Aliquots ( 6OO yal ) of individual samples were counted
and the automatic external channels ratio method was used
to convert c.p.m. to d.p.m. A PDP 8 I computer was used
for these calculations and the conversion of d.p.m. into
% of ^H-label bound as described on page 43
3
The effect of dilution on the binding of either H-labelled
3
free acid or H-labelled PGF^ygmethyl ester to
f-
the
PGF2 H - BSA anti-sera
Sequential dilutions of anti-sera ( 1:200 -
1:12,800 ) were prepared as described on pa^s 44
In addition 8 tubes containing 1 ml of diluent only were
prepared.
To each tube 50 yul of the required ligand jh PGF„^j
( 400,000 d.p.m. ml-"'" in diluent. Approximate Sp.Ac. 167
Ci m mole ^ ) was added and the samples vortexed. Four of
the tubes containing diluent only were then sealed with
parafilm ( counting standards ). After a 60 minute
incubation at room temperature, 50 yul of NRS (1:100) was
added to the four remaining tubes containing diluent only
and the anti-sera samples of 1:3200 dilution or greater.
After a further incubation of 10 minutes at room temperature
50 yul of DARS (1:5) was added to all tubes containing a
dilution of 1:1600 or greater and to two of the blank
tubes. To the remaining tubes lOOyul or greater of the
diluted DARS was added. The samples were thoroughly mixed
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and after an overnight incubation at 4*C, centrifuged
at 2000 x g for 30 minutes. From the supernatant 600yul
was transferred to 14 ml of toluene scintillation mixture
for liquid scintillation counting.
For certain batches of anti-sera, particularly
those harvested after booster immunisation procedures, the
range of dilutions was extended to include 1:25,600,
1:51,200, 1:102,400. In all but the first batch of anti-
sera harvested ^H-labelled PGF^^methyl ester was used as
the radioactive ligand.
Factors influencing the standard curves for prostaglandin
methyl ester
From the dilution curves described on page ^ it
was possible to ascertain the approximate final dilution of
antiserum which gave 60%-70% binding of the -labelled
prostaglandin F^^ methyl ester. A fresh batch of this
antiserum was then diluted to l/24th of this value such
that when 50^ul was added to the following reaction vessels,
the final dilution was the same as that previously giving
60^-70% binding. Duplicate tubes containing prostaglandin
F^^methyl ester ( in 1.0 ml of diluent buffer ) at the
following amounts (pico-grams added ): 0 (zero standards),
10,30,50,70,150,310,630,1270 and 2550 were prepared. In
addition eight blank tubes containing 1.0 ml of diluent
3
buffer only were prepared. To each tube 50yil of H-
labelled prostaglandin F2^ methyl ester was added (Spec.
Act. 167 Ci m Mole""'**; 400pg ml"'*'), and the tubes vortexed
and equilibrated at room temperature for ten minutes.
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Four of the blank tubes were then sealed. Then 50yil of the
diluted anti-sera was added to all the tubes ( except the
four remaining blanks ) and the samples vortexed and
equilibrated at room temperature for a further 60 minutes.
Then 50yul of diluted normal rabbit serum (NRS) at Is100
dilution was added to all the tubes ( except the four
sealed blank tubes ) which were vortexed. Following a
further incubation of 10 minutes at room temperature, 50
yul of diluted donkey anti-rabbit gamma globulin serum
(DARS) at 1:5 was added and the samples were then assayed
by the liquid scintillation method described on page 43 -
For each anti-serum tested this was repeated with
the NRS and DARS concentration ranges described on page 45 &, 46.
but with the range of added prostaglandin Fmethyl ester
being limited to O, 10, 30, 50 and 70 pico-grams.
Anti-serum specificity studies
Prostaglandins F^^. ll-deoxy-F2^; 9,15-
dihydroxy-10, 13-trans-prostadienoic acid ( 9-hydroxy
PGA2 ) and B2 methyl esters were supplied by Dr. R.L.Jones,
who had previously prepared and purified them from authentic
prostaglandins supplied by the Upjohn Company, Kalamazoo.
Prostaglandins 15(R)F2^and 15(R)F2"j&methyl
esters were prepared and purified as described on page 49 .
Where an anti-serum was capable of binding 60% of
the added H-labelled prostaglandin F2 ^methyl ester at a
final dilution of 1:3000 or greater, the anti-serum was
further characterised for its ability to discriminate
between prostaglandin ?2^ ester and the above
prostaglandins. In all cases a standard curve for
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prostaglandin F0 -methyl ester over the range of 0, 10,
2r
30, 50, 70, 150, 310, 630, 1270 and 2550 pico-grams was
prepared as described on page 55 for each comparison.
For prostaglandin methyl ester the range of added
prostaglandin was identical. For all other prostaglandins
the range was : 0.2; 0.8; 3.2; 12.8; 51.2; 204.8; and
820 nanograms of added prostaglandin.
The samples were analysed as described on page 43 •
Factors influencing the reduction of prostaglandin to
prostaglandin F^ by sodium borohvdride
High specific activity 3H-labelled prostaglandin
l-2 ( 5,6,3,11,12,14,15-3H-PG£2; 167 Ci m mole"1 ) was
diluted with a methanol solution of prostaglandin E such
that 0.2 ml contained approximately 0.5yn Ci ( 10 ng )•
Into twelve clean stoppered test tubes 0.2 ml of this
an
solution was pipetted and the tubes cooled with anoi
solution. Identical tubes containing only 0.5Ci ( 1.0
ng ) of the high specific activity 3H-labeIled PGE2 were
also prepared. To each tube 0.2 ml of a methanol suspension
of sodium borohydride ( Ca, 20 mg ml-1 ) was added, the
contents mixed and incubated for 30, 60 or 120 minutes
(quadruplicates)• The reaction products were diluted with
2 ml of distilled water and 10-15 drops of 6H HC1 were
added. The contents were than extracted twice with 4 ml
of redistilled ethyl acetate and the pooled organic phases
washed with 1.0 ml of distilled water. The ethyl acetate
was taken to dryness and the residue applied as a narrow
band 2 cm from the base of a thin-layer chromatography plate
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( 200 mm x 200 mm x 0.25 mm on glass )• Marker standards
3of H-labelled prostaglandins and were
spotted on the side of each plate. The plate was then
developed to a height of 16-18 cm in the FVI solvent
system of Andersen ( 1969 ). This solvent is composed of
ethyl acetate-acetone-glacial acetic acid ( 90s 10s 1 by
volume )• The plates were then dried under a stream of
cold air and re-developed in the G.C.M. solvent of Millar
( 1974 ). This solvent is composed of ethyl acetate-methanol-
glacial acetic acid ( 100s10si by volume ). After the
plates had again been dried under a stream of cold air,
they were scanned for radioactivity using a Panax radio
thin-layer chromatographic plate scanner. Prom the
resulting scans, zones corresponding with peaks of radio¬
activity were scraped from the plates into test tubes
containing 5 ml of methanol. The contents were vortexed
and centrifuged at maximum speed on a bench centrifuge for
5-10 minutes. The supernatants were removed and fresh
methanol added to the compacted silica gel. After re-
extraction as described above the supernatants for each
tube were pooled, taken to dryness under reduced pressure
( at 40#c ) and vacuum desiccated at room temperature.
The residue from each zone was re-dissolved in 1.0 ml of
methanol and 4 X 50j\l aliquots were assayed for radio¬
activity by liquid scintillation counting. The samples
were counted in 5 ml of the toluene-ethoxyethanol based
scintillant mixture described on page . , .
h.2
In an identical experiment, 10 ng samples (n«4
for each time period ) of prostaglandin E? were treated
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with methanolic sodium borohydride as described above.
Prior to extraction 250 ng of 3,3' ,4,4"-tetra-deutero
prostaglandin F^^was added to each sample. The samples
were extracted as described above and then converted to the
methyl ester, trimethylsilyl ether derivative by the method
described on page ^ . These derivatised samples were
then subjected to multiple ion detection gas chromatography-
raass spectrometry. The instrument used, a Finnigan 3000D
mass spectrometer was interfaced with a Finnigan 9500 gas
chromatograph equipped with a glass column ( 1.5 m x 2 mm
i.d. ) packed with 3% OV-1 on Supelcoport. The oven
temperature was 220*c and the carrier gas ( helium ) flow
rate was 25-35 ml min"^. The ions monitored were at M-
( 90+-71 ) and at M-( ( 2x90 ) + 71 ) for both the protium
and deuterium forms. For protium prostaglandins F -.and
2
f^^these ions were at 333 and 423 whilst they were at 337
and 427 respectively for the deuterium prostaglandin F20< *
The instrument was calibrated for the protium forms of
prostaglandins F^ and the range of 0-60 ng and
for deuterium F^^loo ng (constant) per injection. Samples
were dissolved in 50yul of BSTFA and 5A1 aliquots were
injected. Triplicate determinations were made for each
sample.
The metabolism of prostaglandin E- by rabbit and sheep
blood and rabbit popliteal lymph node
A female New Zealand white rabbit was bled from the
marginal ear vein as described on page ^ into a tube
containing 3.0 ml of citrate anti-coagulant (sodium citrate
2.2 g; citric acid monohydrate, 0.8 g; dextrose, 2.45 g in
100 ml of distilled water ) until the total volume collected
was 20 ml. Fresh sheep blood { 850 ml ) was collected
into polythene bottles containing citrate anti-coagulant
(150 ml) and the contents thoroughly mixed.
Two female New Zealand white rabbits were killed
by a blow to the neck followed by exsanguination from the
throat. The popliteal lymph nodes were located at the
back of each knee joint and removed. These were pooled and
homogenised in 20 ml of 100 mM sodium phosphate buffer
( NaH.P0A# 2.7 gr Na_HP0A# 12.54 g; in 1 litre distilled
waterusing a Polytron horaogeniser at maximum speed.
The resulting horaogenate and 10 ml aliquots of rabbit and
sheep blood were incubated with 3H~labelled prostaglandin
E2 (1.0 yuCi t 10 ng ) for 75 minutes at 37 "C in a water
bath ( with agitation )• The resulting products were
diluted with 100 ml of distilled water and acidified to
pH4 with lO/o glacial acetic acid. These were then
extracted twice with 2 volumes of re-distilled ethyl acetate.
The pooled organic phases were twice washed with 25 ml of
distilled water before being taken to dryness under reduced
pressure at 40*c and vacuum desiccated. The residues
were re-dissolved in 25-50 ml of freshly prepared 67%
aqueous ethanol and twice partitioned with an equal volume
of heavy petroleum ( 60*- 80"bp )• The aqueous phase was
taken to dryness and vacuum desiccated. The products were
then separated by thin-layer chromatography. The plates
used were freshly prepared from a slurry of Kieselgel G
( 45 g s 80 ml distilled water ) spread to an even thickness
of 0.25 mm on glass plates ( 50 mm x 200 mm ) previously
59
cleaned with chloroform. Prior to use the plates were
activated by heating at 110*-115*0 in an oven for 20-30
minutes. The samples and authentic H-labelled
prostaglandins and A^ were applied as narrow bands
approximately 3.0 cm from the base of the plates. The
plates were developed with the organic phase of the A VII
solvent system ( Bygdeman and Samuelsson, 1966 ). This
solvent system was prepared the day prior to use in
stoppered separating funnels and is composed of watery
ethyl acetate; 2,2,4-trimethyl pentane; glacial acetic
acid ( 100:110:30*20 by volume )• The plates were developed
to a height of 15-16 cm in closed equilibrated glass tanks
lined with Whatman No. 1 filter paper. After development
the plates were dried and scanned for radioactivity using
a Panax radio thin-layer chromatographic plate scanner.
A comparison of the thin layer development obtained for
sheep blood extracts bv different solvent systems
3
Three samples of blood were incubated with h-
labelled PGE2 an<* extracted as described above. The
products were subjected to thin-layer chromatography on
prepared neutral silica gel thin layer plates ( 50 mm x
200 mm x 0.25 mm on glass. Merck ). Three groups of
developing solvents were compared :
Group I - First and Second development G.C.M. solvent
(page 84 )
Group II - First and Second development FVI solvent
(page 84 )
Group III - First development FVI; Second development G.C.M.
solvent.
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The plates were scanned for radioactivity using a Panax
radio thin layer plate scanner.
Confirmation that the metabolism of prostaglandin by
sheep whole blood is not artifactual
A sample ( 50 ml ) of freshly collected citrated
sheep whole blood ( page 5q ) was heated at 70*C for 5
minutes in a water bath and cooled to room temperature.
Aliquots ( 10 ml ) of this sample and a sample of the
3
untreated blood were incubated with H-labelled PGE2
( l.Oyu Ci : 10 ng ) as described previously. In addition
lO ml of the untreated blood was incu&ated in the absence
of prostaglandin in parallel with these samples. At
the end of the incubation period 1.0 Ci ( 10 ng ) of
3H-PGE2 was added to the sample and then all three samples
were extracted and subjected to multi-development thin
layer chromatography as described previously. The plates
were then scanned for radioactivity as described
previously•
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Preparation of derivatives for qag-llcmid-chromatographv
i) Methyl and Ethvl esters
Diazomethane was freshly prepared by adding
approximately lg of 'DIAZALD' to 10 ml. of diethyl ether
and 9.5 ml of 95% aquous ethanol. The reaction vessel was
equipped with a 'clear fit' joint to reduce the explosive
nature of diazomethane. The glassware was thoroughly
cleaned with chromic acid and distilled water at regular
intervals to reduce contain!nation. The diazomethane
producing reaction was started by adding 2 ml of KOH
(30 g made up to 50 ml with distilled water ) to the
reaction vessel. The product ( diazomethane ) was
distilled from the reaction vessel by bubbling nitrogen
saturated with diethyl ether through the reaction mixture
and collecting the vapour in a mixture of diethyl ether /
»C€- - ftteftmrtct
methanol ( 13.5 s 1.5 ) chilled with ^ solution.
Diazoethane was prepared in an identical manner by
substituting N-ethy1-N'-nitro-N-nitroaoguanidine for
Diazald.
Esters ( methyl or ethyl ) were then prepared by the
methods of Green (1969) and Thompson, Los and Horton (1970).
The samples to be esterified were transferred in methanol
to Bppendorf polypropylene capped tubes and the volume
carefully reduced ( if necessary ) to approximately 0.1 ml
under a stream of dry air. The residue was then treated
with excess esterifying solution ( eg diazomethane ) and
if excess bubbles ( ) were evolved the volume was again
reduced and fresh esterifyi^* solution added until no
further gaseous evolution occurred. The reaction was then
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vortexed arid left for a maximum of 15 minutes at room
temperature. The samples were then taken to dryness
under dry air and vacuum desiccated until dry.
II) O-alkvl hvdroxvlamines
Pyridine solutions of a variety of oximating
reagents were prepared by dissolving the respective solid
hydroxylamine hydrochloride salt analogue in anhydrous
pyridine ( stored over KOH pellets ) to a final concentration
of 5 mg ml""*. The series of oximating reagents used
included the hydrochloride salts of the following i
a) hydroxylamine ( NH^OH )
b) O-methyl hydroxylamine ( Nil OCH-. )
£» «■?
c) O-ethylhydroxyiamine { NH0OC5 )
d) O-n-propylhydroxvlamine ( NH OC,H_ )
» w f
e) O-iso-propylhydroxylamine ( NH^OCH(CH^)7 )
f) O-n-butylhydroxylamine { NH.oc.H_ )
g) O-n-pentylhydroxylamine { !flH2OC5Hll ^
The reagents d,e,£ and g were generously prepared
by Dr. N.H. Wilson of the Department of Pharmacology,
Edinburgh University, using the method of Pujii, Wu and
Yamada (1967)• The others were obtained from commercial
sources.
The samples to be oximated were initially converted
to the methyl or ethyl eater and thoroughly dried by
vacuum desiccation. The oximation process was then
performed by adding 100-20C^il of the required O-alkyl
hydroxylamine hydrochloride pyridine solution vortexing
and either :
a) leaving at room temperature for a minimum of
16 hours.
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or b) heating at 60*-70'C for 1% to 3 hours.
The second process has been found to produce higher
yields of the derivatised prostaglandin metabolites and
the n-butyl and n-pentyl homologues in general.
Following oximation the samples were taken to dryness
under dry air and vacuum desiccated.
iii) 966 116^cyclic n-butyl boronates
These derivatives were routinely prepared by the
method of Pace-Asiak and Wolfe (1970). The esterified
( and in certain examples oximated ) prostaglandin samples
that were suspected of having a 90£ ll<yhydroxyl ring
structure ( eg prostaglandin to thoroughly
dried by vacuum desiccation prior to forming the 9&6 11#^
cyclic n-butyl boronate. To these samples 200-300^ul
of a solution (5 mg ml "*") of n-butylboronic acid in 2,2-
dimethoxypropane was added. The samples were then
vortexed and heated at 60*-7o*c for l-l^ hours. The
solvent was then removed under a stream of dry air and the
samples vacuum desiccated.
An alternative method ( R.W. Kelly personal
communication ) of derivatisation was used for a small
number of samples. This method required the addition of
25yil of n-butyl boronic acid reagent ( 3 mg ml"-'- in dry
acetonesbenzene 4:1 v/v ) to the dried esterified samples.
After miing, the samples were placed in a vacuum oven and
the pressure was reduced by 25 mm Hg for 15-20 minutes.
The residual solvent was eventually removed by increasing
the vacuum. This alternative method was not extensively
used because of the lower yields of derivative produced.
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iv) Trimethvlsilyl ethers
The final stage of derivatisation for all
prostaglandin samples analysed was the formation of
trimethylsilyl ethers. These were prepared by the method
of Thompson, Los and Horton (1970)• To the prostaglandin
samples 50pl of N, N-bis (trimethylsilyD-trifluoroacetamide
( BSTFA ) was added and after mixing the samples were
either left at room temperature for 3 hours or alternatively
heated at 60#c for 15 minutes. In most cases the samples
were injected into the gas chromatograph in BSTPA although
for certain samples the BSTFA was removed under a stream
of dry air and the residue dissolved in an equal volume
of n-hexane for injection into the gas chromatograph.
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RESULTS
Rabbits immunised by either the multiple intra¬
dermal or the intra-nodal techniques with a prostaglandin
E2-bovine serum albumin ( PG£0 - BSA ) conjugate were
found to produce very few antibodies with any affinity for
3
H-labelled prostaglandin . In all the anti-sera tested
the maximum binding of the 3H-labelled PGE2 obtained at a
dilution of 1/200 was never greated than 45% and in most cases
and usually less than 35% of the added radiochemical ligand.
Consequently the ability of these anti-sera to bind 3h-
labelled prostaglandins and was tested. In all cases
the 3H-labelled prostaglandin B2 was the ligand that was
maximally bound by any given anti-serum. In addition the
dilution of anti-serum required to bind 60-70% of the added
3
H-PGB? was found to increase with time after the primary
immunisation procedure. Examples of the binding to anti-
sera obtained from rabbits twelve weeks after they have
been immunised with PGE^-BSA by the two methods described
is shown in figure 5* on page . The changes in
dilution of these anti-sera, giving 60% binding of 3h-
labelled with time after the primary immunisation is
shown in figure £> on page &7
It can be clearly seen from these results that the
rabbits immunised ( by either immunisation technique ) with
PGE -BSA conjugate produced antibodies mainly with a
specificity for prostaglandin B2» in none of the anti-sera
tested was there any evidence for large numbers of anti¬
bodies ( as determined by dilution ) to prostaglandin E^.
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Figure 5. The binding of 3H PGE2; •5HPGA2 and \ PGB2
(400 pg per ligand) to successive dilutions
of anti-sera obtained twelve weeks after
rabbits were immunised by either Hie









































Weeks after immunisation with PGE? BSA conjugate.
Figure 6. The variation in dilution of antiserum
binding 60% of added 3H PGB2 (400 pg)
with time after primary immunisation by
the multiple intradermal technique.
However, to confirm that the low levels of 3H-PGE2
binding antibodies being measured were not artifactual, it
was decided to test the effect of increasing the concentration
of normal rabbit serum (NRS) and donkey anti-rabbit gamma
globulin serum { DARS ) being added to the anti-sera under
evaluation. In most cases slight increases oc#brred in
the apparent binding of VpQE2 by a given dilution of
anti-serum. However, the levels of non-specific binding
also increased and thus any apparent increase was probably
due to the added non-specific binding.
The failure to raise antibodies to prostaglandin E.,
in rabbits by either of the two immunisation procedures could
not be readily explained. The possibility that the ^^2"
BSA conjugation reaction had induced a chemical dehydration
and subsequent isomerisation of the prostaglandin e2 to
prostaglandin B2# therefore resulting in a PGB0-BSA conjugate
was studied. The unconjugated material recovered after
dialysis of the conjugation reaction products was subjected
to ultra-violet spectrophotometry and thin-layer chromat¬
ography. No evidence for the chemical breakdown of the
unconjugated prostaglandin E2# to either PGA2 or PGB2 was
obtained by either method. On thin-layer chromatography
the recovered material had a mean Rf value of 0.32 whilst
authentic prostaglandins A2 and E2 had Rf values of 0.45
and 0.31 respectively. Although this did not confirm that
the conjugated prostaglandin E2 had been dehydrated it did
provide evidence to suggest the contrary. The probability
therefore existed that the prostaglandin E2 conjugated to
the BSA was being dehydrated and isomer!sed in vivo by the
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rabbits after immunisation. Whether this conversion was
chemically or enzymatically induced was not known, however,
the rabbit was known to contain within its blood plasma
a prostaglandin A isomerase ( Jones and Cammock, 1973?
Jones, Cammock and Horton, 1972? Horton, Jones, Thompson
and Poyser, 1971 ) that isomerises prostaglandin A2 to B2»
If this enzyme was capable of accepting PGA^-bSA as a
substrate it is possible that the conversion may have
proceeded via this enzyme ( or a similar undiscovered one
in rabbit tissues ). The dehydration reaction that converted
the conjugated PGE^ to PGA2 could have been either enzymatic
or due to chemical instability, however, as will be discussed
later in this section, attempts to detect a prostaglandin
E2 dehydrase were also made.
The possibilities remaining for the development of
a successful radioimmunoassay specific for prostaglandin E2
were re-evaluated. These possibilities included t the use
of an alternative animal for raising antibodies to PGE -BSA?
mm
the synthesis of a prostaglandin E2 analogue resistant to
dehydration into the corresponding prostaglandin A2 and
its subsequent use as an immunogen? the development of
antibodies to a compound that prostaglandin E is readily
Mm
chemically converted to? the purification of prostaglandin
antibodies from a mixture of E2, A2 and B2 prostaglandin
antibodies by affinity chromatography.
The use of sheep for the raising of antibodies
was considered, however, the subsequent discovery of an
enzyme ( see page ^ in this section ) in ovine blood
capable of reducing PGE2 to PGF^and the fact that anti-
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sera from sheep immunised with PGE2~BSA had high cross-
reactivities with prostaglandins A0, b2 and F2 (M.Withnall,
personal communication ) suggested that one of the other
possibilities be considered. The synthesis of a prostaglandin
analogue that was resistant to dehydration was actively
considered. Such compounds included 10,10-dimetnyl
prostaglandin E2 and the 9-O-methyloxime analogue. The
first compound was not available. However, the second
could be readily produced in micro-gram quantities by the
methods described on page 61 • However, at the time that
this work was considered the ability to quantitatively convert
sub-nanogram quantities of prostaglandin into this
derivative with any degree of reproduceability was not
available. Consequently, it was decided to raise the anti¬
bodies in the rabbit to prostaglandin F a compound
readily produced from prostaglandin E by treatment with
methanolic sodium borohydride. One problem with this
method was that approximately equal amounts of prostaglandins
F2Qtand F2p are produced by the reduction reaction. Thus
for the radioimmunoassay method to be successful the anti-
sera produced must be able to successfully discriminate
prostaglandin j^from prostaglandin FFurthermorejgfrom prostaglandin F2^.
the conversion of prostaglandin E.7 to prostaglandin
must be constant and reproducable for the assay method to
be successful.
Evaluation of the antisera raised to prostaglandin F,^g>bovine sarum albumin conjugate
All the antisera harvested were found to contain
antibodies capable of binding 3H-labelled prostaglandin F^
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methyl ester. The dilution of each antiserum required for
6056 binding of the H-PGF2^was found to increase with time
after the primary immunisation. These increases were found
to be enhanced by secondary immunisation in several of the
rabbits. Examples of the increases are shown in figure 7
on paqe 72 • *n examples the incubation had been
optimised for NRS and DARb as described previously on
pages 45 & 46.
Antisera specificity studies
Several of the antisera were further evaluated
for their ability to discriminate between prostaglandin
methyl ester and various other prostaglandins as their *
methyl esters. The major po$®ntial prostaglandins that
were envisaged as being likely to be encountered in any
potential use of this assay were tested where possible.
These are listed on page ^ . The major prostaglandins
not tested that were likely to be encountered were the
13, 14-dihydro derivatives of prostaglandins F^^and
and their 15(R) epimers. These compounds were not
available at the time of testing. Prostaglandin and
B2 were tested because under the reaction conditions that
convert prostaglandin E2 into F^and F2^sodium borohydride
does not reduce the 9-ketonic function also present in the
prostaglandins and B2 (R.L. Jones, personal communication).
Similarly, prostaglandin A2 when reacted with sodium boro¬
hydride produces 3-hydroxy products. Two of these are
prostaglandins 11-deoxy F^and F2p, in which the IO, 11
double bond has also been reduced. The third compound
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Weeks after primary immunisation with PGF2p - BSA conjugate
Figure 7. The increase in dilution of antiserum
binding 60% of the added PGF2^
methyl ester (400pg) with time after
primary and secondary immunisation procedures,
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example only one of the two 9-hydroxy epimers are produced
(R.L. Jones, personal communication).
The cross reactivities of the prostaglandins tested
were obtained by comparing the quantities of each prostag¬
landin necessary to cause a fall of 10% in the binding of
%-PGF0 B methyl ester from its maximum binding. The amount
zr
of prostaglandin F2^ methyl ester causing the fall was
nominated 10096 cross reaction, the remaining prostaglandins
were expressed relative to this value. The results obtained




1:25600 1:12800 1:12800 1:6400
Weeks after primary
immunisation
20 20 16 12
Compound (methyl
esters)
percentage cross reaction relative to
PGF2 methyl ester
PGF2 B 100 100 100 100
PGF, 3 104 100 100 108
PGF2 ^ 3 1 4 2
PGF1 ^ 3 2 2 2
15(R) PGFp n 7 3 9 G
15(R) PGF2 ^ 1 1 1 1
PGB1 0.1 0.1 0.1 0.1
pgb2 0.1 0.1 0.1 0.1
9-OH PGA2 1 1 2 1
11-deoxy PGF2^ 1 1 1 1
Table 1. Relative cross-reactivities of four rabbit PGF2
BSA anti-sera to various prostaglandin methyl
esters.
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Factors influencing the reduction of prostaglandin to
prostaglandin ftby sodium borohvdride
'
3
The reduction of H-labelled PGE2 by methanolic
sodium borohydride results in the production of several
products as determined by thin layer chromatography. An
example of the products produced is shown in figure $ on
page ^ . The two major products were prostaglandins F2 ^
and F2r The proportion of prostaglandins F2 ^and F2 ^
produced after 30# 60 and 120 minute incubations of 10 ng
prostaglandin E2 with methanolic sodium borohydride were
assayed by two methods. One method was based on the
recoveries of radioactivity from the zones of thin-layer
chromatography plates. The necond method was based on
deuterium isotope dilution analysis by multiple ion
detection gas chromatography-mass spectrometry. The results
obtained by these two methods are shown in tables •? cm| 3
on pages ^ ^ respectively.
Table 2.
The percentage conversion to PGF2Mand PGF2^of 10 ng of









1 2 3 4 mean S.E.M Variance
43 46 44 41 43.50 1.04 4.33
44 41 42 46 43.25 1.11 4.92
43 49 43 44 44.75 1.44 8.25
37 41 43 44 41.25 1.55 9.58
33 44 44 40 41.50 1.50 9.00
42 43 43 40 42 .00 0.71 2.00
The values quoted are the percentage that each zone




Figure 8. The thin layer radio scans obtained for
■5?
authentic H prostaglandins ^; F2^,
E2 and A2 (upper) and the products
obtained after treating % PGE2 n£ :
0.5^tCi) with methanolic sodium




The percentage conversion to PGF^^and PGF^of 10 ng of




tion 1 2 3 4 mean S.E.M Variance
time
(minutes)
30 44 43 45 43 45,00 1.08 4.67
60 42 43 40 45 42.50 1.04 4.33
2*
120 43 48 43 46 45.00 1.22 6.00
30 39 40 42 43 42.25 2.02 16.25
F2i7 6° 39 46 42 43 42.50 1.44 3.33P 120 41 42 44 42 42 .25 0.63 1.53
The values quoted are the percentage that each prostaglandin
comprises of the added prostaglandin E^.
The reduction of 1 ng ^H-PGE^ sodium borohydride
was also studied by the radiochemical method. The results
are shown In Table on page .
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Table
The percentage conversion to prostaglandin ^and F2






i 2 3 4 mean S.E.M Variant
30 40 42 49 47 44.50 2.10 17.67
F2<K 60
120
39 46 48 43 44.00 1.96 15.33
44 43 41 49 44.25 1.70 11.58
30 41 40 40 43 41.00 0.71 2.00
F2B 60 34 41, 44 43 41.75 2.95 34.92
r120 37 46 44 42 42.25 1.93 14.92
The metabolism of prostaglandin by rabbit and sheep
whole blood and rabbit popliteal lymph node
The metabolism of prostaglandin E by the above
samples was studied by means of thin-layer chromatography.
The resulting scans of the radioactivity present in each
sample are shown in figure ^ on page • ** can k®
seen that only the sheep blood samples appeared to metabolise
prostaglandin The metabolite produced was more polar
on the thin-layer chromatography system than prostaglandin
E2» Several prostaglandins, including PGF20^and PGF2^
are more polar than prostaglandin E . However, the
identity of the metabolite could not be solely determined
by thin-layer chromatography Before the identity of this
metabolite could be ascertained it was necessary to find a
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SHEEP
Figure 9. Thin layer radiochemical scans of authentic
% prostaglandins E2 and and the products
obtained by incubating rabbit and sheep
whole blood and rabbit popliteal lymph
*
node homogenate with H PGE^ as
described on page 57-59*
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thin-layer chromatography system that not only separated
the metabolite from prostaglandin E2 but also separated
this metabolite from the majority of blood pigments that
were also extracted from the incubate. In addition, if the
metabolite was an F type prostaglandin it would also be
necessary to separate the two possible F isomers, namely
and PGP2that coul<3 be produced for prostaglandin
E2. it was known that the G.C.M. solvent system ( Millar,
1974 ) would separate the majority of blood pigments from
prostaglandins F20£« E2 an<* A2* However, the ability of
this solvent to separate prostaglandin and F2jgwas
unknown. Consequently the FVI solvent system ( Andersen,
1969 ) which was known to separate these two prostaglandins
was compared with and in combination with the G.C.M. solvent.
It was found that although the best separation of prosta¬
glandins F20^an<* F2^gcould be obtained by a multi development
in the FVI solvent system, the best separation of these
prostaglandins in combination with their separation from
the major blood pigments was obtained by an initial
development with the FVI solvent and a second in the G.C.M.
solvent. In addition, the metabolite had a chromatographic
mobility in all the systems conducive to it being
prostaglandin F2^and not the alternative epimer prostaglandin
F2f-
Confirmation that the metabolism of prostaglandin by
sheep whole blood was not artifactual
When prostaglandin was incubated with sheep
whole blood at 37#c a metabolite, provisionally identified
80
aa prostaglandin F2nc.' was Pro<3uce<i» T^Q possibility that
this could have been produced by non-specific reduction of
the prostaglandin E during the incubation and extraction
mm
procedures had to be discounted. Thus sheep whole blood
that had been heated at 70#c for 5 minutes to destroy
the enzymes present was used to determine whether the
incubation or extraction procedures were responsible for
the formation of the metabolite. The results of incubating
at 37*C at 70*C
sheep whole blood, before and after incubation, sure shown
in figure 10 on page ®' • In addition the effect of the
extraction procedure on prostaglandin E2 is shown. It can
be seen that the metabolite is only produced by sheep whole
blood that had not been heated to 70 *c and thus it was
concluded unat the production of this metabolite was not
artifactual. The identification of this metabolite and
further studies on the metabolism of prostaglandin E.^ by





Figure 10. Thin layer radio scans of^the products
obtained after incubating sheep whole
blood at 37*C for 75 minutes before (top)
and after (middle) heating at 70*C for
5 minutes and the extraction procedure
(bottom) on PGE2 (1 yuCi : 10 ng).
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SECTION XI
STUDIES ON THE METABOLISM OF PROSTAGLANDIN E^. BY WHOLE
BLOOD FROM THE SHEEP AND OTHER ANIMAL SPECIES
Introduction
During the attempts to raise anti-bodies to
prostaglandin in the rabbit, it was observed that the
majority of the antibodies produced had a low affinity for
prostaglandin but a much higher one for prostaglandin
. It wa3 therefore concluded that the PGE2 conjugated
to the BSA was being dehydrated and isomerised in vivo
by the rabbits prior to the antibodies forming. It was
already known that rabbit plasma contained a prostaglandin
A isomerase ( Jones and Cammock, 1973 ) and thus the
possibility existed that after dehydration the PGE^ was
being isomerised through PGC2 to PGB„ by this or a similar
enzyme. Therefore, an attempt to find the enzyme that was
possibly dehydrating the PGE^ to PGA was made.
lb Am
No such enzyme was found in the rabbit tissues
studied. However, in studies with sheep, which was
considered as an alternative animal in which to raise
antibodies to PGE^ because of the absence of a prostaglandin
A isomerase within its plasma, it was discovered that a
prostaglandin Emetabolising enzyme was present in its
blood. The metabolite produced was more polar than PGE^
and had thin layer chromatographic mobilities comparable
with it being PGF^. It was therefore decided to study the
metabolism of PGE^ by sheep blood in more detail and to
identify the metabolite conclusively. In addition it was
decided to screen the blood samples from as many animals as
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possible for their ability to metabolise PGE2 into either
more or less polar compounds.
A) The metabolism of Prostaglandin by blood samples
from the sheep; rabbity cat? dog; guinea-pig; horsey cow?
rat; chicken; and man
i) Incubation and extraction procedures
Fresh blood was added to sodium citrate anti¬
coagulant ( 8.5 s 1.5 v/vj sodium citrate, 2.2 g? citric
acid raonohydrate, 0.8 g? dextrose 2.45 g in lOO ml distilled
water ) and thoroughly mixed. A 10 ml volume of the anti-
coagulated blood samples wa3 then incubated with 5, 6, 8,
11, 12, 14, 15-3h-PGE2 (lOyug i 0.2 to l.Oyu Ci ) at 37*C
for 75 min ( with agitation ) in a water bath. The reaction
was stopped by the addition of 5-10 vol. of ice-cold ethanol
and thorough mixing. After 30 minutes at room temperature
the mixture was centrifuged at 1875 x g for 15 min at 4*c.
The supernatant was transferred to a 850 ml flask and the
t e
precipita washed with the same volume of absolute ethanol
before being re-centrifuged. The supernatant was then
pooled with the first batch and taken to dryness under
reduced pressure at 40*c. The resulting oily residue
was redissolved in 50-100 ml of distilled water and
acidified to pH 4.0-4.5 with 10% acetic acid. This solution
was then partitioned twice with an equal volume of re¬
distilled ethyl acetate and the pooled ethyl acetate
fractions were subsequently washed with 2 x 20 ml of
distilled water before the ethyl acetate was taken to dryness
under reduced pressure at 40*c and desiccated under vacuum
at room temperature. The resulting residue was dissolved
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in 20 ml of 6 1% aqueous ethanol and partitioned twice
with an equal volume of heavy petroleum before the 67& aqueous
ethanol phase was taken to dryness and desiccated,
ii) Thin layer chromatography
The residue was then dissolved in 0.2 ml of a
methanolbenzene mixture ( 90 : 10# v/v ) and applied with
a micro syringe as a thin band (0.3mmx25mm)
approximately 2 cm from the bottom end of a thin layer
chromatography plate. Neutral silica gel ( 2GO mm x 200 mm
x 0.25 mm ) on glass plates were used ( E. Merck A.G. ) and
when necessary the plates were pre-washed with methanol to
remove fluorescent indicator. Marker standards of ^H-labelled
prostaglandins were spotted on the plate at the side of the
samples being chromatographed. A multi-run development
of the plate was performed using the FvTT system of
Andersen ( Andersen 1969 ) a3 the first run ( ethyl acetate;
acetone; glacial acetic acid 90s 10:1 by vol.) and the G.C.M.
solvent of Millar ( Millar 1974 ) as the second development
( ethyl acetate; methanol; glacial acetic acid 100:10:1
by vol.) In both cases the plates were developed to
approximately 2 cm from the top of the plate in closed
equilibrated glass tanks containing the developing solvent
at a depth of approximately 1 cm. These tanks were lined
with sheets of Whatman No. 1 filter paper to assist the
equilibration of the solvents. The solvents were changed
at regular intervals before use.
The plates were dried thoroughly after each
development under a stream of cold air until no small of
solvent was detectable. After the final development the
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individual samples on the plates were scanned for radio¬
activity using a Panax radio thin-layer chromatographic
plate scanner. From the resulting scans it was possible
to determine whether a particular blood sample metabolised
prostaglandin Eand also to provisionally identify the
metabolites by reference to authentic prostaglandins.
( Figure It ; Page 86 ) •
iii) Elution of prostaglandins from thin layer chromatography
plates
From the resulting radioactive scans zones
corresponding to peaks of radioactivity were scraped from
the thin layer plates into test tubes containing 5 ml of
methanol. The contents were vortexed for 15-30 seconds
and then centrifuged on a bench centrifuge at maximum
speed for 5-lO minutes. The supernatant was carefully
transferred into a pear shaped flask. The compacted silica
gel was washed with a further 5 ml of methanol, centrifuged
and the supernatant pooled with the first eluant before
being taken to dryness under reduced pressure at 40*c
and vacuum desiccated. The residue was then dissolved
in 1.0 ml of methanol and 4 x 50jil aliquots were removed
to enable a quantitative determination of radioactivity to
be made.
iv) Liquid scintillation counting
The liquid scintillation counting was performed
with a Mark II Nuclear Chicago liquid scintillation counter.
The sample aliquots were counted in 10.0 ml of a toluene,
ethoxyethanol-based scintillant mixture (toluene?






Figure 11. Thin layer radio scans obtained fro© ths
X
products produced by incubating PGE2
with cat, human and sheep whole blood
x
and authentic H prostaglandins F2^ ,
F2 , E2, and Ag. The experimental
details are described on page 84.
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methyl-5-phenyloxazolyl))-benzene ( dimethyl POPOP ) (2000;
400? 8.52? 0.22 v/v/w/w))• Counting efficiency was 35-40%
and correction for quenching was made by use of tie automatic
external standard channels ratio method and a quench-calibration
curve constructed for the scintillant mixture.
3
Preparation and purification of H-labelled prostaglandins
£2ftcand Fzp
Prostaglandin E2 ( o.4 ml s 1 mg ml-1 ) was added
to 200^a Ci of ^H-labelled prostaglandin ( Sp. Ac. 167
Mole-1. Amersham ) in a 25 ml stoppered pear-shaped flask
and the mixture coaled to^~20*c with an ice-acetone' mixture.
A small quantity ( approximately 100 mg ) of sodium boro-
hydride ( NaBH^ ) was added to the reaction vessel and
mixed with the contents before incubating at -20*c for 1
hour. The reaction mixture was then brought to room
temperature for a further period of 1 hour. During this
time 10yjl of the reaction mixture was diluted to 2.0 ml
with methanol and 0.2 ml of 1 M KOH added in a spectro¬
photometer cell. The sample was then assayed for
prostaglandin ( Andersen 1969 ) by scanning at a fixed
wavelength of 273 nm with a Pye Unicam. SP8oo U.V. spectro¬
photometer and SP825 programme controller. Methanol ( 2.0
ml + 0.2 ml 1 H KOH ) was used as a reference. No
prostaglandin B2 was detectable, thus the reduction of
prostaglandin with sodium borohydride was taken as
complete. The reaction mixture was then diluted with
40 ml of distilled water, acidified to pH 4 with 10% acetic
acid solution and extracted twice with an equal volume of
diethyl ether. The pooled ether fractions were taken to
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dryness under reduced pressure, vacuum desiccated and
redissolved in 1,0 ml of methanol.
( 50 mm x 200 mm x 0.25 mm on glass ) of an aliquot of
the products when developed by the G.C.M. solvent ( Millar
1974 ) revealed a broad major peak of mean Rf 0.30 and
minor peak of Rf 0.47 ( after detection by spraying with
10* phosphomolybdic acid in ethanol and heating at 110*C
for 15 min. ). Authentic prostaglandin E2 used as a marker
on the thin layer plate had an Rf of 0.42, thus suggesting
that the products of the sodium borohydride reaction were
more polar, a chemical feature compatible with the products
being prostaglandins F^^and
chromatography of the methyl ester trimethylsilyl ether
derivative indicated that prostaglandin F2o^was t*le major
isomer produced. Purification of the reaction mixture by
reversed phase partition chromatography on a glass column
( 350 x 10 mm) containing 6.5 g of LH-20 ( graded particle
size 40t5 um diameter ) was performed. The column was
eluted at a flow rate 7-8 ml h 1 with a mixture of methanol,
water, butanol, chloroform, acetic acid ( 50?50s5;5:0.1
by volume ). Fractions of l.O ml were collected in glass
test tubes on an LKB Ultrorac fraction collector. From
each fraction 10ji1 was' removed and the radioactive content
determined by liquid scintillation counting. This
chromatographic step allowed the pooling of several
fractions to be performed such that on thin layer
chromatography in the FVI solvent system ( Andersen 1969 )
Thin layer chromatography on neutral silica gel
Preliminary results o ained from radio gas
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the prostaglandin F-^and F-»were found to be greater
Ca4»o-cVNt«vMCMVf r
than 90&Apure with respect to each other.
Preparation of derivatives for gas-liquid chromatography
Samples were treated by the methods described
previously ( page 61 ) to produce the following derivatives :
a) Methyl ester trimethylsilyl ether (MeTMS)
b) Methyl ester O-methyloxirae trimethylsilyl
ether ( Me Mo TMS )
c) Methyl ester 9,11-cyclic n-butyl boronate,
15-trimethylsilyl ether ( Me NBB TMS ).
Radio-gas liquid chromatography
A Pye Unicam Series 104 gas chromatograph was
interfaced with a Panax radio gas chromatogr&ph detector
for the simultaneous recording of mass ( flame ionisation
detection ) and radioactivity. The gas chromatograph
was equipped with a glass column ( 1.5 ra x 2 mm i.d. )
packed with 3% OV-1 on Supelcoport { 100-120 mesh ).
The carrier gas ( argon ) flow rate was 25-40 ml rain"^
and the oven temperature 190-210"c. Gas chromatography
derivatives ( Me Mo TMS: Me TMS; Me KBB TMS ) were dissolved
in 50ja1 of either n-hexane of BSTFA and 10yal was injected.
The radio-gas chromatograph was calibrated for carbon values
( C values ) by plotting the log retention time versus
carbon value for normal saturated fatty acid methyl esters
( C^6~c24 C2 un^ts )•
Combined gas-liquid chromatography-mass spectrometry
This was performed using an LKB 9000 combined gas
chromatograph-mass spectrometer. The instrument was fitted
with a glass column ( 1.5 mx 2 mm i.d. ) packed with 3%
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OV-1 on Supelcoport ( 100-120 mesh). The gas chromatograph
oven temperature was 195-205*c and the carrier gas ( helium )
flow rate was 20-30 ml hr \ The instrument was calibrated
for 'C' values and the derivatised prostaglandins were
prepared as described above for radio gas liquid chromatography.
The instrument in addition was calibrated for a variety
of authentic iprostaglandi;: derivatives at the beginning
of each operation period. Mass spectra was recorded at
the crest of the gas chromatography peaks ( total ion
current detector ) corresponding to those calculated from
the ' C' value obtained from radio-gas chromatography. The
electron energy of the ion source was initially set at 22.5
eV but automatically switched to 27.5 eV when a mass spectral
scan was L^gun.
B) Characterisation of the 9-keto reductase present in
sheep whole blood
i) Determination of the blood compartment the enzyme is
present in
Freshly collected and citrate anticoagulated
sheep whole blood ( see page 57 ) was centrifuged at #9c
for 20 minutes at 1875 x g. Tne plasma, buffy layer and
red cell fractions were carefully separated and stored at
4*c in silanised glass containers. A sample of the red
cell fraction was treated with an equal volume of lOO mM
sodium phosphate buffer ( NaH2P0412.7 g? Na2HP04, 12.54
g? reduced glutathione, 10 mg in 1 litre of distilled water )
and the haemolysed cells recentrifuged at 1875 x g for a
further 20 minutes at 4*c. The supernatant was removed
and the resulting cell debris resuspended in fresh buffer
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solution ( 2:1 v/v ).
A sample of sheep whole blood and each of the
following fractions ( 10 ml ) was then incubated with
prostaglandin E2 ( 10 yug: 1 yiCi ) at 37 *C for 75 minutes
in a water bath. The products of the incubation were




d) Haemolysed washed red cells
e) Haemolysate
ii) The effect of pH incubation temperature and pre¬
incubation temperature on the enzyme
In all cases the enzyme preparation used was
equivalent to sample 'd' described above ( i.e. haemolysed
washed red cells ). The substrate concentration of
prostaglandin E^ was 3 yuM (1 ^ig ml"1; 1 yi Ci ) and the
substrate was added in 100yul of sodium phosphate buffer.
The incubation volume was 10 ml and the incubation time
75 minutes.
For the pH study 10?6 aqueous acetic acid solution
was used to acidify from pH 5.0 7.0 and aqueous O.IM Na OH
solution was used for the pH range 7.7-9.0. The substrate
was added immediately the pH was attained and then incubated
at 37 *c.
The pre-incubation temperatures were obtained by
heating the enzyme sample ( in a glass container ) in a
water bath ( with agitation ) at the elevated ( or lowered )
temperature for 15-20 minutes. The enzyme preparations
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were then cooled to 0*C by immersing the container into
an incubator containing an ice-methanol mixture. The
sample was then incubated with prostaglandin at 37"C.
The effect of incubation temperature was obtained
by heating the sample to the required temperature and then
adding the substrate ( prostaglandin ). The enzyme
preparation was then incubated at the required temperature
with agitation in a water bath.
iii) Cofactor requirements for the conversion of PGfc^ to
PGF2*>by sheep red blood cells
a) Haemolysed red blood cells were prepared from
freshly collected sheep whole blood as described previously
( page 90 ). The substrate concentration of prostaglandin
E2 was 3 yiM ( 1 yigxal-1; 1 ^iCi ) cofactor concentration
2 mM and enzyme volume 10 ml. An enzyme preparation
without added cofactors was incubated with prostaglandin
E2 for the determination of basal conversion of PQE2 to
PGE^. In two experiments prostaglandin F2« ! 3 /*M'
1 yuCi ) was incubated with and without NAD or NADP
( 2 mM ) for the determination of the conversion of PGF
to PGE2# The cofactors studied for the conversion of
PGE2 to PGFj^were NADHy NADPH y reduced flavin mono¬
nucleotide ( FJttl - ) and reduced flavine adenine
dinucleotide ( FADH2 ). Incubations were for 75 minutes
at 37*c in a water bath { with agitation ). The products
were extracted as described previously ( page ,
and purified by thin layer chromatography on neutral
silica gel { 200 mm x 200 mm x 0.1 mm on glass ). Marker
standards of ^H-labelled prostaglandins E2
and A2 were spotted at the side of the samples and the
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plates were developed in a multi-run system. The first
development was in the FVI solvent ( Andersen 1969 ) and
the second in the GCM solvent ( Millar 1974 ). After
development the plates were scanned on a Panax radio thin
layer chromatographic plate scanner and the zones of
radioactivity scraped into test tubes containing methanol
( 5 ml ). After vortexing the tubes were centrifuged at
maximum speed on a bench centrifuge for 5 minutes and the
resulting supernatant transferred into a pear-shaped flask.
The compacted silica gel was re-extracted with methanol
( 5 ml ) as described above. The supernatants for each
zone were pooled and taken to dryness and the residue
re-dissolved in 1.0 ml of methanol. From each zone 4 x
50yil was removed and assayed for radioactivity by liquid
scintillation counting. The remaining residue from the
pgf2 zones transferred to Eppendorf tubes and converted
to the methyl ester trimethylsilyl ether as described
previously ( page 61 ). These derivatives were then
subjected to combined gas chromatography-mass spectrometry
on an LKB 9000. The instrument was equipped with a glass
column (3mx4mmi.d. ) packed with 3% OV-1 on
Supelcoport ( 100-120 mesh ). The column temperature
was 255*c and the carrier gas ( helium ) flow rate
35 ml min-^.
b) In an experiment designed to confirm the
quantitative results obtained by the radioactive method
quantitative gas chromatography-multiple ion detection
mass spectrometry was employed.
Groups of fresh enzyme samples ( 10 ml volume )
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as described above were incubated with prostaglandin
( 1.4yaM; 1 jxCi ) in the presence and absence of NADH or
NADPH ( 2 mM ) . Samples were incubated in all CdS&$ -•
for 25, 50 and 75 minutes. At the end of the required
time period 200 ul of the reaction mixture was transferred
to a test tube containing 2 ml of 10?6 aqueous acetic acid
and 1 ^ug each of 3,3,4,4 tetra-deutero PGE2 and 3,3,4,4
tetradeutero PGF2^mixed and left at room temperature for
15 minutes. The rewining reaction mixture was extracted
as described above. After 15 minutes aqueous glacial
acetic solution was vortexed with 4 ml of redistilled ethyl
acetate and then the mixture centrifuged for 5 minutes on
a bench centrifuge. The aqueous solutions were then frozen
solid by partial immersion in ethylene glycol at -10 to
-20'c and the ethyl acetate fraction poured off into a
clean 25 ml pear-shaped flask. The frozen aqueous phases
were then thawed and re-extracted. The pooled ethyl
acetate fractions were taken to dryness at 40#c under a
stream of air and then vacuum desiccated.
The extract of the major portion of each incubation
sample ( 9.8 ml ) was treated in an identical manner as
described on pages % nr-84 ana 85
The extract from the minor portion of each
incubation sample ( 0.2 ml ) was transferred to capped
Eppendorf tubes. The prostaglandin E2 present in the
samples was converted into the methyl ester and either
the methyl oxime or the ethyl oxime trimethylsilyl ether.
The prostaglandin F2o^present in the samples was converted
into the methyl ester trimethylsilyl ether by the methods
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described previously. The samples were dissolved in
50 yil of BSTFA and 5^ul aliquots subjected to quantitative
analysis by the method described briefly elsewhere ( Hensby
and Naylor 1974 ). This method was based upon quantitative
gas-chromatography-multiple ion detection mass spectrometry.
A Finnigan 300GD quadrupoiemass spectrometer was interfaced
with a Fli$migan 9500 gaa chromatograph equipped with a
1.5 in x 2 mm i.d. glass column packed with 3& OV-1 on
Supelcoport. The carrier gas ( helium ) flow rate was
25-30 ml rain * and the oven temperature 230-250*C. The
instrument was calibrated at the beginning of each run for
protium and deuterium by measuring the ratios of the peak
heights of given ions over the range 1-100 ng of protium
( 10O ng deuterium constant ). The ions monitered were
295 and 423 for the protium forms of prostaglandin
an<3 resPect^ve^y AOd. at 299 and 427 for the
corresponding deuterium ions. Triplicate determinations
for standard and biological samples were made.
iv) Substrate specificity studies
a) PGB;? 15 (R)PGE^t FGE2 methvl ester? PGE^; 13.
14-dihydro-PGE^ ? PGA2 and PGB^.
Haemolysed red blood cells were prepared as
described previously (page 90 ). The substrate
concentration was l^ig ml"1 ( 2.8yiM ) for all the
prostaglandins studied. For prostaglandins K^i &2 ro®thyl
ester; h2 and B2 l^i Ci of the corresponding 3H-
labelled prostaglandins was incorporated in the incubation.
For prostaglandins and the reaction volume was 10 ml
and for the rest 50 ml. Blood samples were incubated at
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37*C in a water bath ( with agitation ) for 75 minutes
and then extracted into ethyl acetate as described
previously ( page 5q )•
Thin layer chromatography
The residue from the extraction procedure was
vacuum desiccated and then re-dissolved in 0*2 ml of
methanol. For the 8-iso-PGE^, 15{R)PG£2 and the 13,
14-dihydro-PGE^ samples of 0.5^aCi ( 1.5 ng ) of 3H-
labelled PGA,> was added prior to thin layer chromatography
to act as an internal standard for this step. The sasqples
were then applied to neutral silica gel thin layer
chromatography plates ( 200 mm x 200 mm x 0.1 mm, on
glass ) . The extracts from the FG&2# PGA2 and PGB2
incubations were spotted on the same plates as marker
standards containing 3a-labelled prostaglandins
F20< 0 E2 and A2# The 11,14-dihydro PGEj and
15(R)PGE2 samples were spotted on the same plate as the
3
PGEj methyl ester sample and marker standards of H-
labelled prostaglandin F2p* F2W E2 and A2 ""^y1
esters. A standard plate was also prepared containing
3H PGA2 and the Fpf and E standards of the 8-iso,
13,14-dihydro and 15(R) prostaglandins used as substrates.
The thin layer chromatography plates were then
subjected to a multi-run development using the FVI
solvent of Andersen ( Andersen 1969 } as the first run




The plates were dried thoroughly after each
development under a stream of cold air until no scent
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of solvent was detectable. After the final development
the individual samples were scanned for radioactivity
using a Panax thin layer chromatography plate scanner.
The cold marker prostaglandins were detected by spraying
with a solution of 10/4 phosphomolybdic acid in ethanol
and heating at 110*c for 15 minutes.
Station of prostaglandins from thin layer chromatography plates
From the scans obtained for the radioactive
substrate ( eg PGE2, PGE2 methyl ester, PGE^ PGA2 and PGB2)
residues, zones corresponding to peaks of radioactivity
were scraped from the thin layer plates into test tubes
containing 5 ml of methanol. For the non-radioactively
labelled substrates ( eg 8-iso-PGE^j 13,14-dihydro-PGE^
and 15(R) PGE2 ) the corresponding F^F^and E zones
were scraped into test tubes containing 5 ml of methanol.
The position of the 3h-PGA2 zones of the biological
samples ( added as an internal standard ) was used to
check that the thin layer plates containing the marker
standards and the biological samples had chromatographed
essentially the same. The prostaglandins were eluted and
separated from the silica gel by vortexing with the
methanol for 15-30 seconds and then centrifuging on a
bench centrifuge at maximum speed for 5-10 minutes. The
supernatant from each zone was carefully transferred into
pear-shaped flasks and the compacted silica gel re-
extracted with a further 5 ml of methanol as described
above. The supernatants for each zone were pooled, taken
to dryness under reduced pressure, vacuum desiccated and
the residue dissolved in 1.0 ml of methanol.
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Quantitative and qualitative analysis of the zones
obtained from thin layer chromatography
From the radioactively labelled substrate samples,
4 x 50jxl was removed from each zone and quantitatively
assayed for radioactivity by liquid scintillation counting.
For all the prostaglandin samples 0.5 ml of the methanol
solution was transferred to an Eppendorf tube and mixed
with either 20yug of omega-dihomo-PGE2 ( e zones ) or
10yug of omega-dihomo-PGF2 ^( f zones ). The E zones
were then converted to the corresponding methyl ester
trimethylsilyl ether ( Me TMS ) by the methods described
previously ( page 51 ) . The omega-dihomo-prostaglandins
E2 and F2^were a generous gift from Dr. N. Crossley,
ICI Ltd.
These derivatives were dissolved in 50 jil of
BSTFA and 10 ^al was injected into the gas chromatograph
of an LKB 9000 combined gas chromatograph-mass spectrometer.
This instrument was fitted with a glass column ( 3 m x
4 mm i.d. ) packed with 3% OV-l on Supelcoport ( 100-120
mesh ). The oven temperature was 240-250'C and the
carrier gas ( helium ) flow rate was 30-35 ml hr"^".
Mass spectra for qualitative identification were recotjSed
at the crest of the gas chromatography peaks corresponding
to the corresponding authentic prostaglandins. Quantitative
analysis was performed by comparing the area of the
derivative on gas chromatography with that of the added
internal standard. Duplicate quantitative determinations
were performed.
b) PGD2
Freshly citrated sheep blood was treated as
described previously ( page 5g ) to produce six
different stock enzyme preparations (A-F)• For each
stock enzyme preparation 10 ml aliquots were used for
the comparison of an<i as substrates. The
incubation was performed at 37'c ( with agitation ) in a
water bath at a substrate concentration of 14yuM. Aliquots
( 0.2 ml ) were removed from each sample at 1, 5. 10.
15. 30. 60 and 90 minutes and incubated with 2 ml of
10& aqueous acetic acid solution containing 1 jxg of 3,
3, 4, 4-tetradeutero After 15 minutes at room
temperature the sables were extracted into ethyl acetate
as described previously ( page 94 )• The ethyl acetate
for each sample was pooled and taken to dryness at 40*c
under a stream of air.
To the enzyme preparation obtained at the end
of the incubation period ( approximately 100 minutes )
from samples D. E and F that had been incubated with
prostaglandin D2 l.o^i ci of ^-PGF^ ( approximately
2.5 ng ) was added and the sample was then diluted with
100 ml of distilled water, acidified to pH 4 with glacial
acetic acid and extracted twice with an equal volume of
'
re-distilled ethyl acetate. The pooled ethyl acetate was
washed twice with 20 ml of distilled water, taken to
dryness under reduced pressure and vacuum desiccated. The
residue was then re-dissolved in 25 ml of 67% aqueous
ethanol and partitioned twice with an eyual volume of
petroleum spirit before the aqueous phase was taken to
\
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dryness and vacuum desiccated. The residue from each
fraction was then re-dissolved in 0.2 - 0.5 ml of methanol
and treated with excess diazomethane at room temperature
for a maximum of 15 minutes. The sanqples were then
taken to dryness and vacuum desiccated.
Straight phase partition chromatography on a lipophilic
substituted LH-2Q gel column of prostaglandin methyl
esters
A silanised glass column ( 450 nun x 21 mm )
was packed with a lipophilic Sephadex LH-20 gel to a
bed volume of 85 ml. This gel was Sephadex LH-20
substituted with 51% ( w/w ) of C to C14 hydroxyalkyl
sidechains and was prepared by Mr, A.R. Brash. Prior to
packing the gel had been thoroughly equilibrated with a
heptane-chloroform mixture ( 70s30 v/v ) and was further
equilibrated in situ before being used. The flow rate
was 6-8 ml hr"1 and fractions of 4.25 ml ( &% bed volume )
were collected on an LKB Ultrorac fraction collector.
A minimum of 10 bed volumes were collected before a
further sample was chromatographed on the column.
Samples ( standards and biological ) were converted to
methyl esters prior to chromatography. The vacuum dried
residue obtained after methyl esterification was dissolved
in 150yil of chloroform and made up to 500 jil with
n-heptane. The total volume applied to the column was
never greater than 1.5 ml ( including washings ).
The column was calibrated for authentic
prostaglandin and three prostaglandin F2 ring isomers.
These were the 9 110<( pgf2<y) * P6F2 a) and the
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9«H ( llj5PQF2^) isomers. The prostaglandin D2
and 9&{lly£F2 ^?ere detected by gas chromatography after
conversion to the MeMoTMS and MeTMS derivatives
respectively. The 90C11 Aland 9y01]&<F2^pimers were
detected by liquid scintillation counting.
The elution profile of the biological samples
D. E and F that had boon incubated with PCT>2 was monitored
by liquid scintillation counting of an aliquot from
alternative samples. This enabled the 96^11 . zone
* w
to be determined ( 3h-PGF20<added ) and from this the
position of the 90C11^B zone could be calculated. The
fractions present in each zone were pooled, taken to
dryness under reduced pressure and vacuum desiccated.
Quantitative gas chromatography-mass spectrometry
This was performed on a Finnigan 3GOOD quadrupale
mass spectrometer interfaced with a Finnigan 9500 gas
chromatograph equipped with a glass column ( 1.5 m x
2 mm i.d. ) packed with 3% OV-1 on Supelcoport. The
carrier gas ( helium ) flow rate was 25-35 ml rain"* and
the oven temperature 240-255*c.
Authentic prostaglandin F^and the biological
samples were converted to methyl ester trimethylsilyl
ethers, dissolved in 50Jil of BSTFA and 5^ol aliquots
injected into the gas chromatograph• Triplicate
determinations were made for each sample. The instrument
was calibrated for deuterium ( 100 ng per injection ) and
protiura { O-lOO ng per injection ) forms of authentic
prostaglandin F2o<* T^e ^ons Produced in the mass
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spectrometer were focussed and repetitively scanned by
means of an automatic peak selector. The ions chosen
for the analysis were at m/e 423 (m-(90v71)) and 333
(M-{ 2 x 90 + 71)) for the protium. The corresponding
deuterium ions were at m/e 427 and 337.
Qualitative gas chromatography-mass spectrometry
This was performed on an LKB 9000 combined gas
chromatograph-raass spectrometer. The instrument was
equipped with a glass column ( 3 m x 4 mm i.d. ) packed
with 3£ 0V-1 on Supelcoport. The carrier gas ( helium )
flow rate was 35 ml min 1 and the column temperature
245*c. All prostaglandins( authentic and biological )
were prepared as the methyl ester n-butyl boronic acid,
triraethylsilyl ether ( Me NBBTMS ) as described previously
( page ^ ). Under these conditions only F type
prostaglandins with both the 9 and 11 hydroxyl groups
in the cis configuration ( eg 9Of11Hpgf ) will form2 &<
the 9, 11 cyclic n-butyl boronate ether. Consequently
the 9b<ll^PGF2 ^epimer produces the methyl ester
trimethylsilyl ether only.
15-keto PGE^ ; 15 keto PGE^r 15-keto F.^ and 15-keto ^
The 15-keto derivatives of prostaglandins E^;
^2 and F-^were prepared purified and generously
supplied by Dr. R.L. Jones.
Preparation of 15-keto PGF^^y
A sample of solid ( 11 rag ) was transferred
to a 25 ml pear-shaped flask and dissolved in 1.0 ml of
absolute ethanol. This was cooled to approximately 4LO"c
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in a beaker containing ice / acetone mixture. To this
solution approximately 20 m Ci of tritium labelled sodium
borohydride ( Amersham, Na B3h4? 320 Ci mole"1 ) was
added and the contents mixed. After incubating at -10'c
for 60 minutes the solution was diluted to 50 ml with
distilled water, acidified to pH4 with IN HC1 and
extracted twice with two volumes of diethyl ether. The
pooled diethyl ether was washed twice with 20 ml of
distilled water and then filtered through solid Mg SOw.
SetutioA
The diethyl ether^was then taken to dryness and vacuum
desiccated. The residue was dissolved in methanol ( 10 ml )
and an aliquot spotted on neutral silica gel ( 50 mm x
20O nun x 0.1 rnrar on glass ) . Marker standards of authentic
prostaglandin F^yj and F^were spotted at the side of the
sample and then the plate was developed in the FVI system
( Andersen ,Qi , After drying the plate under a stream of
dry air the plate was scanned on a Panax radio thin layer
chromatography plate scanner. Two radioactive peaks were
detectable that corresponded with the authentic prostaglandin
nd standards.
An aliquot ( 3.0 ml ) of the methanol solution
was treated with diazomethane until it remained pale
yellow. After 10 minutes at room temperature the sample
was taken to dryness under reduced pressure and vacuum
desiccated.
The residue was then re-dissolved in 150 jx1 of
re-distilled chloroform and made up to 500yul with
n-heptane. This was applied ( with 2 x 0.2 ml washings )
to a 50 ml bed volume column of lipophilic substituted
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LH-20 gel. This gel was LH-20 ( 30^uM particle size )
substituted to 62% (w/w) with hydroxyalky1 groups
( Cis~ciq)• The column had been thoroughly equilibrated
in situ with a n-heptane chloroform mixture (70s30) prior
to sample loading. The flow rate was 7-8 ml hr"1 and
fractions of 2.5 ml were collected on an LKB Ultrorac
fraction collecter. From alternate fractions 10yal
aliquots were removed and assayed for radioactivity by
liquid scintillation counting. This chromatographic
step enabled the separation of the PGF and PGF„ a
20< 2^5
methyl esters such that on thin layer chromatography in
the GCM solvent system they were greater than 99% pure
with respect to each other.
The residue of the PGF.^methyl ester fractions
was dissolved in methanol ( 5 ml ) and 4 ml was transferred
to a 50 ml pear-shaped flask containing approximately 50
mg of PGF^ methyl ester ( 5 ml methanol ) and the pooled
sample taken to dryness and desiccated. The residue was
re-dissolved in 5 ml of spectroscopic grade 1,4-dioxan
and to this 35 ml of a l#4-dioxan solution containing
2,6 dichloro-3,5-dicyano-para benzoquinone ( DDQ; 25 mg
"*") was added. After mixing the solution was refluxed
at 90*c in a waterbath for 3 hours. At one-hourly
intervals 50yul aliquots were removed, mixed with 4 ml
of 0.1% NaHCO^ aqueous solution ( lg ) and then
partitioned twice with an equal volume of diethyl ether.
The pooled ether fractions were washed, with 2 ml of
distilled water and then taken to dryness. The residue
was re-dissolved in 5 ml of methanol and 2 ml placed in
a silica cell of 3 ml volume and 1 cm pathlength. The
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spectrum between 280 nm and 220 nm was recorded against
a cell containing 2 ml of methanol using a Carey 116
ultraviolet spectrophotometer. After 3 hours UV
absorbence at 235 nm was almost identical with the 2
hour sample. The solution under reflux was then added
to 150 ml of 0.1% NaHC03 solution and solid NaHC03 added
until the pH was 7.5-3.0. This was essential to maximise
the amount of DDQ in the ionised form and thus minimise
the amount excracTtable into diethyl ether. The aqueous
solution was extracted twice with an equal volume of
diethyl ether and the pooled ether washed successively
with 100 ml of 0.1% NaHCO^ solution and 100 ml distilled
water. The ether phase was then taken to dryness under
reduced pressure and the residue vacuum desiccated and
then re-dissolved in 5 ml Analar methanol.
The methyl ester was removed by treating the
sample with 35 ml of methanolic 0.05N KOH overnight at
room temperature. The sample was then diluted with 150
ml distilled water, acidified to pH4 with 10% acetic
acid solution and extracted twice with an equal volume
diethyl ether as described above.
The vacuum dried residue was purified by
reversed phase partition chromatography on Lipidex 1000,
a hydroxyalkyl substituted LH-20 gel. The column used
was 30O ml bed volume and had been equilibrated with a
mixture of methanol, water, chloroform, butanol, glacial
acetic acid ( 50,50,5,5,0.1 by volume ). The sample was
loaded onto the column in 2.5 ml of this solvent and
fractions of 23 ml were collected ( flow rate approximately
-1 106
40 ml hr ). The elution profile was determined by
liquid scintillation counting of 100yul from each fraction.
This step yielded 7.5 mg of 15-keto PGP that was
essentially pure by thin layer chromatography in the FVI
solvent system. Conclusive evidence of identification
was obtained by converting an aliquot to the methyl ester,
o-n-butyloxirae, triraethylsilyl ether ( see page ^ )
and subjecting this to combined gas chromatography-masa
spectrometry.
Incubation and extraction procedures
Whole blood ( 850 ml ) from ewes was treated with
citrate anticoagulent ( 150 ml ) as described previously
( page ). The enzyme preparation was OBTAINED by
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treating the red cells with 100 mM 3odium phosphate
buffer as described previously. The substrate concentration
for all the 15-keto prostaglandins was 28 yiM ( 10yig ml )
and the reaction volume 10 ml. The samples were incubated
at 37*c in a water bath { with agitation ) for 75 minutes.
In all cases the reaction was stopped by the
addition of 150-250 ml of distilled water and immediate
acidification to pH4 with glacial acetic acid. The
aqueous phase was then extracted twice with an equal volume
of diethyl ether-ethyl acetate ( 4:1 V/V ) mixture. The
pooled organic fractions were then washed twice with 20
ml of distilled water before being taken to dryness under
reduced pressure at 40*C and vacuum desiccated.
This residue was then dissolved in 20-30 ml
of aqueous 67% ethanol and partitioned twice with an equal
volume of heavy petroleum, before again being taken to
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dryness and desiccated.
The residue was dissolved in 0.5 to 1.0 ml of
methanol and treated with excess ethereal diazomethane at
room temperature to convert to methyl esters. Where
necessary ( eg if material had precipitated out of
solution ) the resulting solution was filtered through a
glass wool plug inserted in a Pasteur pipette. The
original flask was washed with methanol (5-10 ml) and
this was also filtered. The pooled fitrate was taken to
dryness and desiccated.
Straight phase gel partition chromatography on Lipidex 5000
A glass column ( 350 x 10 ram ) was silanized
by treatment with a 5/6 solution ( v/v ) of dichlorodi-
methylsilane in toluene for 2 hours at room temperature.
The column was then rinsed with successive washings of
chloroform and methanol ( to remove excess silanising
reagent ) and plugged at the base with glass wool, and
sand to a depth of approximately 1.0 cm. The column
was then pecked to a bed volume of 30 ml with Lipidex
50QQ ( a lipophilic Sephadex LH-20 derivative ) as
described previously ( Brash and Jones 1974 ). Prior to
packing, the gel had previously been equilibrated with
a heptane-chloroform mixture ( 80:20 V/V ) and was further
equilibrated in situ with this mixture before use. A
constant pressure head at the top of the column was
maintained and a flow rate of 8-lO ml hr"^ obtained.
The samples were dissolved in 100-200jal of chloroform
and then n-heptane was added until the solvent composition
was the same as the column eluant. The total loading.
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including washings, was never greater than 1.5 ml.
Fractions of 3 ml ( 10?6 bed volume ) were
collected on an LKB Ultrorac fraction collector until
the 2000/6 bed volume point was reached.
The elution profile of the column was obtained
by liquid scintillation counting of an aliquot ( 200 jil )
from alternate fractions. Authentic prostaglandins were
used to calibrate the Lipidex 5000 tfolumn and these were
detected by either liquid scintillation counting or gas
liquid chromatography.
From the elution profile it has been possible
to bulk fractions into zones that have subsequently
been taken to dryness and vacuum desiccated. The residue
from each zone was re-dissolved in methanol (1.5 ml) and
4 x 50jaI aliquots from each quantitatively assayed for
radioactivity by liquid scintillation counting.
Liquid scintillation counting
This was performed with a Mark II Nuclear
Chicago liquid scintillation counter.
Aliquots of either the column fractions or
the methanol solution containing the pooled fraction
residue were counted in 5 ml of a toluene-ethoxyethanol
based scintillation mixture ( toluene, ethoxyethanol
1500? 900 v/v napthalene? 8,5-diphenyloxazole (PPO) and
l,4-di-(2-(4-methyl-5-phenyloxazolyl ))-benzene (dimethyl
POPOP) 112.5? 10.5? 0.9 by weight).
Where dpm were required these were obtained by
correcting for quenching using the automatic external
standard channels ratio method and a quench-calibration
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curve constructed for the scintillation mixture. These
calculations were performed using a POP 3 I computer.
Preparation of derivatives for gas-liquid chromatoqraphv-
mass spectrometry
An aliquot ( 500 jxl ) of the methanol residue
from the appropriate zone of the Lipidex 5000 columns
was taken to dryness under a stream of dry air and vacuum
desiccated in capped Eppendorf tubes. The residue was
derivatised by the methods described previously ( page g-j ) .
The derivatives employed were * MeTMS, Me Eo TMS and
Me N3BTMS.
Combined gas-liquid chromatography-mass spectrometry
Mass spectra were obtained using an LKB 9000
combined gas-chromatograph-mass spectrometer. The
instrument was equipped with a glass column ( 3 m x 4 ram
i.d. ) packed with 3% OV-1 on Supelcoport ( 100-120 mesh )•
The oven temperature was 225-235*c and the carrier gas
(helium) flow rate was 30-35 ml itiin-1.
Authentic prostaglandins were injected in 5-10
^ll of BSTFA.
Solvents and chemicals
All solvents were of analytical grade or re¬
distilled before use. The chloroform was re-distilled
over anhydrous calcium chloride and 1% ( by volume ) of
absolute ethanol was added to the redistillate for
stabilisation purposes.
The metabolism of 15-keto PGE^, by sheep whole blood and
cellular fraction
Freshly collected sheep blood was mixed with
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citrate anticoagulant ( 85:15 v/v ) and separated into
plasma and cellular fractions by centrifugation (at 4*c)
for 20 minutes at 1875 x g as described previously
( page go >•
Aliquots ( 10 ml ) of whole blood, plasma and
cellular fraction were incubated with 15-keto PGE2 at a
substrate concentration of 28 jiM ( Sp.Ac, 2C:mole~^ )
for 75 minutes in a water bath ( with agitation ) at
37*c. The products of the reaction were extracted,
purified, quantitatively and qualitatively assayed by
the methods described on page' 107 ♦
The metabolism of 15-keto PGE^ by sheep blood cellular
fraction with time
Haemolysed sheep blood cells were obtained from
freshly collected sheep whole blood after treatment with
citrate anticoagulant by the methods described previously
( page go ).
Three aliquots ( 10 ml ) were incubated with
15-keto PGE2 at a substrate concentration of 28 jxM.
( Sp.Ac. 2Ci mole--1- ) for 5, 15 and 75 minutes respectively.
The incubation was performed in a water bath ( with
agitation ) at a temperature of 37 *c. The reaction products
were extracted, purified, qualitatively and quantitatively
assayed by the methods described on page: 1Q7
The effect of incubation pH and temperature on the metabolism
of 15-keto PGE^ and 15-keto PGE^ respectively by sheep blood
cellular fractions
The haemolysed red cell fraction of fresh sheep
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blood was prepared as described previously ( page; ).
In all cases the substrate concentration for both 15-keto
PGE2 ( Sp.Ac. 2 Ci mole"3, ) and 15-keto PGE^ { Sp.Ac. 2
Ci mole 1 ) was 28yuM, the incubation volume 15 ml and the
duration of incubation 5 minutes.
The pH study was performed by using 10% aqueous
acetic acid solution to acidify the enzyme preparation
from pH 5.5 to 7.0 and 0.1M sodium hydroxide aqueous
solution for pH 7.5 and pH 8.0. The substrate used for
this study was 15-keto PGE2 and the incubation ten$>erature
was 37*c.
The temperature profile was obtained by incubating
15-keto PGE^ with the en2yrae preparation at the given
temperature.
The incubation products were extracted, purified,
qualitatively and quantitatively assayed by the methods
described previously ( page* -jq7 ) .
A comparison of the enzyme activity in blood samples from
normal female and male with pregnant female and castrated
male sheep
Freshly collected sheep whole bbod was collected
and immediately mixed with citrate anticoagulant ( 85:
15 v/v ) as described previously ( page 53 ).
Prostaglandin E^ ( 2.8^uM l.Oyi Ci ) was
incubated with 50 ml aliquots of sheep whole blood at
37*c in a water bath ( with agitation ) for 75 minutes.
The incubation was stopped and the products extracted
by the addition of 5 volumes of ice-cold ethanol and
thorough mixing. After 30 minutes at room temperature
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the mixture was centrifuged at 1875 x g for 15-20 minutes
at 4*c. The supernatant was transferred to a 1000 ml
flask and the precipitate washed with an equal volume of
ethanol before being centrifuged. The pooled supernatants
were taken to dryness and the residue extracted into
ethyl acetate and purified by thin layer chromatography.
Quantitative analysis was performed by liquid scintillation
counting and conclusive qualitative analysis by combined
gas chromatography-mass spectrometry. The details of
these methods have been described previously (pages &93 )•
The metabolism of 15-keto PGfc^ by human blood sampled^..
Fresh human blood ( 10-30 ml ) was collected by
venepuncture and mixed with citrate anticoagulant
( 5sl v/v)• Eight normal healthy males and one female
each donated 50 ml of blood for this stud/. In all cases
the 15-keto PGE2 substrate concentration was 28yiM; the
reaction volume 10 ml; the incubation temperature 37*c
and the duration of incubation 75 minutes.
The incubation products were extracted by the
methods described on page 107 and purified after
conversion to methyl esters on a Lipidex 5000 straight
phase gel partition chromatography column by the method
described previously on page . The quantitative
analysis was performed by liquid scintillation counting
of aliquots ( 4 x 50jjlI ) of the residue ( 1.5 ml )
obtained by pooling the fractions obtained from the
Lipidex 5000 column. Conclusive qualitative analysis
was performed by combined gas chromatography-mass
spectrometry using the derivatives previously described
(page 61 ).
113
Attempts to prepare prostaglandin analogues for
substrate specificity and metabolism studies
a) PGE_-1 alcohol
The method of Schneider, Pike and Lincoln (1973)
was used. A sample of solid prostaglandin E2 (io mg )
was transferred to a 50 ml pear-shaped flask containing
a methanol solution ( 10 ml ) of -labelled PGE0
urn
( Amershamj Sp.Ac. 147 Ci m mole-1; SOyuCi ). The solid
PGEj waa dissolved in the methanol and the sample converted
to the methyl ester by the method described on page 61 )•
The resulting solution was taken to dryness and vacuum
desiccated. The residue was re-dissolved in 10 ml of
anhydrous pyridine followed by the addition of solid
hydroxylamine hydrochloride ( Ca. lOO rag ) . After the
solid had been dissolved the resulting solution was
heated at 70*c for 2 hours to produce the corresponding
oxime of the PGE^ methyl ester. Whilst the sample was
allowed to come to room temperature an aliquot ( 50 yal )
was transferred to a test tube containing 2 ml of
distilled water at pH4 ( with 6NHC1 ). This was extracted
twice with an equal volume of diethyl ether. The pooled
ether fractions were taken to dryness and the residue
dissolved in 100-200yul of a pyridine solution containing
O-substituted n-butyl hydroxylamine hydrochloride salt
and 50of BSTFA as described on page 62 • When
subjected to gas chromatography this sremple was found
only to contain the methyl ester hydroxylamine oxime
analogue of PG£2 and thus it was concluded that the original
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reaction was complete.
The original reaction medium was diluted with
100 ml of distilled water acidified to pH4 with 6 NHC1
( to ensure complete ionisation of any residual unreacted
oximating reagent ) and extracted twice with an equal
volume of diethyl ether. The pooled ether phases were
washed twice with 20 ml of distilled water and then
taken to dryness under reduced pressure. The residue
was transferred in methanol to a 50 ml pear-shaped flask,
taken to dryness and vacuum desiccated for approximately
60 minutes before being re-dissolved in 2 ml of anhy rous
solvent T(K©ck tugktr).
A freshly prepared solution of lithium aluminium
in t
hydride ( c 50 mg ml~^ ) was added dropwise to the reaction
vessel until 3 to 4 ml had been added. The reaction
vessel contents were thoroughly mixed and the vessel neck
sealed with a cotton wool plug. The contents were allowed
to react at room temperature for 6C minutes before ethyl
acetate was added dropwise to react with and neutralise
the excess lithium aluminium hydride. During this process
the reaction vessel was kept cool with an ice/acetone
mixture. After the addition of 25 ml of ethyl acetate the
reaction mixture was left at room temperature for 15
minr&es before being diluted with 100 ml of distilled
water. This was then extracted twice with an equal volume
of ethyl acetate. The pooled ethyl acetate was reduced
to a constant volume ( ca. 5 mlj mainly non-volatile
solvent T ) under reduced pressure. An aliquot ( 10jx1 )
of the resulting oil when converted to the trimethylsilyl
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ether derivative ( by the method described on page 54 )
had gas chromatographic and mass spectral properties
consistent with it being the O-hydroxylsmine oxime
analogue of prostaglandin alcohol.
The resulting oil was then applied to a 25 g
column of silicic acid equilibrated in toluene-ethyl
acetate ( 80 t 20 v/v )• The column was eluted ( under
negative pressure ) successively with toluene ( 250 ml )
toluene-ethyl acetate-methanol ( 250 ml, 40t59:l by vol.)
and methanol ( 50 ml ). Each fraction was taken to dryness
under reduced pressure and the residue re-dissolved in 5 ml
of methanol. Aliquots of each fraction were assayed for
radioactivity by liquid scintillation counting. Fraction
1 was found to contain the majority of solvent T but
fraction 2 to contain the majority of radioactivity. The
residue from fraction 2 was taken to dryness and vacuum
desiccated before being re-dissolved in 5 ml of 90%
aqueous acetic acid and cooled to O-5'c. To this solution
10 ml of 6 M sodium nitrite ( at 5*c ) was added and
the contents allowed to react ( at 5'c ) for 60 minutes.
The products were then extracted twice with an equal
volume of diethyl ether and the pooled ether phases
washed with 10 ml of distilled water ( twice ) before
being taken to dryness under reduced pressure. The
residue from the ether was re-dissolved in 5 ml of methanol
and an aliquot (25 jxl )' transferred to a capped Eppendorf
tube. This was taken to dryness and reacted with 10G-
200yul of a pyridine solution containing the o-substituted
n-butyl hydroxylamine hydrochloride salt and 50 nl BSTFA
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as described on page 52 . An aliquot of the resulting
solution was subjected to combined gas chroraatograph-mass
spectrometry using an LKB 9000 instrument.
14
b) C-labelled prostaglandin
Dihomo- y-linolenic acid { 8, 11, 14-
eicosatrienoic acid ) labelled with ^4c in thecarbo||rlic
acid position was purchased from New England Nuclear
with a specific activity of 58.8 Ci mole"^. The hexane
solution purchased contained approximately 750 uCi of
1 4
C radioactivity ( Ca 3.9 mg ). This was diluted to
approximately lo ml with n-hexane and an aliquot ( lo ill )
was applied to a neutral silica gel thin layer
chromatography plate ( 50 mm x 200 mm x 0.25 mm on glass ).
After development in a n-hexane-ether-glacial acetic acid
( 70:30*1 by volume ) mixture the plate was scanned for
radioactivity using a Panax radio thin layer plate scanner.
The radiochemical purity was found to be greater than 98%.
This dihomo- ^ -linolenic acid was then incubated with
an acetone powder preparation of the ram seminal vesicle
prostaglandin synthetase.
The acetone powder was prepared from fresh
deep-frozen ram seminal vesicles by the method Wallach
and Daniels (1971). Deep-frozen ram seminal vesicles
( 1C4.8 g wet weight ) were cut into pieces ( 1-2 car* )
and stored on ice until homogenised. Homogenisation was
performed in 210 ml of 0.154 M ( 11.6 g h~l ) KCl ( BDH
analar ) using a Polytron homogenisar at maximum speed.
The homogenate was centrifuged at 2500 x g for 20 minutes
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at 4*c • The resulting supernatant was filtered through
cheesecloth to remove aggregated fat and cellular debris
and then acidified to pH 4.8 by the addition of solid
citric acid. This solution was thoroughly stirred and
then centrifuged at 4O0O x g for 15 minutes at 4*c.
The supernatant was carefully decanted off and blen< ed
twice with 10-15 volumes of acetone at -35*c. The
it
resulting precipate was filtered under reduced pressure
A
through a Whatman No. 1 filter paper ( at O'C ) and then
vacuum desiccated until no solvent scent could be detec^r/d.
A sample of this enzyme preparation ( 102 mg )
was incubated with arachidonic acid to check that under
the conditions to be employed for dihomo- -linolenic
acid \ ; a sufficiently high yield of prostaglandin
£2 would result. The conversion ( measured by U.V.
spectroscopy ) of arachidonic acid to PGE2 was 56-S8&.
The dihomo- ^ -linolenic acid solution ( 750
yaCi 3.9 rag ) was taken to dryness in a 50 ml pear-3haped
flask and vacuum desiccated. The residue was re-dissolved
in 130jil of absolute ethanol to which 7.3 ml of sodium
EDTA buffer ( pH8.0» 31.2 mM ), 2.6 ml of reduced
glutathione ( 10 rail ) and 2.6 ml of hydroquinone { 2.5 mM )
solutions were added. The sample was incubated at 37*c
for 5 minutes and then 435 mg of the acetone powder
of the prostaglandin synthetase was added and the mixture
incubated at 37*c for 30 minutes in a water bath with
constant stirring. The reaction products were diluted
with 100 ml of distilled water, acidified to pH4 with
glacial acetic acid and extracted twice with two volumes
of diethyl ether. The pooled ether was washed twice
with 25 ml of distilled water and then taken to dryness
and vacuum desiccated. The residue was re-dissolved
in 25 ml of 67% aqueous ethanol and partitioned twice
with an equal volume of heavy petroleum. Both phases
were taken to dryness for purification by reversed phase
partition chromatography.
The 67% aqueous ethanol residue was re-dissolved
in 5 ml of methanol and the heavy petroleum residue in
5 ml of n-hexane. An aliquot from each sample was applied
to a neutral silica gel thin layer chromatography pi ite
( 50 mm x 200 mm x 0.25 mm on glass.) Marker standards
of prostaglandins E2 21x1(1 D2 ^ ca* ®^ each ) were
applied at the side of the 67% ethanol aliquot. This
plate was developed in the FV1 solvent system of Andersen
( Andersen 1969 ) whilst the other plate was developed
in n-hexane-ether-glacial acetic acid ( 70:30sl by
volume). After development both were scanned for
radioactivity using a Panax radio thin layer chromatography
plate scanner. The 67% ethanol plate was in addition
sprayed with a saturated solution of phosphomolybdic acid
in ethanol and then heated for 15 minutes at 110*c to
develop the marker prostaglandins. The major peak on
thir layer chromatography of the material in the 67%
aqueous ethanol residue corresponded to authentic PGE
A
( and PGE^ are not resolved on this thin layer system )
whilst the major component of the heavy petroleum had
chromatographic properties compatible with it being
unreacted dihomo- ^ -linolenic acid. Both fractions.
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however, were contaminated with other radioactive compounds
and thus required purification.
The methanol solution containing the 67% aqueous
ethanol residue was taken to dryness and vacuum desiccated.
The residue was re-dissolved in 0.5 ml of a mixture
containing methanol, water, chloroform, butanol, glacial
acetic acid ( 50;50:5:5:0.1 by volume ) and applied to a
35 ml bed volume of Lipidex 1000 equilibrated in this
solvent. Fraction of 3.5 ml were collected on an LKB
Ultrorac fraction collecter and assayed for radioactivity
by liquid scintillation counting. This step resulted in
the purification of the 14c PGEX ( fractions 24-27 )
such that it was greater than 98% radiochemically pure
on thin layer chromatography in the FVl solvent system.
The heavy petroleum residue was purified by
reversed phase partition chromatography on a column
( 80 ml bed volume ) of Lipidex 5000. The sample was
dissolved in 1.0 ml of a mixture containing methanol-
water-dichloroethane-glacial acetic acid ( 800:200:100:
1.1 by volume ) and applied to the Lipidex 5000 column
previously equilibrated in this solvent. Fractions of
8.0 ml bed volume were collected on a LKB Ultrorac
fraction collecter and assayed for radioactivity by liquid
scintillation counting. This step resulted in the
purification of the dihomo- ^ -linolenic acid to greater
than 98% radiochemical purity as determined by thin layer
chromatography.
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c) 15-Q methyl ether PGE-^ methyl ester
A methanol solution (15 ml) of ^ ia3?
10 yuCi ) was converted to the methyl ester by the treatment
with excess ethereal dia zometnane as described on page 61
The solution was taken to dryness and vacuum desiccated
for 30 minutes before being re-dissolved in approximately
3 ml of freshly prepared ethereal diazomethane. To this
solution 2 drops of 1% solution (v/v) of boron triflouride
etherate in anhydrous diethyl ether ( sodium dried ) v/as
added. The diazoraethane solution instantly turned from
a golden yellow to a pale straw colour after which tie
solution was diliggsd with 25 ml of distilled water and
partitioned twice with an equal volume of diethyl ether.
The pooled et/ier fractions were twice washed with 10 ml
of distilled water before being taken to dryness and
desiccated.
The residue was re-dissolved in 0.5 ml of a
n-heptane-chloroforra mixture (80*20) and purified by
straight phase gel partition chromatography on a column
of Lipidex 5000 equilibrated in the solvent mixture. The
column had a bed volume of 25 ml and fractions of 2.5 ml
were collected on an LKB Ultrorac fraction collecter.
These were assayed for radioactivity by liquid scintillation
counting using the methods described on pages 85 &. 88rwo
peaks of radioactivity were detected. The first ( fractions
6-8 ) contained material identified by combined gas
chromatography-mass spectrometry as the 11,15-di-o-raethyl
ether methyl ester of PGE^. The second peak ( fractions
11-14 ) contained material that had mass spectra compatible
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with it being a mixture of the 11 and the 15 mono-o-
xnethyl ether methyl esters of PGE2# The material in
this peak was re-chromatographed on a column ( 55 ml
bed volume ) containing lipophilic LH-20 ( 30 /iM particle
diameter ) substituted to 62% (w/w) with C15-C18
hydroxalkyl side chains. The eluting solvent was a
mixture of n-heptane-chloroform ( 90;10 v/v ). The
sample was loaded on to the column in 0.5 ml of this
solvent mixture and fractions of 2.5 ml were collected
on an LKB Ultrorac fraction collecter. Alternate fractions
were assayed for radioactivity by liquid scintillation
counting. Two peaks of radioactivity were detected by
'jjf-thi^ method. The material in the first ( fractions
■ " ! - . • •- f -
30-35 ) had a mass spdctrum compatible with it being the
; .i ' ' V
11 mono-o-methyl ether methyl ester of PGE2 whilst material
in the second ( fractions 70-77 ) had a mass spectrum
compatible with it being the 15 mono-o-methyl ether of
pge„. rv
f ,





The metabolism of prostaglandin blood samples from
the sheep; rabbity eat? dog? guinea-pig; horse; cow; rati
chicken and man
After incubation of 3H-labelled prostaglandin
1*2 with the above citrated blood samples, only sheep
whole blood had apparently metabolised the prostaglandin
as determined from the thin layer radio-scans. In the
case of sheep whole blood two peaks of radioactivity were
observed as described previously ( page figure 9 )•
An example of the thin layer radxo^scans obtained from
the sheep, cat, guinea-pig and human blood is shown in
figure f j page . The two peaks obtained from the
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sheep blood sample had Rf values corresponding with their
being the original prostaglandins E2 ( least polar ) and
prostaglandin F . The Rf values of several prostaglandins
on this thin layer chromatography system are given in
Table 5 °n page . The metabolite, tentatively
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identified as prostaglandin F2^comprised 43% of the
radioactivity recovered from the thin layer plate. When the
«net»bolil"i
^subjected to radio gas chromatography as either the methyl
ester, O-raethyl oxime, triraethylsilyl ether or the methyl
ester, n-butyl boronate, trimethylsilyl ether derivative,
only a peak of radioactivity was observed corresponding
to the relative volume of 3H-labelled prostaglandin F2^.
An example of the radio gas chromatography of authentic
H-labelled prostaglandins '2 R and F2^ and the sheep blood
metabolite is shown in figure )X on page . When
subjected to combined gas chromatography-mass spectrometry
122
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Figure 11a. Thin layer radio scans obtained from the
products produced by incubating ^ PGE.,
with sheep, cat, guinea-pig and human
whole blood. The experimental details
are described on page 84.
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F VI GCM FV1 x 1
double double plus
development development GCM x 1
Cornpowids
(free acids)
WF2 ^ 0,10 0.15 0.13
0.16 0.24 0.21
PGEp 0.20 0.35 0.29








PGA2 0.61 0.67 0.57
Table 3. The Rf values of some prostaglandins and
their metabolites on thin layer chromatography








SHEEP B LOO D
i ...... -N-rniL
Figure 12. Radio gas liquid chromatography of
authentic % prostaglandins and F2^
methyl ester trimethyl silyl ethers (upper)
and the corresponding derivative obtained
from the PGF2^ zone of t.l.c. plates
after sheep blood had been incubated with
PGE2 (lower).
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as both of the above derivatives, the sheep blood metabolite
was conclusively identified as prostaglandin Example®
of mass spectra obtained are shown in figure 13 on
page -j 26
Characterisation of the 9-keto reductase present in sheep
whole blood
When incubated with the plasma? buffy. layer?
red cells? haemolysed washed red cells and the resulting
haemolysate, prostaglandin was only metabolised to
prostaglandin F to a similar extent as whole blood by
the red cells and haemolysed red cells. The buffy- layer
did metabolise prostaglandin b2 to prostaglandin F2ft<but
the conversion was only 6.3% of the corresponding metabolism
by whole blood. This was possibly due to contamination
of the buffy layer by red cells, however, this requires
further clarification. It was thus apparent that the i^aVr
fraction of the enzyme responsible for the metabolism of
prostaglandin E^ to prostaglandin was in the
erythrocyte fraction of sheep blood.
The effect of temperature and mH on the 9-keto reductase
The enzyme present in haemolysed red blood cells
and capable of reducing the 9-keto group of prostaglandin
was found to be heat labile. The values quoted in
tables and on page ^29 anc* represented graphically
in figures on pages 127&£bhow that incubation at
temperatures above 50 *c, as did prolonged incubation at
50*c, destroyed the ability of the haeroolysed red cells
to metabolise prostaglandin It can also be seen fro m
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Figure 13. Mass spectra of authentic prostaglandin F2^
methyl ester, 9> 11 cyclic n-butyl boronate,
15 trimethyl silyl ether (upper) and the same
derivative of the material obtained from
3
sheep whole blood incubated with H PGE2
and previously identified by t.l.c.
and radio gas liquid chromatography as
PGF2U *
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Figure 14. The effect of incubation temperature





TEM PE RATURE ( °C )
Figure 15. The effect of pre-incubation on the
3 1
conversion of H PGE2 to PGF^
by sheep blood.
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apparently activated by either pre-treatment or incubation
at temperatures up to 45•<;. The reason for this activation
is unknown, but it is possible thet it may be due to a
heat labile inhibitor being inactivated at these temperatures
more quickly than the 9-keto enzyme.
Table
The effect of pre-incubation temperature on the 9-keto
reductase activity in sheep haemolysed red cells.
sample
pre¬
incubation 1 2 mean value
temperature
(0-c)
37 100 100 lOO
40 174.31 143.15 158.73
45 132.08 126.86 129.47
50 99.76 89.72 94.74
55 0 11.27 5.64
The values quoted represent the recovered
radioactive material in the PGF^^zone of thin-layer
plates relative to the value recovered from the 37*c
incubation control.
Table *7
The effect of incubation temperature on the 9-keto
reductase activity in sheep haemolysed red cells.
Incubation Percentage radioactive material in PGF^^
temperature zone of thin-layer plates relative to
(0*c) the values recovered from the 37*C
incubation control
28 H : 11
37 100
40 120 . 82
45 137 . 08
50 56 • 64
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The effect of pH on the 9-keto reductase
activity is indicated in table S below and
graphically shown in figure I fa on page 131 • There,
is an apparently sharp pH profile, with the optimum
activity around pH 7.0. The substrate ( 3h-PGE2 ) is
relatively unstable above pH 9.0 and therefore atte pts
to obtain values for enzyme activity at pH values greater
than 9.0 were not made. Nevertheless, it can be seen
that the activity is rapidly lost outside a narrow pH
range.
Table 8
The effect of pH on the 9-keto reductase activity in
sheep haemolysed red cells.
Sample
Incubation 1 2 mean value
PH
5.0 0 13.2 6.6
5.5 16.1 - 16.1
6.4 - 44.5 44.5
7.0 100 100 100
7.7 - 19.3 19.3
8.0 41.4 - 41.4
8.4 - 16.5 16.5
9.0 32.2 23.1 27.6
The values quoted represent the recovered
radioactive material in the PGF^zone of the thin-layer
plates relative to the value from the 37'c incubation
control.
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Figure 16. The effect of incubation pH on the
conversion of PGEg to PGF2^
by sheep blood.
I JC.
Co-factor requirements for the conversion of PGE^. to PGF2q^.
by haemolysed sheep red blood cells
The values quoted in Table ^ below
represent the amounts of prostaglandin P2 ^( as a
percentage of the total recovered radioactivity ) produced
by haemolysed sheep red blood cells when incubated with
prostaglandin in the presence and absence of various
cofactors. None of the cofactors tested produced marked
changes in the total conversion of prostaglandin to
prostaglandin F . The reverse reaction, namely the
2X
conversion of prostaglandin F to prostaglandin E_ wastot ~ £
studied.
Table
The effect of various reduced cofactors on the




(2mM) 1 2 mean value







Flavin mononucleotide 102 lOO 101
Flavin adenine
dinucleotide lOO 106 103
The values quoted represent the recovered
radioactive material in the PGF^^zone of thin-layer
plates relative to the value recovered from the 37*c
incubation control
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In none of the examples tested was the recovered
radioactivity present in the prostaglandin E2 zone of
the thin-layer plates greater than 2%. It was thus
concluded that the reverse reaction was not occuring at
a significant rate under the conditions tested. The
prostaglandin F,^ produced from the prostaglandin E£
was conclusively identified { after conversion to the
methyl ester triraethylsilyl ether ) by combined gas
chromatography-mass spectrometry. Mass spectra recorded
at the crest of the gas chromatography peak corresponding
to authentic prostaglandin essentially the MM
as that shown in figure 38 on page 211 . Prominent
ions were at m/e, 584 (M+) 7 569 (M-15) 7 513 (M-71) 7 494
(M-90)j 423 (M-9071) 7 404 (M-2x90) 7 333 M-< (2x90) + 71 ) 1
2177 1997 191 and 173.
The possibility that changes in rate of
prostaglandin to conversion would not be apparent
from measurements of the conversion after 75 minute
incubations existed. Similarly, it was desirable to
confirm the quantitative results obtained v- the radio¬
chemical method as being valid. Both these problems were
tested, by comparing the values obtained for recovered
prostaglandin Pausing the radiochemical method and a
deuterium isotope dilution technique for different incubation
times, in the presence and absence of added NADH and HADPH.
The values obtained for the two methods are shown in
Table 10 on page 134 .
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Table IQ
The effect of ixedh and NADPH on the conversion
of prostaglandin E^ to prostaglandin ^aera°lysed
sheep red blood cells as determined by two different
isotope dilution methods.
Sample
Incubation no added NADH added NADPH added
time cofactor (2mM) (2mm)
(minutes) 3h 2h 3h 2h 3h 2h
25 31 29 32 29 23 31
50 46 45 43 46 44 45
75 58 59 60 61 62 60
3 = radiochemical method
2
h = deuterium method
3
The values quoted in the h columns represent the recovered
radioactive material in the PGF25tzone as a percentage of
the total recovered radioactivity. The values quoted in
the h columns represent the prostaglandin F^as a
percentage of the total ?GE2 recovered when
assayed by multiple ion detection combined gas chromatography-
raass spectrometry.
It can be seen from the results quoted in Table IV
above that both methods give essentially the same
result and that neither NADH nor NADPH would appear to
influence the conversion of PGE2 to PGF2 by haemolysed
sheep red blood cells.
Substrate specifity studies
a) PGE2; 15(R)PGt2? FGE2 methyl ester; PGl^ r 13.14-dihvdro-
PQb1? PGA2? PGB2 and a-iso-PGL^
Two quantitative assay methods were employed for
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the analysis of the zones obtained from the thin-layer
chromatography plates. One method employed for
prostaglandins ^ ^^kyl ester; E^; A2 and was
baaed on the recovery of the 3H-labelled material. The
other method used for prostaglandins 15(R)E2; 13,14-
dihydro-PGE^ and 3-iso-PGE^ was a quantitative form of
gas chromatography utilising omega-dihomo-PGE and
omega-dihomo-PGF^ as the internal standards respectively
for the E and F*< zones obtained from thin-layer
chromatography. The results obtained are presented in
Table || on page 136 .
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Table /1 _
Enzyme activity with different substrates,
sample
substrate 1 2 mean value
*PGE0 (free acid) 100 100 lOO
raethV1 e3ter lOO 101 100.5
215(R)PGE2 22 19 20.5
* PGE^ 106 104 105
2
3-iso PGE^ 4 10 7




*PGB_ 0 0 0
* assayed by radiochemical method
2 assayed by the quantitative gas chromatographic method
The values presented represent the recovered
material in the PGF ^zones of the thin-layer plates
relative to the value obtained from the PGF^^zone when
PGE2 free acid was used as a substrate.
The material from each E and F^zone was conclusively
identified by combined gas chromatography-mass spectrometry.
Prostaglandins A2 and B2 were apparently not substrates
and therefore these samples were not subjected to gas
chromatography-mass spectrometry. The mass spectrum of
authentic 3-iso-prostaglandin and the material obtained
from the 3-iso F-^ zone from thin layer chromatography are
shown in figure 17 on page «j -grj .
It was apparent from these substrate specificity
studies that the enzyme present in sheep blood and capable
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210 250 290 330 310 410 450 490 530 530 610
M/E
Figure 17. NUI spectra of authentic 8-iso-PGF^ ^
methyl ester trimethyl silyl ether (upper)
and the corresponding derivative of the
material obtained from the 8-iso-PGF^ ^
zone on t.l.c. of the extract of sheep
blood incubated with 8-iso-PGE^ (lower).
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of reducing prostaglandin E2 to F2 ^had certain substrate
structural requirements for maximal enzyme activity. It
was apparent from the results obtained with prostaglandins
8-iso-E^• 13,14-dihydro E1? 15{R)?GE2 and PGB2 that the
configuration of the atoms around carbons C-7j c-8y C-12;
C-131 C-14 and C-15 was essential for maximal activity.
Similarly the presence of a hydroxyl group at C-ll is
indicated as being essential for enzyme activity from the
result with prostaglandin as substrate. Since
prostaglandins and E2 methyl ester were equally good
substrates as prostaglandin E2 the 5,6-cis double bond
and the C-l carboxylic acid are apparently less essential
for maximal enzyme activity. Consequently it was decided
to investigate what effects on enzyme activity would be
caused by substituting ketonic functions for the hydroxyl
groups at C-ll and C-15. In addition it was hoped to
ascertain whether these ketonic functions would also be
reduced to hydroxyl groups and therefore further characterise
the substrate specificity of the enzyme system.
b) Prostaglandin
Prostaglandin D0 is a structural isomer of
prostaglandin as shown by figure | on page 3
When reduced with sodium borohydride, prostaglandin
unlike prostaglandin produces only one of the two
hydroxyl isomers possible ( R.L. Jones, personal communication).
The configuration of the resulting hydroxyl group is 0(
and thus the product is prostaglandin F2^. The possibility
that the enzyme system of haemolysed sheep red blood cells
that stereospecifically reduced the 9-keto function of E
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prostaglandins to the 90< -hydroxyl group may also
reduce the 11-keto group of D prostaglandins to either or
both the 11&<or 11^ hydroxyl epimers had to be considered.
Preliminary results indicated that the thin-layer
chromatography systems tested ( G.C.M., FVI and AI )
would not offer a sufficient separation of the llb<and
llyghydroxy epimers of prostaglandin ^(unpublished
results ). Consequently the separation of these two
h
epimers had to be performed using a lipophilic substituted
LH-20 gel chromatography system. An example of the
separation of authentic prostaglandins • 9K, 110<,
PGF2; g K Hp, PGF2 and 9yS , 11^, PGF2 on this
chromatographic system as their corresponding methyl
esters is shown in figure IS on page . Using
this system the separation of the 9 llfc<and 9S< , 11^3
epimers was greater than 98% with respect to each other.
The products obtained after a 100 minute incubation of
prostaglandin with three batches of this en2yme
preparation were subjected to chromatography on this
system, after extraction and conversion to methyl esters.
The zones corresponding to 9^<11V£>GF2 were detected by
liquid scintillation counting and from these the zones
corresponding to 9&ll^epimer were predicted. When the
material from each zone was subjected to combined gas
chromatography-mass spectrometry as the methyl ester,
n-butyl boronate, trimethylsilyl ether only 90<llfc(
PGF2 (PGF2* ) was detectable. An example of the gas
chromatographic trace obtained is shown in figure
on page 1^1 . It was thus concluded that prostaglandin
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BED VOLUMES
Figure 18. The separation of the methyl esters of
prostaglandins D2, 9 u , 11 p PGF'2;
9 u , 11V PGF2 and 9p 11 V PGF2 on
straight phase gel partition chromatography.
The column used was a lipophilic Sephadex
LH-20 derivative eluted with heptane,
chloroform (70:30 v/v). The details are
described on page 100.
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MASS SPECTRUM
Figure 19. Gas chromatography traces (total ion current)
obtained for authentic prostaglandins
11 * PGF2(^ (A), 9« 11£ PGF2k, (B) and
the product obtained by incubating PGD^
with sheep blood (C) and previously
identified as 9# 11 0^ PGF2 ^ -like on
straight phase gel partition chromatography
when derivatised as the methyl ester, cyclic
n-butyl boronate trimethylsilyl ether.
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Dj# like prostaglandin is reduced to prostaglandin
^2^by sheep red blood cells.
The rate at which these two substrates are
converted to prostaglandin F20fc*>y this enzyme was
quantitatively determined for six samples by multiple ion
detection combined gas chromatography-mass spectrometry.
The samples were assayed as the methyl ester trimethylsilyl
ether. The values for the recovered prostaglandin F2 ^
for each substrate obtained from 0.2 ml aliquots of the
enzyme preparation are shown in Table IZ on page .
„ 143Table
The quantities of prostaglandin F produced













bstrate 1 20 15 20 18 24 21 19.7 0.3 0.12 0.09
5 75 60 70 55 33 73 69.3 1.0t 0.14 1.05
10 130 120 140 150 190 170 150 2.6 1.06 6.3
D2 15 190 180 210 230 230 240 222 §.66 1.5 13.4
30 410 420 3 50 390 500 390 410 5.0 2.0 25 .0
60 580 550 480 520 590 530 542 4.0 1.66 16.5
90 660 600 550 610 690 640 625 4.9 2.0 24 .3
1 16 10 18 13 17 12 14.3 0.31 0.13 0.10
5 45 32 49 36 51 41 42.3 0.74 0.30 0.55
10 82 79 83 73 94 79 81.6 0.7 0.28 0.49
15 116 115 118 111 131 113 119 0.75 0.31 0.57
30 365 370 380 290 340 380 355 3.45 1.41 11.93
60 562 520 480 450 570 570 526 5.1 2.09 26.37
90 650 610 520 580 640 630 605 4.8 1.9 23.5
The values quoted are nanograms of PGF2^per 0.2 ml of
enzyme preparation. The values for each sample were
obtained from triplicate determinations and are the mean



















































































































































c) 15-keto PGEj^; 15-keto PG£_; 15-keto PGF^ and 15-keto
PGF
2&
When incubated with sheep whole blood, 15-keto
PGE^ was found to be metabolised to a variety of compounds
that were purified and provisionally identified (as their
methyl esters) by chromatography on Lipidex 5000. An
example of the elution profile obtained i3 shown in
figure page , „ . The two major metabolites
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(peaks C and D) were conclusively identified by gas
chromatography-mass spectrometry as prostaglandins Eo and
The mass spectrum of the prostaglandins
produced when derivatised as the methyl ester, isopropyloxime
trimethylsilyl ether is shown in figure Q! on page 147
and WaS identical with authentic prostaglandins E
p
. Confirmation that the two ring hydroxyl group
were both cis (ie. 90<, 11 6<) in the material identified
as prostaglandin F^^was obtained by means of the 9,11
cyclic n-butyl boronate derivative. The major evidence
for the assignment of the hydroxyl configuration at C-15
being 15(S) and not 15(R) was that on Lipidex 5000 the
15(S) and 15(R) epimers of PGS are separated ( Brash
and Jones, 1974 ). However, although the methyl ester
iso-propyloxime, trimethylsilyl ether derivatives of
15(S) and 15 (R) PGE^ did not separate on the gas
chromatography system employed, there were certain
noticeable differences in their mass spectra, particularly
of the first isomer eluted from the gas chromatograph.
For example in the 15(R) derivative major ions are
146
BED VOLUMES
Figure 20. The elution profile from a Lipidex 5000
gel partition column of the products
( after conversion to methyl esters )
obtained by incubating 15-keto PGE2 with
sheep whole blood at 37*C. The
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500 540 580
Figure 21. The mass spectra obtained for authentic
PGE2 (upper) and the material in the PGE2
zone (lower) obtained from Lipidex 5000
( peak C, figure 20, page 146 ) after
15-keto PG£2 was incubated with sheep blood.
The derivative analysed in each instance
was the methyl ester isopropyloxime,
triraethylsilyl ether, produced as described
on page 61•
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present at nye 437 and 451 whereas in 15(S) PdE, these are
virtually absent. In the material identified above as a
PGE^ these ions at m/e 437 and 451 were virtually absent
and therefore it was concluded that the material was
15(S) PGE2.
The material eluted in peak B was divided into
two portions, and B2» The portion, (fractions
23-31) was conclusively identified by combined GCMS as
being mainly 15-keto prostaglandin F0^. The2 ™ flHifer
portion, (fractions 32-39) of the recovered material
was identified as being a mixture of 15-keto prostaglandin
&2 and 13,14-dihydro-prostaglandin Although this
latter prostaglandin was identified the corresponding
13,14-dihydro PGF^^wss not detected in any of the peaks.
Had this material been present in the prostaglandin
peak (D) then two prostaglandins would have been detected
as the cyclic n-butyl boronate derivatives of these two
prostaglandins as they readily separate on the gas
chromatography system employed. Only prostaglandin
was detected.
When 15-keto prostaglandin was used as
substrate an identical pattern of metabolites were produced.
The major metabolites were conclusively identified by the
combined gas chromatography-mass spectrometry methods
described above as prostaglandins E, and F, . In
1 1*
addition 15-keto PGF.^. and 13,14-dihydro PGE- were alsoI
identified as metabolites.
When incubated with sheep whole blood both 15-
keto prostaglandins F^^and i"20^were each converted to
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one major metabolite. An example of this is shown in
figure on page 150 . These metabolites were
conclusively identified as the 13,14-dihydro prostaglandins
F
^ and $204 respectively. Preliminary evidence of
identification was obtained when t?*ese metabolites were
found to have gas chromatography retention times and mass
spectra identical with authentic 13,14-dihydro prostaglandins
F^^and F2^methyl ester triraethylsilyl ethers. However,
the 13,14-dihydro derivatives did not separate from their
respective parent prostaglandins when chromatographed as
this derivative on the gas liquid chromatography system
employed. Conclusive identification was obtained by use
of the methyl ester, 9OC, 110^-cyclic n-butyl boronate,
trimethylsilyl ethers. This derivative did enable the
required separation of these compounds. ' ; . ■ None
of the metabolites produced were identified as the parent
prostaglandin; instead the majority were conclusively
identified as the 13,14-dihydro prostaglandins F ^andX 0\
F2(X •
From the substrate specificity studies with the
15-keto E and prostaglandins it was apparent that at
least one other enzyme, namely a 13,14 reductase, was
present in sheep whole blood. In addition the possibility
existed that the enzyme reducing the 9-keto functions of
the E series may have been a different one to the enzyme
reducing the 15-ketonic functions. It was therefore
decided to further characterise the metabolism of 15-keto
prostaglandins by sheep blood, in an attempt to define
whether the reduction of the 9 and 15-keto groups was by
150
BED VOLUMES
Figure 22. The elution profiles obtained from Lipidex
5000 eluted with heptane, chloroform
(80;20 v/v) of the products, after conversion
to methyl esters, obtained by incubating
% 1&-keto PGF2(X (upper) and % 15-keto PGF^
(lower) with sheep blood at 37*C.
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the same or different enzyme.
Metabolism of 15-keto prostaglandin by sheep whole
blood, plasma and cellular fraction
After incubation of 3H-labelled 15-keto
prostaglandin with citrated sheep whole blood for 75
minutes at 37 *c, the products were converted to methyl
esters and chromatographed on the Lipidex 5000 column
described previously. An identical qualitative pattern
of metabolites were produced as described in figure <23
on page .
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After centrifugation at 1875 x g to separate
citrated sheep whole blood into plasma and cellular
3
fractions, each fraction wa3 incubated with H-labelled
15-keto prostaglandin and the extracted products, after
conversion to methyl esters, subjected to chromatography
on Lipidex 500C. The plasma fraction did not apparently
metabolise the 15-keto prostaglandin . However, the
cellular fraction did metabolise the 15-keto prostaglandin
in an identical manner to sheep whole blood. Again,
prostaglandin E2# B^^and 13,14-dihydro E^ were
conclusively identified by combined gas chromatography
as the major metabolites produced.
The metabolism of 15-keto prostaglandin by haemolysed
sheep red blood cells with time
The pattern of metabolites produced at different
incubation times is shown in figure 34- on page
153
These figures represent the elution profiles from Lipidex




Figure 23. The products obtained (after conversion to
methyl esters) when sheep plasma (upper),
whole blood (middle) and cellular fraction
(lower) were incubated with -*H 15-heto PGE2«
The column used was a Llpidex 5000 eluted
with heptane,chloroform (30:20 v/v). The
details are described on pages 107 & 109.
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Figure 24. The products obtained (after conversion to
methyl esters) when sheep red blood cells
were incubated for 5# 15, and 75 minutes
with 15-keto PGE2. The column used
was Lipidex 5000 eluted with heptane,
chloroform (80:20 V/V). The details are
described on pages 107 and 110.
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After a 5 minute incubation there are two major
and two minor peaks of radioactivity. The material in
peak A was not identified. Again peak B was divided into
two sections as described on page . • The first portion
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was found by GCMS to be mainly unmetabolised 15-keto
PGE^, whilst the second contained a mixture of 15-keto
PG*2°ian<i 13,14-dihydro PGB2. The third and fourth peaks
( C and D ) were again identified as prostaglandins E2
an<* F26<res^ect^ve^#
After 15 minutes it can be seen that the levels
of 15-keto PGE2 have decreased whilst those of 13,14-
dihydro PG£2# 15-keto PGF^, PGE2 and PGF^have all
increased. These changes are even further amplified
after a 75 minute incubation.
It can be seen from these results that significant
reduction of the 15-keto group has occurred after a 5
minute incubation. This is in contrast to the reduction
of the 9-keto group ( see Inbl-fi, 12. on page ^4.3 ) which
is much slower. Thus the possibility existed that the
reduction of the 9 and 15-keto functions was performed
by different enzyme systems. Consequently it was decided
to determine the effect of pH and temperature on the
reduction of the 15-keto group in a further attempt to
compare its reduction with the reduction of the 9-keto
group.
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The effect of incubation pH and temperature on the
metabolism of 15-keto prostaglandins and
respectively by haemolysed sheep red blood cells
The values quoted in table 14- on page 157
and graphically represented in figure ,35 on pagel 56
show that reduction of the 15~keto group to the 15(S)
hydroxy1 group is heat labile. The incubation time was
limited to 5 minutes because, as shown previously,
(figure 34- page 153 ) the principal metabolite
produced from 15-keto prostaglandin in this time period
is prostaglandin E2» in addition, the substrate, namely
15-keto prostaglandin E^, used in the teaiperature profile
study would probably have been non-enzynaatically degraded
by prolonged incubation at elevated temperatures.
It can be seen that incubation at temperatures
above 40*c destroyed the ability of this enzyme system
to reduce the 15-keto group. Similarly the reaction is
activated by incubation temperatures up to 37-40*C.
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INCUBATION TEMPERATURE
Figure 25. The effect of incubation temperature on
the reduction of the 15-keto group in
15-keto PGE^ to the corresponding 15 (S)
hydroxyl group by sheep blood cells ,at 57" c-
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Table lM-
The effect of incubation temperature on the
metabolism of 15-keto prostaglandin E^ by haemolysed
sheep red blood cells.
Percentage of recovered
radioactive material in
Incubation Temperature the PGE^ zone relative to
*c the same material recovered










These results are in contrast with those for the
metabolism of prostaglandin E2 by this system { pages -j28 &"29)
where the enzyme actively increases with incubation
temperatures up to 45 *c and it is only at incubation
temperatures above this that enzyme activity is lost.
The effect of incubation pH on the metabolism
of 15-keto prostaglandin by this system is described in
Table \ 5 bel oto and in figure on page ^59 .
Table 1 S
The effect of incubation pH on the metabolism




Incubation pH zone relative to
the same material







9.0 * 0 *
* at this pH most of the 15-keto prostaglandin E2 was
degraded to an unidentified compound.
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Figure 26. The effect of incubation pH on the
reduction of the 15-keto group in 15-keto
PGE2 to the corresponding 15 (S) hydroxy1
group by sheep red blood cells.
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The optimum enzyme activity is apparently
around pH 7.5. This again is in contrast with the
reduction of the 9-keto function where optimum activity
was found to be around pH 7.0. In both cases the ability
to reduce ketonic functions is rapidly lost at pH value
above 7.5 and below pH 6.0. From comparisons of the
reaction rates, pH and temperature profiles for the
reduction of the 9 and 15-keto functions it would appear
that there are possibly two different enzymes operating.
Alternatively it may be that the enzyme reducing the
15-ketonic functions is a low substrate specific enzyme.
This is supported by the fact that the 11-ketonic
function of prostaglandin Dis also reduced by the
cellular fraction of sheep blood. The presence of a
further enzyme, namely the 13,14-prostaglandin reductase,
was also found in sheep blood cellular fraction.
Consequently it was decided to determine whether the
blood samples from other species also contained enzyme
systems capable of metabolising 15-keto prostaglandins.
It was, however, known from the experiments previously
recorded in this thesis ( pages -j24 — 124^ many
animal blood samples did not contain enzymes capable of
metabolising prostaglandin E.
The metabolism of 15-keto prostaglandin by human blood
samples
The pattern of metabolites produced when freshly
collected and citrated human venous blood is incubated
with 15-keto prostaglandin are shown in figure 17
on page 161
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Figure 27. The metabolism of 15-keto PGE2 ^ human
(upper) and bovine (lower) blood. The
incubation products after extraction were
converted to methyl esters and separated
on Lipidex 5000 columns eluted with heptane
chloroform (80:20 v/v). The experimental
details are given on page 112.
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It can be seen that from the mobility on
Lipidex 5000 of the metabolites { after conversion to
methyl esters ) that they are less polar than the
original substrate ( 15-keto PGE0 ). The major metabolite
( peak B ) was conclusively identified as the methyl ester,
p
isoprcjj/loxime trimethylsilyl ether derivative by combined
gas chromatography-mass spectrometry as 15-keto, 13,14-
<si(lv-\dfC E
V <—
The material in peak C was conclusively identified as
un-metabolised 15-keto prostaglandin E^, whilst the
material in peak A was not identified.
In a comparison of eight male < seven Caucasean
and one Asian ) and one female human venous blood samples
for their ability to metabolise 15-keto prostaglandin
a range of prostaglandin 13,14 reductase activity







1 21 73 6
2 9 39 52
3 17 61 22
4 7 63 30
5 3 39 8
6 4 77 19
7 16 43 36
3 13 53 39
9 12 35 53
Samples 1 to 7 were male Caucasean blood samples.
Sample 3 was © male Asian and sample 9 a female Caucasean.
The values presented are the percentage of the
recovered radioactivity ( from the Lipidex 5000 rones )
that each peak represents.
In an identical experiment 2 samples of female
bovine blood were also studied. These were both found to
metabolise 15-keto prostaglandin E^ to 15~keto-13,14-
dihydro prostaglandin E2# The proportion of the total
recovered radioactivity that this metabolite contributed
was 39% and 93% respectively in the two samples tested.
It is therefore apparent that blood samples from at least
three species namely: ovine, bovine and human, contain an
enzyme system capable of reducing the 13,14 trans double
bond of 15-keto prostaglandins. Whether these or other
enzymes are present in blood samples from ofcta* animal
species remains to be determined. But the absence of
15-keto reductase activity does tend to suggest that the
9 and 15 keto reductase activities have a similar
distribution and may be one and the same enzyme.
the metabolism of prostaglandin by blood samples from
normal female and male, pregnant female and castrated
male sheep
During an experiment to compare the range of
9-keto reductase activity present in sheep whole blood,
it was observed that two samples had much lower activity
than the rest. These two samples were identified as
originating from castrated male sheep. It was therefore
decided to determine the apparent relative 9-keto reductase
enzyme activity present in the above four groups of sheep.
The results obtained are presented in table 17 be\ou> .
Blood
sample
State of 1 2 3 . 4 .5 6 mean. 3.E.J
animal
normal female 48 59 52 43 62 51 52.5 2.86
normal male 58 64 61 - - - 61.0 1.73
pregnant female 27 47 35 41 - - 37.50 4.27
castrated male 39 46 33 — 39.33 3.76
The values quoted represent the recovered radio¬
active material in the prostaglandin F2^zone of thin
layer plates as a percentage of the total recovered
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radioactivity. The length of gestation for the pregnant
female sheep and the duration of castration was not
known.
Preparation of prostaglandin E analogues for substrate
specificity studies
a) Prostaglandin h„--l alcohol
The reduction of the 9-hydroxylamine oxime of
prostaglandin &2 methyl ester by lithium aluminium hydride
was successful and resulted in the corresponding 1-alcohoi.
However, attempts to remove the protecting group
( hydroxylamine oxixne ) at C-9 with nitrous acid at
5*c and thereby generate the corresponding prostaglandin
Ej-l-alcohol were unsuccessful.
. . 14») C-labelled prostaglandin
The elution profile obtained from the Lipidex
lOOO column used to purify the 674 aqueous ethanol
residue is shown in figure on page 166 • Tlie
material in the major peak ( fractions 24-27 ) was found
by thin layer chromatography to be radiochemically pure
and to have a chromatographic behaviour identical with
authentic prostaglandin E^.
The residue obtained from the heavy petroleum
fraction was found by thin-layer chromatography to be
radiochemically impure. The residue was purified by
reversed phase partition chromatography on an 30 ml bed
volume of Lipidex 5000. The elution profile of this
column is shown in figure on page 157 • Two
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Figure 28* The purification on Lipidex 1000 of the
67% aqueous ethanol extract residue
14
obtained after incubating C labelled
dihomo linolenic acid with a ram
seminal vesicle prostaglandin synthetase
preparation. The experimental details
are given on page 116.
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Fraction number
F^g]ii22iL_22. reversed, phase purification on Lipidex
5000 of the impure unmetabolised dihomo-^—
linolenic acid present in the heavy-
petroleum extract residue obtained after
extracting the ram seminal vesicle
incubation described on page 116,
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5-20 ) was not further identified. The second (fractions
54-69 ) was found to be radiocheraically pure and to have
a mobility on thin-layer chromatography compatible with
it being un-metabolised dihomo-%-linolenic acid (C20;
3 (06 ) .
c) 15-0 methyl ether methyl ester
The elution profile from a column ( 25 ml bed
volume ) of Lipidex 5000 of the residue obtained after
J?G32-methyl ester was treated with BF^/diazomethane
in ether is shown in figure 3o on page 169 • Two
major peaks of radioactivity were obtained. Material in
the first peak ( fractions 6-0 ) when converted to the n-
butyloxime trimethylsilyl ether as described on page
and subjected to combined gas chromatography-mass
spectrometry was identified as the 11 #15 di-omethyl
ether methyl ester of prostaglandin . Material in
the second peak ( fractions 11-14 ) when converted to
the n-butyloxime# trimethylsilyl ether and subjected to
combined gas chroraatography-mass spectrometry was found
to be a mixture of the 11 and 15 mono-0-methyl ethers
of prostaglandin E2 methyl ester. Thi3 material was
therefore re-chromatographed on a column ( 55 ml bed
volume ) containing a lipophilic substituted ( 62% w/w
C-15 to C-13 hydroxyalkyl side chains ) LH-20 gel. The
elution profile of this material is shown in figure 31
on page 1 jq . Two major peaks of radioactivity were
obtained. The first ( fractions 30-35 ) contained
material identified as the 11 -rnono-0-methyl ester
of prostaglandin The second peak ( fractions 70-77 )
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Figure 30. The elution profile from a Lipidex 5000
column (eluted with heptane, chloroform
80:20 v/v) of the reaction products obtained
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Figure 31. The elution profile from a lipophilic
substituted (62$ w/w C15 to C18 hydroxy-
alkyl side chain) LH-20 gel of fraction
11-14 obtained from the Lipidex 5000
column shown in figure 30, page 169. The
eluting solvent was heptane, chloroform
(90:10 v/v).
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was identified as the corresponding 15 mono-O-methyl
ether methyl ester of prostaglandin E^. In both cases
the material was identified as the n-butyloxime,
trimethylsilyl ether derivative.
These confounds have as yet not been tested as




DISTRIBUTION STUDIES ON THE REDUCTION OF PROSTAGLANDIN
2
TO PROSTAGLANDIN BY TISSUE HOMOGENATES
' zo< ■
Introduction
During the experiments recorded in Section II of
this thesis, it was confirmed that sheep whole blood
contained at least one enzyme that was capable of stereo-
specifically reducing the 9-keto group of PGE2 to the
corresponding 9^hydroxy group and thereby producing PGF .
At the time of this work few reports had been made concerning
the interconversion of PGE2 to PGF.^ . It was known that
these two prostaglandins were not interconverted during
their biosynthesis from arachidonic acid ( Anggard and
Samuelsson, 1965y Hamberg and Samuelsson, 1967 ). Therefore
when these experiments with sheep whole blood began the
major evidence for the possible interconversion of E and F
prostaglandins was based on studies of the guinea pig
urinary metabolites of The major metabolite (see
figure 3 on page ) was shown to have Fcring
.24
configuration which is the opposite configuration of the
hydroxyl group at C-9 to the one normally produced by the
prostaglandin synthetase. Therefore, if the enzyme present
in sheep whole blood that stereospecifically reduced the 9-
keto group into the F^configuration was widely distributed,
it could have major implications for the physiology,
pharmacology and pathology of E prostaglandins. In many
circumstances the E and ^prostaglandins have qualitatively
different actions ( see general introduction ). It was
therefore felt necessary to determine what the
distribution of 9-keto reductase enzyme activity was
in the tissues from a variety of animal species.
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Materials and Methods
Kidney, heart and liver samples from guinea-pig,
rat, dog, cat, cow, sheep, horse, pig and rabbit of both
sexes were removed as soon as possible after death. If
transport of the samples was required they were kept in
crushed ice until used. Homogenates were prepared by
chopping the tissues into small pieces approximately 1
3
cm
# weighing and then homogenising in 3 volumes ( by
weight ) of ice-cold 100 mM sodium phosphate buffer
(NaH2P042.7g; Na2HP04l2.54g in 1 litre of distilled water
pH 7.4 ) using a polytron homogeniser at maximum speed £•«- 3cr<0sccS-
The resulting horaogenate was then centrifuged at 4*c for
30 minutes at 2400 x g and the supernatant decanted off
and stored on ice until used.
Incubation and extraction procedure
The resulting supernatant was added to a 100 ml
conical flask containing tritiated prostaglandin E
( Amersham, 5, 6, 8, 11, 12, 14, 15-3h-labelled PGE2 Sp.
Ac. 36.4 Ci mole""1" ) at a substrate concentration of 14 yuM
and a cofactor concentration of NAD and NADH^ of 10 mM each.
The samples were then incubated at 37*C for two hours
( with agitation ) in a water bath.
The products of the incubation were diluted to
150 ml with distilled water and acidified to pH4 with 10&
aqueous acetic acid. After extraction twice with 2 volumes
of either diethyl ether of diethyl ether/ethyl acetate
( 4:1 v/v ), the pooled organic phases were washed twice
with 50 ml of distilled water before being taken to dryness
under vacuum and desiccated.
The resulting residue was dissolved in 50 ml of
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67/6 aqueous ethanol and partitioned twice with an equal
volume either benzene or toluene, before the aqueous
phase was taken to dryness and desiccated. Where
prostaglandin F2©< appeared to be a metabolite of
prostaglandin (eg rabbit, horse and guinea-pig livery
horse heart ) the experiment has been repeated at a
substrate concentration of 140 jiM. and in addition l-14c
PGE^ has been compared in parallel at the same substrate
concentration•
Preparation of methyl esters
The residue from the 67?6 ethanol phase was
converted to methyl ester by the method described
previously on page^ . Where necessary ( eg if material
had precipitated out of solution ) the resulting solution
was filtered through a glass wool plug inserted into a
Pasteur pipette. The original flask was then washed with
excess methanol ( 5-lO ml ) and this was also filtered.
The pooled solution was taken to dryness under vacuum and
desiccated.
Straight phase gel partition chromatography on Lipidex 5OOP
Glass columns ( 300-400 mm x 9-10 mm ) were
silanised and packed under free flow with Lipidex 5O00 gel
equilibrated in heptane-chloroform ( 80:20 v/v ) as
described on page . Columns of 29-30 ml bed volume
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were used throughout and fractions of 10^6 bed volume were
collected on an LKB Ultrorac fraction collecter until the
200O& bed volume point was reached. The flow rate was 6-12
ml hr The samples being chromatographed were dissolved
in 100-200 ul of chloroform and then n-heptane was added
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until the solvent composition was the same a3 the column
eluant. The total loading volume { including washings )
was never greater than 1.5 ml.
The elution profile of the column was obtained by
liquid scintillation counting.
All columns were calibrated for authentic "*h
prostaglandins A^, and Certain columns were
calibrated for other prostaglandins and their metabolites
by either liquid scintillation counting or by gas liquid
chromatography. Columns which have begun to lose performance
( as shown by peak broadening ) have been purged by reverse
flowing the column with a more polar solvent { eg methanol-
chloroform-n-heptane 10:50|50 by volume ) before re-
equilibrating in the original solvent. These columns
have been found to be re-usable and reproduceable for both
authentic prostaglandins and biological samples.
From the elution samples it has been possible to
bulk several fractions into corresponding zones. These
have been taken to dryness and re-dissolved in 1.0 ml of
methanol and an aliquot ( 50 - 100 ji1 ) counted by liquid
scintillation counting for the quantitative determination
of the % of the total recovered radioactivity.
Thin-layer chromatography
Neutral silica gel ( 200 mm x 200 mm x 0.25 mm )
on glass plates ( A.G. Merck ) were used. Marker standards
3
containing H-labelled prostaglandins A , E , 13, 14-
dihydro F,)(J^and F2^ methyl esters were spotted on the
plate at the side of the samples from the Lipidex 5000
zones being chromatographed. The plates were then developed
in closed equilibrated glass tanks using a modified form
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of the G.C.M. solvent ( Millar 1974 )• The solvent used
was ethyl acetate-methanol-acetic acid ( 100:10:1 by volume).
Liquid Scintillation Counting
This was performed with a Mark II Nuclear Chicago
liquid scintillation counter.
Aliquots of either the individual column fractions
or the methanol solution containing the pooled fraction
residue were counted in 5 ml of the toluene-ethoxyethanol
based scintillant described on page ^07 . Where dpm were
required these were obtained using a PDP3I computer to
correct for quenching by the automatic external standard
channels ratio method and a quench-calibration curve
constructed for the scintillation mixture.
Preparation of derivatives for Gas Liquid-Chromatograpny
An aliquot of the methanol residue from the
appropriate zone of the Lipidex 5000 columns was taken to
dryness in a capped Eppendorf tube and converted to the
trimethylsilyl derivative using BSTFA by the method described
on page ^ . The derivatised prostaglandin was injected
into the gas chromatograph in 5-10 jxl of BSTFA.
Radio Gas-Liquid Chromatography
A Pye series 104 gas chroraatograph interfaced
with a Panax radio detector was U3ed for the simultaneous
detection of mass and radioactivity. Only ^ *c-labelled
prostaglandins were analysed toy this method due to the
3
unreliability and insensitivity for H-labelled
prostaglandins. The gas chromatograph was equipped with a
glass column ( 2-3 m x 4 mm i.d. ) packed with 3% OV-1
on Supelcoport ( 100-120 mesh ). The oven temperature
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was 230-240*C# the carrier gas ( argon ) flow rate was
35-40 ml min 1 and the oxidation furnaces were at 650-
630-c.
The instrument was calibrated for •*carbon values'*
( mass and radioactivity ) by the method described previously
{ Bergstrom, Ryhage, Samuelsson and Sjovall 1963 ). A
log retention time versus carbon value for normal saturated
fatty acid methyl esters ( C16"C24 in C2 units ) was
constructed.
Combined Gas-Liquid Chromatography-Maas Spectrometry
Mass spectra were obtained using an LKB 9000
instrument equipped with a glass column ( 3 m x 4 mm i.d. )
packed with 3% OV-1 on Supelcoport ( 100-120 mesh ). The
oven temperature was 240-260*c and the carrier gas ( helium )
flow rate was 30-35 ml min \ The instrument was calibrated
for ''Carbon values •' and authentic prostaglandins as
described above.
3
H-labelled prostaglandin quality control
The ^-labelled PGE2 used in these experiments
was checked at regular intervals prior to use. The initial
criteria of radiochemical purity was determined by thin
layer chromatography as described on page . Where the
material has been found to be contaminated ( 5% or greater )
it has been purified by reversed phase porhhon chromatog¬
raphy as described previously on page 34 .
Solvents and Chemicals
All solvents were of analytical grade or re¬
distilled before use. The chloroform and n-heptane were
re-distilled over anhydrous calcium chloride. Absolute
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ethanol ( 14 by volume ) was added to the re-distilled
chloroform for stabilisation purposes.
The e;feet ol Fseudopreqnancy on the in vitro metabolism
o£ Prostaglandin E__J>y rabbit liver homogenates
This work was performed using rabbit liver samples
provided by Dr. N.L. Poyser and Miss F. bytten, whose
generosity is duly noted.
Normal New ^ealand White rabbits were injected
h
with 500 international units of human cjprionic gonadotrophin
( H.G.C. ) between 3 and 4 pm in the afternoon. The
following day was designated day 1 of pseudopregnancy.
Control rabbits were injected witn isotonic saline (0.94 w/v).
ihe livers from pairs of female rabbit3 on days
o ( control ), 3, 7, 10, 13, 15, 16, 17, 18, 19 and 20 of
p3eudopregnancy and males ( six ) were removed after the
rabbits had been lightly anaesthetised with Urethane ( 254
w/v solution ol ethyl carbamate in isotonic saline; 7-8
ml kg A i.v. ). From each liver a 20 g sample was obtained.
Thi3 was homogenised in 1GG mM sodium phosphate buffer
and centriiuged as described on page -|y^ . An aliquot
( 20 nil ) Oi the resulting supernatant was incubated with
^H-labelled FGE^ ( 14 ymi; SpAc 3.64 Ci mole ) and a
cofactor concentration for .NAD and NADH^ of lO mM each.
After 2 hours at 37*c in a water bath ( with agitation )
the samples were extracted as described on page 174
After conversion to methyl esters the samples were purified
by juipidex 5000 straight phase gex partition chromatography.
The glass column employed ( 290 am x 25 mm ) was packed
with Lipidex 5000 ( 55 ml bed volume ). Fractions of 54
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bed volume wore collected and assayed for radioactivity
as described on page 107 • zones of radioactivity
obtained from each sample were quantitatively assayed
for radioactivity as described previously on page 107
Conclusive evidence of identification was obtained
by combined gas chromntography-ma3s soectroraetry on an LKB
9000 instrument. The derivatives employed and the methods
used have been described previously on page-3 (o\
respectively.
The effect of Pregnancy on the in vitro metabolism of
prostaglandin L„ by rabbit liver homogenates
Normal New Zealand White rabbits were used in
these experiments. Pregnant rabbits of known, gestation
period were purchased from Animal Livestocks Ltd.,
Bradford. Adult rabbits were killed by a blow to the
neck and exsanguination whereas the offspring were killed
by exsanguination after diethyl ether anaesthetisation
had been induced. Female rabbits were killed during the
gestation period on days 25, 26 or 27, pregnancy being
confirmed by autopsy examination.
From each adult rabbit 20 g samples of liver
were removed. For the offspring whole livers ( minus
the gall bladder ) from litter mates of the same sex were
pooled. In all cases the liver samples were homogenised,
centrifuged, incubated with a mixture of H-labelled
prostaglandin Erj { 14 yuM Sp.Ac. 3.64 Ci mole-1 ) NAD and
NADH^ ( 10 mtf ) and extracted as described on page 174 ,
The products of the extraction were separated
by thin layer chromatography as the free acids using
181
the multi-run development described on page qJ+ . After
development, the plates were scanned for radioactivity
using a Panax thin layer plate scanner. The resulting
zones of radioactivity were scraped from the plates into
test tubes containing 5 ml of methanol as described on
page . The radioactivity was quantitatively assayed
by liquid scintillation counting of an aliguot of the
radioactivity from each zone ( see page ge ).
Prostaglandins F and E„ were quantitatively assayed
A UC £
( as described on page ) by multiple ion-detection
gas-chromatography-maS3 spectrometry using a Finnigan
3000D quadrupole mass spectrometer interfaced with a
Finnigan 9500 gas chromatograph equipped with glass columns
i 1.5 to 2 m x 2 mm i.d. ) packed with 3% OV-1 on
Supelcoport. The derivatives used were either the methyl
or ethyl ester trimethylsilyl ether for ?nd the
corresponding iso-propyl oximes for PGE0. The ions
monitored for PGP Hand PGE? and the corresponding 3,3,4,




methyl ester TM3 PGF2 ^ 423 333 427 337
ethyl ester TMS PGF^ 437 347 441 351
methyl ester iso-Ptf
TMS PGE2 295 299
ethyl ester iso-Pr
TMS PGE~ 309 313
Conclusive evidence for the qualitative identification of
PGF ~as obtained by combined gas chromatography-mass
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spectrometry. An LKB 9000 instrument was used end the
derivative chosen was the methyl ester trimethylsilyl
ether. The method used is described on page 98
The in vitro metabolism o£ prostaglandin male human
liver, heart and kidney horaogenates
These samples were generously donated by
Professor Carrie of the Pathology Department, Edinburgh
Royal Infirmary. The samples, taken during autopsy
examination, were stored in ice during transport and used
as soon as possible after removal. One batch of samples
was taken from a male 3ged 19 years approximately 4 hours
after death. The cause of death was cardiac failure
following a prolonged illness diagnosed as Cushing's
syndrome. The other male patient was a 62 year old male
who died from cardiac failure of non-specified origin
( natural causes ). These samples were not obtained until
16 hours after death.
Tissue samples ( 10 g ) were homogenised in
3 volumes of 100 mM sodium phosphate buffer as described
on page 174 . The resulting homogenate was centrifuged
at 2400 x g for 30 minutes at 4*C. An aliquot ( 15 ml )
of the resulting supernatant was incubated for 2 hours
at 37*c with ^H-labelled prostaglandin E2 ( 14jiM. 36.4
Ci mole""* ) and co-factor concentration for NAD and NADH2
of 10 mM each. The products of the incubation were
extracted and converted to methyl esters as described on
page 174 . T|je methyl ester ified products were
purified on a Lipidex 5000 column of 30 nil bed volume.
The eluting solvent waa a mixture of n-heptane-chloroform
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( 80:20 v/v ) and the method used to detect and quantify
the zones of radioactivity by liquid scintillation counting
has been described on page 107 • Where prostaglandin
( or more polar compounds with respect to PGE^
methyl ester ) appeared to be incubation products the
residue obtained from the zone was converted to the
trimethylsilyl ether ( page ^ ) and subjected to
qualitative analysis by combined gas chromatography-mass
spectrometry using an LKB 9000 instrument.
The in vitro metabolism of prostaglandin L,. by male and
female human bronchiolar tissue
These samples were generously donated by the
Pathology Department at the London Hospital, London and
the experiments were performed at the Medical Products
Research Laboratories, May and Baker Ltd., Dagenham.
In all cases the samples were removed during surgical
procedures ( usually performed for the removal of lung
carcinoma ) and transported in ice until used. These
samples ( 5-10 g ) were homogenised in 3 volumes of lOO
mM phosphate buffer and centrifuged at maximum speed on
a bench centrifuge for 5 minutes at room temperature.
3
The supernatant ( in toto ) was incubated with II-labelled
prostaglandin E2 ( 3 jaMy 0.5 yuCi ) and cofactor
concentrations for NAD and NADH2 of 10 mM each. After 2
hours at 37*c the products were diluted with 20 ml
distilled water, acidified to pH 4 and 10/6 aqueous acetic
acid and extracted as described on page . The
extraction products were then subjected to thin layer
chromatography on neutral silica gel ( 50 mm x 200 mm x
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0.1 on nylon ) using the multi-run development described
previously on page ^4 . Auth ntic -labelled
was run on identical plates in parallel. The plates
were scanned for radioactivity corresponding with the
peak3 of the resulting scans were eluted with methanol
as described previously. The residue from each zone was
quantitatively assayed for radioactivity by liquid
scintillation counting.
The in vitro metabolism of prostaglandin by adult male
chicken liver, heart and brain samples
These samples were generously collected and
dissected out from animals killed by decapitation by
Mr. W.R.G. Stephen of the Department of Pharmacology,
Edinburgh University.
Samples of liver ( 10 g; n-12 ) heart ( 5 g?
n ® 6 ) and brain ( 5 g; 0^3 ) were homogenised in 3
volumes of iOO mM sodium phosphate buzzer as described
previously ( page 174 ). For brain and heart horaogenates
samples from different animals had to be pooled. The
resulting homogenates were centrifuged ( 2400 x g 20 mins.
at 4*c ) and 10 ml of the resulting supernatants incubated
with Ja-labelied PGb2 ( 23 yuMj Sp.Ac. 3.64 Ci mole -1 )
for 2 hours at 37*c. After extraction by the method
described on pagd!74 the residue was purified ( as
the free acids ) by thin layer chromatography using the
multi-run development system described on page q4 •
After development the plates wore scanned for radioactivity
and the resulting zones eluted with methanol by the methods
described previously on page 85
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The residue from each gone was re-dissolved
in 1.0 ml of methanol and 4 x 50 ul aliquots were
quantitatively assayed for radioactivity by liquid
scintillation counting.
Aliguots from the prostaglandin F zones
were converted to :
a) Methyl ester trimethylsilyl ether ( 500 yul ) and
subjected to combined gas chromatography-mass spectrometry
on an LKB 9000 instrument as described previously.
b) Ethyl ester trimethylsilyl ether ( lOO ) and
subjected to quantitative multiple-ion detection gas
chromatography-mass spectrometry using a Finnigan
3000D instrument as described previously. The ions
monitored for the protium PGF^were 347 + 437 and for
the corresponding deuterum isotopes 351 and 441.
Changes in the in vitro metabolism of prostaglandin
by male and female chickens with r3ge
The chickens used in the experiments were all
purchased from the Poultry Research Station, Edinburgh.
Male and female chickens ( n = 3 ) were killed
by decapitation following diethyl ether anaesthetisation
on days 1, 3 and 22 after birth and the livers removed.
For 1 day old chickens the livers from three animals of
the same sex were pooled. In all cases 5 g of liver was
homogenised in 3 volumes of 100 mM sodium phosphate buffer
and treated as described previously. From the resulting
homogenate 10 ml was removed and incubated with PGE2
( 14 jjuhj 35.4 Ci mole"* } for 2 hours at 37*C. The
resulting products were extracted into diethyl ether-ethyl
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acetate ( 4s1 v/v ) as described on page 107 and
purified by multi-run thin layer chromatography as
described on page 84 . The samples in the PGP
2W,
obtained after thin layer chromatography were subjected
to qualitative and quantitative gas chromatography-mass
spectrometry as described previously ( page 93 )•
v
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The effect of oestradiol and progesterone administered in
vivo on the in vitro metabolism of prostaglandin by
liver homogenates from ovariectomised guinea-pigs
Dr. N.L. Poyser and Mr. B. Naylor generously
provided the liver samples for these experiments.
Virgin female guinea-pigs, which had cycled
normally, were ovariectomised during the luteal phase*
The guinea-pigs were randomly divided into four groups
and four to eight weeks after surgery were injected with
0.5 ml arachis oil containing steroids as follows :
Group I - 0.5 ml vehicle only for 10 days ( Control );
Group II - 0.5 ml vehicle for 7 days followed by
oestradiol benzoate ( 10 yig daily for 3
days ) in arachis oil;
Group III - 0.5 ml vehicle containing progesterone
( 2.5 mg daily ) for 10 days;
Group IV - 0.5 ml vehicle containing progesterone
( 2.5 mg daily ) for 7 days then 0.5 ml
vehicle containing oestradiol benzoate ( 10
ug daily ) and progesterone ( 2.5 mg daily )
for 3 days.
Guinea-pigs were killed by a blow to the neck
and exsanguination on the 11th day after the treatment
started. Normally cycling non-ovariectomised guinea-pigs
were also killed on day 7 ( n « 4 ) and day 13 ( n = 3 )
of the oestrous cycle { oestrous = day 1 ). The livers
were removed and 10 g samples homogenised in 3 volumes of
100 mM sodium phosphate buffer as described on page .
Aliquots ( 20 ml ) of the supernatant obtained after
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centrifugation at 4*c for 20 minutes at 2400 x g were
incubated with prostaglandin ( 28 Jill; 36.4 Ci mole"""'' )
as described on page -^74 . The incubation products
were extracted and purified by the raulti-run thin layer
chromatography system previously described. The plates
were scanned for radioactivity using a Panax radio thin
layer chromatography plate scanner. The sones of
radioactivity were eluted with methanol and quantitatively
assayed by the methods described on page ge> . The
prostaglandin zones were qualitatively assayed an
the methyl ester trimethylsilyl ether using an LKB
9000 combined gas chromatograph-mass spectrometer.
Quantitative analysis of the zones by combined gas
chromatography-mass spectrometry of an aliquot ( 104 )
of the methanol residue was performed using a Finnigan
30GQD mass spectrometer as described previously.
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RESULTS
Distribution studies on the reduction of prostaglandin E^.
to prostaglandin by tissue homocrenates
In addition to confirming that guinea-pig liver
homogenates convert prostaglandin E or E, into theJL
corresponding F^ derivatives, three other tissues,
namely, the liver or horse and rabbit and the heart of
horse, have also been found to be capable of converting
PGE to PGP^ . At no time has any evidence been obtained
for the conversion of PGE to PGFi
r *
3
The separation of authentic H-lsbelled
prostaglandins A^i * F^ an<5 J} methyl esters is shown
in figure on page can ke seen that there
is a good separation of these prostaglandins on the
lipophilic LH-20 gel chromatography system employed.
The separation of prostaglandins ?2V and ?2^ was
essential because it has been demonstrated that in the
guinea-pig, in vivo. PGE^ is reduced to a urinary metabolite
( see figure 3 page ^ ) with the PGF2^ring
configuration ( Haniberg and Israelsson, 1970 ). In vitro,
however, it has been demonstrated that guinea-pig liver
homogenates produce PGF as one of the metabolites of
( Hamberg and Samuelsson, 1969 ). The possibility
therefore existed that the 9-keto group of PGE^ could be
reduced to either the 9©^ or 9^ alcohol configuration by
some of the tissues being studied. In addition, the use
of these columns has enabled the detection of approximately
1& conversion of the PGE. to PGP. > .
2 2Gc
Figure on page also shows an example
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Figure 52. The straight phase separation on a Lipidex
5000 gel partition column of authentic
%-labelled prostaglandins A2, E2» ^2^
and methyl esters (upper) and the
metabolites produced by incubating
% PGE2 with a homogenate of rabbit liver.
The experimental details are given on
page 174.
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of the elution profile obtained when a rabbit liver
homogenate ( after conversion to methyl esters ) is
chromatographed on the same column as the authentic
standards immediately after these standards had been
chromatographed. It can be seen that rabbit liver
homogenates produce several metabolites when incubated
with PGE^, at least one of which is more polar than
and has chromatographic properties identical with
PGf -^in this system.
The majority of these metabolites have only been
provisionally identified by their retention volumes on
Lipidex 5000 and their relative Rf values on thin-layer
chromatography. These values for authentic prostaglandin
standards are given in Table 18 on page . The 1
and 2 series prostaglandins did not separate on the thin-
layer chromatography system employed.
= The broad peak of radioactivity eluted between
fractions 51 and 64 on the Lipidex 500C column ( see
figure on page 190 ) indicated that although this
peak probably contained at l©sst one other metabolite
was present. Thin layer chromatography of these fractions
confirmed that this was so. An example of the radio scans
obtained is shown in figure 33 on pagei<j2 • Using the
modified G.C.M. solvent described on page^74 it was
thus possible to show that fractions 51-55 mainly contained
a material that was identical with authentic 13,14-dihydro
methyl ester, together with a smaller amount of
material identical with PGE^ methyl ester. In contrast,
fractions 56-64 contained material which was identical with




Figure 55. The separation on silica gel thin layer
chromatography using the modified G.C.M.
solvent (page 174) of fractions 56-64
(upper) and 51-55 (middle) obtained from
the Lipidex 5000 column described in
figure 32 page 190. The bottom trace
shows the separation of authentic methyl
esters of prostaglandins F2 jg » F2ty »
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2 * 0.49 3.9
15-oxo-13,14-dihydro E2 0.58 1.7
15-oxo-13#14~dihydro ^ ^ 0.50 1.9
13,14-dihydro 0.48 -
13,14-dihydro F ^ 0.39 -
Table 18. The chromatographic mobilities of some authentic
methyl esters of prostaglandins and their
metabolites on silica gel G using the modified
GCM solvent ( ethyl acetate, methanol
acetic acid 100:10:1 by volume ) and their
corresponding retentions on Lipidex 5000 gel
partition column chromatography when eluted
with heptane, chloroform ( 80:20 v/v ).
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with 13,14-dihydro PGE^.
The tissues so far studied have all been found
to produce less polar compounds than PGE^ and these have
provisionally been identified by their mobilities on
Lipidex 50O0 and by thin layer chromatography. The two
major metabolites produced by most tissues were provisionally
identified by the above methods as 15-keto PGE^ an<* 13,14-
dihydro, 15-keto PGE^? where prostaglandin has been
found as a metabolite, the corresponding PGF^ metabolites
have also been identified.
Both the Lipidex 5000 gel column chromatography
and the thin layer chromatography have been found to give
comparable separations of the PGE., metabolites produced in
parallel with the PGE? metabolites.
The tissues found to convert PGE^ into PGF,,^ ,
namely, homogenates from guinea-pig, rabbit and horse
liver and horse heart were incubated with l-*4c PGE^ .
These tissues produced several metabolites, one of which
was provisionally identified by the above methods as pGF^#
An example of this is shown in figure 3q- on page -j gtj •
Here it can be seen from the upper trace that the
methyl ester trimethylsilyl ether of both PGF^ and PGF^^
separate on the gas chromatography system employed. The
lower half of figure 34- shows material produced by a
rabbit liver homogenate and provisionally identified by
Lipidex 5000 mobility and thin layer chromatography as
PGF^ it can be seen that when subjected to gas liquid
chromatography as the methyl ester trimethylsilyl ether,
this material has a retention time for both mass and radio-
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Figure 34. Radio gas liquid chromatography traces
14
obtained for authentic C labelled prostaglandins
and F1&< as the methyl ester trimethyl-
silyl ether (upper) and the corresponding
trace obtained for the product with PGF.^ like
mobility on Lipidex 5000 obtained from
14
rabbit liver homogenwte incubated with C
PGEr
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activity { ^4C ) identical with that of authentic
prostaglandin * TMS .
Radio gas chromatography was not performed on
any of the metabolites produced by any tissues,
because the radio gas chromatography system was not
sufficiently sensitive or reproducible at the time of
these experiments.
Conclusive evidence that PGE^ and PG£U were being
converted into the corresponding PGFy compounds was
obtained by combined gas chromatography-mass spectrometry.
Examples of the tissues producing PGF^^from PGEj 0re
shown in figure 35 . These gas chromatography traces
show that homogenates of horse, guinea-pig and rabbit
liver and of horse heart produce material which, as the
methyl ester trimethylsilyl ether, ehromatographs
identically with authentic prostaglandin Mas3 spectral
scans taken at the crest of each gas chromatography peak
were identical to that of authentic prostaglandin ,
Prominent ions were at rn/e 584 (Mt)y 569 (M-15)y 513
(M-71)y 494 (M-90) y 423 (M-90+ 71)y 404 (M-2 x 90)y 333
(M-2 x 90 + 71) 217y 199y 191 and 173, These ions are
characteristic of prostaglandin methyl ester trimethyl¬
silyl ether. An example of the mass spectrum of this
prostaglandin has been given previously in figure 13 on
page 126 . Similar results were obtained with the PGF^^
14
zones produced from incubating the tissues with the 1- C
PGE^, The corresponding PGF- ^and PGF2^compounds are
separated from the PGF^ and PGF^ by the gas chromatography










Figure 55. Gas liquid chromatograph traces ( total ion
current ) obtained using an LKB 9000 GC-MS
for the analysis of the methyl ester
trimethylsilyl derivative of authentic PGF2
PGF2c^ and the PGF2 ^ zones obtained from
Lipidex 5000 columns used to purify the
products of incubating PGE2 with
rabbit, horse and guinea-pig liver and
horse heart homogenates.
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It has been observed during these experiments
that rabbit and guinea-pig liver homogenates appeared to
contain different levels of 9-keto reductase enzyme
activity as determined by the recovered PGF2^. in the
case of the rabbit the female levels were consistently
lower than the corresponding male levels. The range of
conversion to PGF^ was from 2 5% to 48%. The possibility
that the differences being monitored were due to hormonal
influences was considered a possibility and therefore the
effect of pseudo-pregnancy and pregnancy on the conversion
of to PGF-g^by rabbit liver homogenates was studied.
The effect of pseudo-pregnancy on the in vitro metabolism
of prostaglandin by rabbit liver homogenates
The results obtained in these experiments are
presented in Table I ^ on page 200 an<^ figure
on page 199 .
It can be clearly seen that on average the female
liver homogenate samples possess les3 prostaglandin
metabolising capability than the corresponding male liver
homogenates. Furthermore, the levels of prostaglandin
metabolism vary throughout the duration of pseudo-pregnancy.
There are definite increases in the general metabolism of
prostaglandin E^ and more specifically in the conversion of
PGEj to fGfafter day 15 of pseudo-pregnancy. The peak
of activity for all prostaglandin metabolising enzymes
appears to be at or around day 18 of pseudo-pregnancy. The
peak of peripheral plasma progesterone levels occurred much
earlier in the pseudo-pregnancy cycle ( N.L. Poyser, personal





DAY of PS EU DO-PR EG NANCY
Figure 56. The effect of pseudo-pregnancy on the
in vitro total metabolism (upper) and specific
conversion to PGF2o^ (lower) of prostaglandin
E2 by rabbit liver homogenates.
Table I^
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3 44.1 44.5 75.9
4 49.3 73.3
5 35.7 58.9















The values quoted are expressed as a percentage of the
total recovered radioactivity obtained from Lipidex
5000 columns.
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on the protein synthesising enzymes present in the liver
to stimulate the production of more prostaglandin metabolising
enzymes. The mechanism by which this stimulation occurs is
unknown and similarly whether it is specific for prostaglandin
metabolising enzymes remains to be elucidated.
Similar increases ( as will be shown ) were found
to occur during the gestation period of pregnant rabbits.
The effect of pregnancy on the in vitro metabolism of
prostaglandin by rabbit liver homogenates
The results for the metabolism of prostaglandin E2
by rabbit liver homogenates are shown in Table 2.0 on page
203
The levels of an<^ PGF2«< calculated from the
radioactive recoveries were also quantitatively assayed by
combined gas chromatography-mass spectrometry and found to
be in agreement by both of these methods. In all cases the
PGF produced was conclusively identified as the methyl1 oc
ester trimethylsilyl ether derivative by combined G.C.M.S.
The mass spectra produced were essentially as the one shown
in Figure on page 211 • Prominent ions were found
at m/e 584 ( M +) ; 569 (M-15)r 513 (M-71); 494 (M-90); 423
(M-90 + 71); 404 (M-2 x 90); 217; 199; 191 and 173. These
ions are characteristic of the mass spectrum of this
prostaglandin F^^ derivative. The corresponding PGF was
not identified during any of these experiments.
From the results it can be seen that the levels of
prostaglandin metabolising enzymes are elevated at the end
pregnancy relative to the non-pregnant rabbit. These
elevated levels of enzyme activity apparently fall away
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Table QO
The metabolism of PGE^ by female adult and offspring
rabbits during gestation and after birth.
Day of % conversion % metabolism












1 (male) 7 21
(female) 6 19
6 (male) 11 24
(female) 8 30
The values quoted are expressed as a percentage of the
total radioactivity recovered from thin layer
chromatography plates.
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after parturition in the maternal animal. The offspring
by comparison have apparently much lower enzyme activities
which increases after birth.
Again the mechanism of these changes in the apparent
activities of prostaglandin metabolising enzymes is unknown,
but may bo due to the changes in the oestrogen and progesterone
levels that occur during pregnancy.
The opportunity to study the effect of these two
types of steroid hormones arose during experiments conducted
by Dr. N.L. Poyser and Mr. B. Naylor. These experiments
were designed to study the effect of progesterone and
oestradiol administered in vivo to ovariectomised guinea-
pigs on the in vitro production of PGP, by the guinea-
pig uterus.
The effect of oestradiol and progesterone administered in
vivo on the in vitro metabolism of by liver homogenates
from ovariectomised guinea pigs
The results expressed in Table At on page 206
and Table 42 on page 207 show the percentage conversion
to PGF^ and the percentage total metabolism respectively
of PGF^ by guinea pig liver homogenates.
The conversion of PG^ to PGF.^ by liver homogenates
from ovariectomised guinea pigs can be seen to be significantly
increased with treatment by oestradiol ( P<.0.05 ) or
oestradiol in combination with progesterone ( P<0.01 ).
Progesterone treatment alone did not cause a significant
increase in the conversion of PGE^ to PGF0^. Moreover,
there also appears to he a significant difference ( p <
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0.05 ) between the conversion of PGE2 to PGF >o<*>y
ovariectomised ( non-hormonal treated ) and normal day 7
guinea pig liver homogenates. The statistical comparison
of day 13 guinea pig liver homogenates with either of
these two samples was not made due to insufficient data
being available. However from the data available it would
appear that there are higher levels of 9-keto reductase
activity at day 13 than in either the normal day 7 or
ovariectomised guinea pig liver homogenates.
When statistically analysed, the results presented
in Table on page 207 also show an identical analysis
pattern. There are significant differences between the
total metabolism of PGE^ by liver homogenates from
ovariectomised guinea pigs and identical ones treated with
oestradiol benzoate ( p<^0.05 ) or oestradiol benzoate and
progesterone ( p^G.Ol ) in vivo. Similarly, the day 7
guinea pigs have significantly higher levels of prostaglandin
metabolising enzymes ( p <*0.05 ) than the untreated
ovariectoraised guinea pigs.
It would thus appear from these results that both
oestradiol and progesterone-like hormones can have marked
influences on the degree of activity from the prostaglandin
metabolising enzymes present in guinea pig liver samples.
Whether these influences are common to all species remains
to be elucidated, however, evidence has been presented that
in lung tissue from the rabbit and sheep the activity of
the prostaglandin metabolising enzymes is greater towards
the end of pregnancy { Horton and Maule-Walker, 1975;
Bedwani and Marley, 1975? Hun, 1975 ). Similar changes in
both pregnant and pseudo-pregnant rabbits were reported
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Table >li
The conversion of PG&2 to PGF2e^by liver homogenates
obtained from ovariectomised guinea pigs treated in vivo
with oestradiol benzoate and progesterone.
Sample
Group a b c d e f mean SEM
1 5.22 4.20 3.70 3.73 3.74 7.77 4.73 0.65
2 6.93 8.24 8.63 5.44 6.47 7.91 7.27 0.49
3 4.25 8.57 7.77 4.07 2.9 7.66 5.37 0.93




6.32 7.28 8.62 6.94 — — 7.27 0.49
normal 13 10.14 3.54 9.30 .. — — 9.33 0.46
day
The values quoted are the radioactivity recovered in the




The metabolism of PGE^ by liver homogenates obtained from
ovariectomised guinea pigs treated in vivo with oestradiol
benzoate and progesterone.
Satqple
Group a b c d e f mean SEM
1 48.5 53 44 56 49 61 51.92 2.47
2 70 63 ei 72 70 54 65.00 2.83
3 54 50 49 62 59 63 56.17 2.49
4 77 - 72 78 81 79 77. 40 1.50
normal
day
7 60 58 49 54 - - 55.25 2.43
normal 13 72 79 85 _ - _ 78.67 3.76
day
The values quoted represent the percentage of the total
recovered radioactivity minus the percentage in the
zone.
Groups 1,2,3 and 4 are described on page 187 •
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earlier in this section. It would obviously be interesting
to know whether the levels of prostaglandin metabolising
enzymes present in tissues fluctuate throughout the oestrous
cycle. The different levels of prostaglandin synthetase
in uterine tissue throughout the oestrous cycle of the
guinea pig and sheep is well documented ( see Poyser,
1973, 1975 )• There is also evidence to support the
theory that the 15-hydroxy prostaglandin dehydrogenase
enzyme has a very short half-life { Flower et al1975 ),
Therefore, this and other prostaglandin synthsising and
metabolising enzymes may be regulated throughout the
oestrous cycle by the changes in oestrogen and progesterone
hormone levels.
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The metabolism of prostaglandin by male human liver,
heart and kidney homogenates
One set of samples obtained approximately 16
hours after death were subjected to Lipidex SOOO
chromatography ( after conversion to methyl esters ).
In all cases the PGE0 was found to be metabolised to less
polar compounds, however, the metabolism was only 6%, 11%
and 12% for the kidney, heart and liver samples. These
samples were not further analysed. In the second example
the tissues had been obtained within 4 hours of death and
were found to metabolise exogenous ( as determined by
radioactive recoveries from Lipidex 5000 column eluants )
by 39%, 31% and 46% respectively. All the tissues produced
metabolites that were less polar than PGE2 on Lipidex 5000
columns. These metabolites were not further characterised.
The liver sample, however, was found to produce a metabolite
{ 7% of total recovered radioactivity ) that was more polar
than either PGE2 or figure 3"? on page 210 ).
The possibility that this was a PGF compound was further
investigated. The material was subjected to combined GCM5
as the methyl ester trimethylsilyl ether and found to have
a carbon value of 23.40 . Prostaglandin F26^methyl ester
trimethylsilyl ether had a carbon value of 23.55 when
chromatographed on this system. The mass spectra of the
derivatised metabolite and PGF_^ obtained are shown in
Figure on page 211 • The derivatised metabolite was
found to have a molecular ion at iv/g 582 which indicated
the presence of an extra double bond relative to PGF^ Me
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Figure 37. Lipidex 5000 profile obtained for the
extract ( after conversion to methyl esters )
of the products obtained after incubating
a human liver homogenate with \ PGE2.
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Figure 38, Mass spectra recorded at 70 eV using an
LKB 9000 GC-MS for authentic prostaglandin
F2^1 methyl ester trimethylsilyl ether (upper)
and the corresponding derivative of the
material obtained from the Lipidex 5000
column ( figure 37, page 210 ) with a
polarity greater than PGE2 methyl ester.
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to be at m/e 173, whereas in PGF2 ^Me TMS it was at m/e 191.
This large ion at m/e 173 is characteristic of the sodium
borohydride reduction products of 12-iso pgd ( r.l. Jones,
personal communication ) and indicated that the 13, 14-
trans double bond had been transposed to the 12, 13 position
in the metabolite ( i.e. exo-cyclic to the ring )• This
was supported by the smaller m/e 199 ion relative to PGF2^
This ion also confirmed that the extra double bond present
in the metabolite was not situated in the w-side chain, 33
in PGF^^because the m/e value of the corresponding ion
would have been at 197. Similarly the presence of an ion
at m/e of 421 is probably due to the same fragmentation that
results in the ion at n^e 423 in PGF Me TMS, namely the
loss of one trimethyl-silanol group ( TMSi-OH ) plus the
Cls~c20 ( ) fragment from the w-side chain. The
side chain appeared to be intact from the presence of ions
at m^e of 141. It was therefore concluded that the extra
double bond was in the cyclopentane ring. The most
probable positions being either between C-8 and C-9 or
between C-10 and C-ll. This could have resulted from an
enolisation of the 9-ketonic group. Another possibility
was that the double bond was situated between C-8 and
C-12 as in the B series prostaglandins, however, the
evidence above suggested that the 13,14-trans double
bond had been transposed to the 12,13 position would
indicate that this was not possible. The fact that the
hydrogen atom situated at C-3 is more labile than either
of those at C-10 would suggest that the extra double bond
was situated between C-8 and C-9. Thus the metabolite
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was tentatively identified a3 9,ll,15-trihydroxy-5~cis~
8(9),12(13) prostatrienoic acid.
Further mass spectral or radio gas chromatographic
analysis, however, was not performed to confirm this
structure, due to the lack of metabolite available for
analysis•
It is known that man excretes a urinary metabolite
of with a PGF^^configuration ( Hamberg and Wilson,
1973 ) thus, from the evidence quoted above, the enzyme
responsible for this reduction may be located in the liver.
However, one area where the conversion of PGE to PGF0 ^
could be of marked physiological and pathological importance
is in the bronchiolar tissue. Thus the metabolism of
by human bronchiolar tissue was studied.
The in vitro metabolism of prostaglandin—2~ by male and
female human bronchiolar tissue
An example of typical radio scan of the incubation
produces produced is shown in Figure on page 214 •
It can be clearly seen that no evidence for the conversion
of PGE^ to PGF^^was obtained during these experiments.
For both male and female human bronchiolar tissue homogenates
the two major metabolites produced were always less polar
than PGE^ in the thin layer chromatography system employed.
These metabolites were not conclusively identified, however,
their mobilities on thin layer chromatography suggested
that they were mainly the 15-keto PGE? and the 15-keto-
13,14-dihydro PGE^ respectively. It was thus concluded
that using the incubation procedures described on page











Figure Thin layer chromatography radioscans
obtained for two extracts of human bronchiolar
■x
hoinogenates incubated with PGE2 in the
presence (upper) and absence (lower) of
nadh2.
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in human bronchiolar tissue.
In one experiment it was observed that the
addition of to the incubation medium caused the
appearance of a third metabolite. The polarity of this
metabolite suggested that it was 13,14-dihydro PGE and
thus was probably produced by a reversal of the 15-
hydroxy prostaglandin dehydrogenase. The reversal of
this enzyme, present in bovine lung has previously been
reported ( Shaw et al., 1973 ).
The in vitro metabolism of prostaglandin by male chicken
liver, heart and brain samples
When incubated with above samples
produced a more polar metabolite that had a thin layer
chromatographic behaviour identical with PGF^. «h.n
the material from the PGF^^zones of thin layer plates
was subjected to combined gas chromatography-mass spectrometry
as the methyl ester trimethyl-silyl ether, gas chromatography
peaks and mass spectra identical with authentic prostaglandin
^2&<were obtained. The mass spectra were essentially the
same as those shown on page 211 • Prominent ions were
present at tye of 584 (M +) y 569 (M-15)y 494 (M-90)y 423
(M—9CH71) y 404 (M-2 x 90) y 397y 333 (M-2 x 90 + 71) y 217y
199y 191 and 173. These va/e values are characteristic of
PGF2<^Me TMS.
Due to the fact that the radio gas chromatography
system previously employed for the identification of PGE2
3
metabolites was no longer sufficiently sensitive for H-
labelled compounds, it was decided to confirm the levels
of PGF^^assayed by the radiochemical method by quantitative
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gas chromatography-mass spectrometry. When quantitatively
assayed as the ethyl ester trimathyl-silyl ether, the
3
levels of PGF^^calculated from the recovered H label in
the POSFj .thin layer zone and the specific activity of the
added H-labelled PG^2 substrate were found to be in good
agreement when assayed by either method. It was therefore
concluded that the majority of the PGF^ being quantitatively
assayed was being produced from the PGE added to the
A
homogenates and not by ae novo synthesis. The levels of
conversion to PGF^when assayed by the radio chemical
method are shown in Table on page 2^7 •
It was known from the studies with newly born
rabbits that the levels of 9-keto reductase were lower
immediately after birth than at adult age ( see page 203 )•
Consequently it was decided to measure the levels of 9-
keto reductase present in the liver homogenates obtained
from male and female chickens on days 1,8 and 22 after
birth. The results are presented in Table 0?^" on Page 213
It can be seen from these results that both male
and female chicken liver homogenates contain more 9-teto
reductase activity as the animal ages. However, as can be
seen from the results expressed in Table on page 217.
the levels of 9-keto reductase present in male liver
homogenates can vary quite considerably { 6%-30% ). Thus
it may possibly be that as yet unknown factors other than
age are affecting the levels of 9-keto reductase present in
male chicken liver. The possibility that part of this
fluctuating level may be due to the different levels of
steroid hormones such as oestrogens, androgens or progesterones
Table 2.^ 217
The conversion of P«. to PGF^ by male chicken liver,










































The values quoted represent the recovered radioactivity in




The conversion of PGE^ to PGF^by chicken liver
homogenatas obtained from male and female chickens of
different ages.
AGE













The values quoted are the percentage of the total
recovered radioactivity present in the zone of
thin layer plates.
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cannot as yet be discounted. Indeed, from the results
obtained with the rabbit and guinea pig liver homogenates
previously reported in this section of this thesis it
may well be that one or more of these steroids do have




At the beginning of this investigation the
primary objective was to develop a radioimmunoassay method
specific for prostaglandin . Radioimmunoassay methods
were already well developed for prostaglandin and F2^
in the laboratories at the Pharmacology Department when
the work described in this thesis began. It was therefore
decided to perform the initial developmental methods that
had previously led to the successful radioimmunoassays for
PGB2 and PGF^.
The radioimmunoassay method that was initially
envisaged was to have been used for the analysis of
prostaglandin E„ in a wide range of biological situations.
In collaboration with the research personnel at the
Pharmacology laboratories at May and Baker Ltd., Dagenham,
it was proposed to initially study the uptake and metabolism
of prostaglandin En ( as monitored by the decrease in PGE2
levels in blood administered to guinea pigs by a variety
of routes. These were to include the intravenous, aerosol
and gastro-intestinal routes. However, alternative uses
for the radioimmunoassay of prostaglandin E^ would have
included the analysis of prostaglandin E2 produced and
released from specific areas including the cat and dog
C.N.S.; guinea pig uterus? rabbit kidney in vitro and
in vivo and the isolated cat or dog spleen in response to
a variety of stimuli. It was realised at the time that
the use of a radioimmunoassay procedure, whilst offering
advantages of sensitivity, specificity and efficiency
relative to the classical bioassay procedures that were
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being routinely used, could never offer the conclusive
identification that was available from combined gas
chromatography-mass spectrometry ( GCMS ). It was
therefore apparent that confirmation for some of the
results obtained with the radioimmunoassay of should
ultimately be obtained with combined G.C.M.S.
The first description of an attempt to raise
antibodies to an E series prostaglandin was made by
Levine and Van Vunakis ( 1970 ). This has been followed
in the intervening years by several reports of attempts
to raise antibodies to E series prostaglandins ( Jaffe,
Smith, Newton and Parker, 1971? Yu, Chang and Burke, 1972?
Yu and Burke, 1972 ). In all these examples quoted the
immunogen used resulted in the production of anti-sera
with some significant degree of cross-reactivity to either
the corresponding prostaglandin A or B. The cause of this
has been suggested as being due to the carbodiimide used
to covalently link the E prostaglandin to the protein
immunogen inducing a dehydration of E to the corresponding
A prostaglandin ( Levine, Gutierrez-Cernosak and Van
Vunakis, 1971? 1973 ). The resulting A prostaglandin
immunogen was then postulated to be isomerised to the
corresponding B prostaglandin by the prostaglandin A
isomerase present in either plasma or tissues ( Jones
and Cammock, 1973? Horton, Jones, Thompson and Poyser,
1971? Polet and Levine, 1971 ). The result would be that
the antibody synthesising systems would be presented with
prostaglandin B conjugated to protein and thus antibodies
to this and not prostaglandin E would be produced. An
attempt to detect the conversion of the PGE^ during the
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conjugation reaction with bovine serum albumin into the
corresponding PGA2 was described in Section I. The free
prostaglandin that was recovered after dialysis of the
conjugation reaction was found by U.V. spectrophotometry
and thin layer chromatographic analysis to be identical
with authentic PGE2- No evidence was obtained for the
conversion of the PGE2 to either PGA2 or PGB2» This
result is in good agreement with a similar attempt to
monitor the carbodiimide conjugation step ( Yu and Burke,
1972 ). These workers also failed to detect any carbodiimide
catalysed dehydration of the PGE^.
However, when rabbits were immunised with the
resulting PGE^ immunogen ( conjugated with human serum
albumin ) four out of six rabbits produced antisera that
had virtually complete cross reaction with E, A and B
series prostaglandins ( Yu and Burke, 1972 ). This
indicated that the PGE^ had been dehydrated and isomerised
in vivo. The same result was obtained when, as reported
in Section I, rabbits were immunised using the multiple
intradermal technique with an apparently homologous
BSA immunogen. The major antibodies produced were
apparently a mixed population of PGB, PGA and PGE, the
majority of which had specificities directed mainly
towards PG&2. The possibility cannot be discounted from
the result presented in Section I that although the "free"
prostaglandin was still PGE2 conju9ated prostaglandin
may have been either PGA2 or PGB2. Certainly the
conjugation reaction, which is performed at slightly
alkaline pH (*S) and results in a condensation
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( i.e. dehydration ) of the carboxylic acid group of
PGE^ to the carbodiimide, is favourable for the dehydration
of the 2G&2 to PGA2* Another alternative explanation i3
that although the injected immunogen still retained PGE2
the duration in the animal ( rabbit ) prior to the
antibody synthesising processes being operated, was
sufficiently long to enable the combination of slightly
alkaline body pH ( ca. 7.4 ) and temperature ( 36-38*c )
to induce a chemical dehydration and isomerisation of
the PGE^ to PGA^ and PGB„ respectively.
One other possibility is that there may be
enzymes present in the rabbit ( or other animal species )
capable of dehydrating the PGE to PGA2, even when it is
conjugated with a large molecular weight protein.
Certainly evidence for the dehydration of PGE to PGA by
the rat ( Green, 1971 ) and various plasmas ( Levine et al,
1975 ), has been presented. The resulting PGA^-protein
conjugated could then be isomerised to the PGB., derivative
by the mechanism suggested by Levine et al (1972) or by
simple chemical induced isomerisation.
In an attempt to minimise the duration of time
between injection of the immunogen and the antibody
process being activated, it was decided to attempt to
successfully raise PGE^ specific antibodies in the
rabbit by injecting the immunogen directly into the
popliteal lymph nodes. The use of intranodal immunisation
procedures was pioneered by Boyd and Peart ( 1968) in an
attempt to improve the effectiveness of feeble or scarce
immunogens. The major disadvantages of this method are
that the immunised animals are more susceptible to infection
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because of the operating procedures and also that the
irritant adjuvant emulsions tend to destroy the injected
lymph node tissues. It was for these reasons that the
multiple intradermal technique developed by Vaitukaitis,
Robbins, Nieschlag and Ross ( 1971 ) and used initially
in these experiments has become so popular as the route
of immunisation. However, this method failed to
successfully produce a suitable antiserum for and
therefore the method of Boyd and Peart (1968) was
attempted. Unfortunately the antisera produced were
again principally directed towards
These results could support either the theory
of enzyme or chemical breakdown of the PGE? conjugated
to the BSA. Therefore it was decided to determine whether
any dehydrase enzyme activity could be detected in
the blood or lymph samples obtained from New Zealand
white rabbits. No evidence for such an enzyme was
obtained and therefore the reason for the inability to
raise antibodies to PGE? in the rabbit must remain
unanswered.
In an attempt to develop another form of
radioimmunoassay suitable for the present in
biological samples several alternatives were considered.
The options available includedthe development of antibodies
to a stable compound into which PGE^ was readily convertible
by simple chemical means. One such compound is PGB^
which is produced from PGE^ by treatment with alkaline
media ( Andersen, 1969 ). Antibodies have successfully
been raised to this compound ( Levine et al., 1971?
Levine, 1974, Emslie et al., 1975 ) .
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However, in the absence of specific antibodies to
prostaglandins and C-1# both of which are intermediate
in the conversion of into PGB2, it was decided
that it would be extremely difficult to obtain accurate
results by this method for the levels of PGE , Another
2
chemical step known to produce quantitative conversions
is the reduction of the 9-keto group in with sodium
borohydride. The resulting products and »
are epimeric at C-9. Antibodies had successfully been
P
raised in our laboratories to PGF0^, ( Emslie et al.,
1975 ), however, it was decided that antibodies to PGP.
4
would be a better assay for PGEn. The primary reasons
for this choice were that by assaying a biological sample
for PGF2before and after sodium borohydride, whilst
giving an estimate of the PGE present, would not be an
accurate account for the contribution due to PGF„_
2 3
produced concomitantly or the PGF?^?nd like compounds
produced from both PGF^and PGE2 metabolites, as the
proposed PGF^ antibodies. For example only half the
number of the potential compounds produced would have the
VG£ring configuration when compared with the PGF26^
ring configuration. This is because the PGF^ metabolites
already have this ring configuration. Therefore the
potential degree of interference with the assay by these
compounds is in theory considerably lower. Certainly,
PGF2} radioimmunoassay procedures have been successfully
developed ( Levine et al., 1975 ) and found to give
comparable results for when compared with sampj.es
assayed with a PGF^ antiserum.
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Although in certain rabbits antisera were
successfully developed for PGF2£ in terms of the number
of antibodies produced ( as determined by the dilution
curves ) the cross-reactivities with PGF^ , the major
potential interfering compounds were frequently greater
than 5% of the PGF^^alue causing a 10% fall from 60%
binding. Similarly the difficulties encountered in
obtaining a reproduceable and quantitative conversion
of PGE2 to PGF2^and PGF2^ at the levels probably due
to be encountered in most biological systems { less
than 1 ng per assay ) make the value of this assay at
present of limited use.
During the studies on the metabolism of
by rabbit blood and lymph glands it was thought advisable
to study the metabolism of FGF2 by sheep whole blood.
This animal, unlike the rabbit, does not appear to have
a prostaglandin A isoraerase within its plasma ( Jones,
Cammock and Horton, 1972 ). If thi3 animal lacked
this enzyme and the postulated PGE dehydrase then it may
offer the ideal system for the successful raising of
antibodies and the development of a radioimmunoassay
specific for PGE^. When incubated with sheep whole blood,
however, a metabolite was produced that had thin layer
chromatographic properties identical with authentic PGF^^
This was subsequently conclusively identified by radio
gas chromatography and combined gas chromatography-mass
spectrometry as being PGF^ . The reduction of the 9-
keto group was found to be stereoselective unlike the
comparable reduction by sodium borohydride which results
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in both 9-hydroxy epimers being produced. The reduction
process by sheep blood was found to be heat and pH labile,
and the enzyme responsible to be located in the cellular
fraction. The type of metabolism being described,
namely reduction of the 9-keto, had only been described
in two instances previously at the time of the discovery
of this enzyme in sheep blood. One instance was the
conversion of PGE2 to PGF2^by guinea pig liver homogenates
( Hamberg and Israelsson, 1970; Samuelsson et at, 1970 ),
whilst the other was conversion of the 9-keto group to
a metabolite with the PGF2^ring structure in the guinea
P^9 in vivo ( Hamberg and Samuelsson, 1969 ).
The 9-keto reductase enzyme present in sheep
whole blood was further characterised for substrate
specificity in an attempt to define whether this enzyme
was specific for the metabolism of E series prostaglandins.
It was found that this enzyme had certain structural
requirements for maximal activity. Certainly the
substituents at C-ll were found to be critical because
PGA2 was not acceptable as a substrate. However, the
interesting observation that PGD2# a substrate with a
ketonic function at C-ll and a -hydroxy1 at C-9, was
an equally good substrate stimulated the desire to
discover whether 15-keto PGE2 or 15-keto PGE^ were
substrates. It was surprising to find that in these
compounds not only were the ketonic functions at C-15
stereospecifically reduced to the 15(S) configuration but
also that the 13,14 trans double bond could also be
reduced. From the results obtained with these compounds
as substrates it would appear that the enzyme reducing
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the 9-keto group is different to that reducing the 15-keto
group. However, the possibility that the two reduction
processes may be being performed by a low substrate
specific reductase cannot be discounted. Certainly
reduction of the C-15 ketonic function of prostaglandins
has been described ( Somuelsson et al., 1971? Anggard
and Samuelsson, 1964 ). In addition, reversibility of
the 15-hydroxyprostaglandin dehydrogenase present in
bovine lung is known to be a possibility ( Shaw et al.,
1973 ). This enzyme, however, does not appear to convert
PG&2 into PGF2^when performing the reverse reaction.
Similarly when sheep whole blood was incubated with
PGF2^and NAD+ no conversion to 15-keto PGF2^was detectable,
and yet these are conditions that would normally be suitable
for the oxidation of the C-15 alcohol group ( Anggard
and Samuelsson, 1966; Nakano et al., 1969? Shio et al.,
1969 ). The possibility that the reduction of the ketonic
functions described above was being performed by a 15-
hydroxyprostaglandin dehydrogenase working in reverse
therefore seems minimal.
The metabolism of 15-keto PGE by either human
or bovine blood was also studied and found in both
examples to produce QU major metabolite, namely 15-keto-
13,14-dihydro-PGE. Whether the presence of this ^ 13
prostaglandin reductase ha3 any physiological significance
for the inactivation of circulating 15-keto prostaglandins
is unknown. Certainly both 15-keto PG^2 and 15-keto PGF2|^
rapidly lose most of their biological activity on the
additional reduction of the 13,14-trans double bond
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( R.L. Jones, personal communication ). It could
possibly be that this enzyme is present in the blood
samples of many species to act as an additional protective
mechanism for the cardiovascular system. Normally both
PGE2 and PGF2^lose most of their biological activity
( 95%-99% ) on a single passage through the lungs
( Ferreira and Vane, 1967? Vane, 1969? Horton and Jones,
1969? McGiff et al., 1969 ).
The interconversion of E and prostaglandins
was considered to be of sufficient potential physiological
importance to warrant further distribution studies in an
attempt to ascertain whether this type of metabolism
is a widespread phenomenon. Most previously reported
metabolism studies had not reported the inter-conversion
of PGE and PGF^. Certainly it was known that these two
prostaglandins were not interconverted during their
biosynthesis ( Anggard and Samuelsson, 1965? Hamiberg and
Sarauelsson, 1967 )• However, from 1972 onwards, evidence
has been accumulating for the presence in a variety of
tissues obtained from several animal species of enzymes
capable of interconverting E and prostaglandins
( Hamberg and Wilson, 1973? Leslie and Levine, 1974?
Lee and Levine, 1973? 1975 ). Actively fermenting Baker's
yeast has also been shown to convert to PGF2^
( Schneider and Murray, 1973 ) . The potential importance
of this type of enzyme as a possible modulator of a
physiological or pathological role mediated via fluctuating
levels of PGE and PGF^has been suggested ( Lee and Levine,
1974 ). This certainly could be a distinct possibility in
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the organs where the E and F^ series prostaglandins
have qualitatively and quantitatively different actions.
In the distribution studies described in
Section III of this thesis, in addition to confirming the
presence of 9-keto reductase activity present in guinea-
pig liver homogenates ( Hairiberg and Israelsson, 1970?
Samuelsson et al., 1971 ) several new examples were
recorded. These were namely the horse, rabbit and
chicken liver, horse and chicken heart and chicken brain.
In addition, evidence for a metabolite of PGE2 with a
PGF like structure was obtained from studies with human
liver homogenates. It was not established whether the
enzymatic conversion of PGE2 to PGF2^,is reversible
during these experiments. Similarly, the failure to
detect the conversion of PGE2 to PGF2&( in a11 the tissues
studied may indicate that this type of metabolism is not
widely distributed. However, the possibility that the
correct co-factors for the detection of this type of
metabolism were not being used may exist. Certainly Levine
and Lee ( 1975 ) maintain that the 9-keto reductase
activities in pigeon and monkey tissues is stimulated by
NADPH2 but not by NADH2. This could explain why no
9-keto reductase activity was detectable in rat heart,
liver or kidney homogenates all of which has previously
been described as containing relatively high levels of
Lesley/
9-keto reductase activity ( Levine, 1973? Lee and Levine,
1974 ). Until more detailed comparisons of the two
biochemical and subsequent analytical procedures are made
it will not be possible to define if either or both results
are correct.
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The observations that pregnancy or pseudo-
pregnancy in rabbits or in vivo treatment with oestradiol &
progesterone in guinea pigs can quantitatively change the
metabolism of prostaglandins is significant. It is known
that during pregnancy the ability of lung tissue to
inactivate circulating PGE and PGF^ and PGA increases in
the rabbit and sheep ( Horton and Maule-Walker, 1374?
Bedwani and Marley, 1975 ). This probably explains why
Oakes et al. (1972) claimed that the cardiovascular system
of sheep was insensitive to prostaglandins. It had
previously been reported that this animal was sensitive
to E prostaglandins given intra-aortically but not
intravenously ( Horton, Main and Thompson, 1965 ).
The obvious importance of understanding what
factors control the biosynthesis and metabolism of
prostaglandins hopefully will ultimately reveal the
processes by which these compounds function in vivo. The
significance of the connection between prostaglandin
metabolising capacity in other tissues, particularly
the lung, and the changes in oestrogen and progesterone
hormonal levels may explain how the cardiovascular system
in particular is protected from relatively larger levels
of prostaglandins reported to be circulating during
pregnancy. More detailed studies with particular
reference to a correlation between the prostaglandin
metabolising capacity of other tissues and the changes
in hormonal levels are obviously required.
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APPENDIX
During the work reported in this thesis, many
occasions have arisen where the conclusive identification
of PGE2 bY combined GCMS was essential. Prostaglandins
of the E series contain a ^ -ketolring system that is
readily susceptible to dehydration on the gas
chromatography systems employed and therefore it was
essential to protect this ^-ketol system by oximation.
The initial method of oxiraating PGE was described by2
Green (1969)• In collaboration with Drs. R.L. Jones
and N.H. Wilson the analysis of PGE and 15-keto PGE_
<6 *•
by combined GCMS using a series of O-alkyl oximes was
undertaken. There were three major reasons for wanting
to study these oximes :
1) The oximation process results in the
formation of two oxirae isomers per ketonic
function ( Syn and anti isomers ). This
results in the mass of being split
between the two oxime isomers and therefore
reduces the efficiency of quantitative
analysis.
2) The major ions for PGE2 methyl ester,
trimethylsilyl ether o-methyl oxime ( second
isomer ) were at lq/e 225 and 295. These
ions are thus in the mass spectral region
where many interfering biological compounds
produce ions. Consequently the analysis of
PGE2 using this derivative can be markedly
affected at the nanogram range.
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3) The Me TMS derivative of PGF2^does not
separate well from the corresponding Me Mo
TMS derivative of PGE2. This is unfortunate
because the analysis of PGE2 and PGF2^
together reduces the amount of preparative
work required for GCMS. However, when
analysed together as the above derivatives
the limit of detection for each was
reduced relative to the analysis of each
individually.
196 7
Using the method of Fuiii, Wu and yamada a series
of O-substituted alkyl oximes were prepared. These
included the o-iso-propyl, o-n-butyl and o-n-pentyl oximes.
The carbon values for each isomer of PGE2 when chromatographed
as the methyl ester trimethylsilyl ether of these oximes
is shown
PGE2 oxime Carbon value









It can be seen that the o-n-butyl and o-n-
pentyl -oxime derivatives of PGE2 are well separated from
PGF2 ^Me TMS. These have successfully been employed for
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the analysis of PG22 and PGF.^ produced by the rabbit
kidney by combined GCMS without prior chromatographic
separation. Unfortunately the desired preferential
formation of one oxime isomer only was not obtained,
indeed the ratio of the two oxirae isomers r^»alned
fairly constant throughout the series.
When the mass spectra of the second isomer for
each pGE2 oxirae were studied the ions at ta/e 225 and 295
were found to consistently be the two major ions produced.
The ion at ny/e 225 was proposed to result from the loss
of C—1 to C7 (141) and C-15 to C-20 (173) in the methyl
ester raethoxime TMS derivative of pGE2 ( Green, 1969 ).
However, this could not be the major fragmentation mode
because the ion m/e 225 is the base peak in all the
oxime isomers of PGE., studied. In addition W -dihorao-^
PGE^ has the base peak at nye 253 which indicates that
theU/-side chain remains intact in this ion. Similarly,
when the 15-0 methyl ether raethoxime TMS derivative of
PGE2 was studied the ions corresponding with trv'e 225 and
295 ( PGE^ Me Mo TMS ) were found to be at iry/e 167 and
237 respectively. This result also indicated that the
ion at ny/e 295 in PGE^ could not have resulted entirely
from the loss of the ^-chain and the oxime as previously
predicted ( Green, 1969 )• The results of studying
different substituents on the m/e values of these two ions
are shown in PujiANL 4-0 on page 235 • was thus
concluded from these results that the major mode of
fragmentation resulting in the formation of ny/e 225 and
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Figure 40. Mass spectra obtained using an LKB 9000 GC-MS
at 70 eV of the major isomer (second) eluted
from the gas liquid chromatography column
(3m x 4mm J>% 0V-1 on Supelcoport ) for the
following derivatives of prostaglandin Eg
methyl ester 1) 9—0—n-butyloxime, 11
trimethylsilyl ether, 15 methyl ether (upper);
2) 9-0-n-butyloxime, 11, 15 bis trimethyl¬
silyl ether; 3) 9-0-methyloxime, 11, 15
bis trimethylsilyl ether.
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Figure 41. The proposed mode of fragmentation (at 70 eV)
for the major isomer (second) of prostaglandin
Eg o-alkyl oximes, resulting in the two
major ion intensities present above m/e 150
in the mass spectrum of such compounds.
237
These ions are therefore postulated to be derived from
C8 - C9 and Cll - C12 fissions with additional fissions
respectively at C7 - C8 and C15 - C16.
When the bis-o-alkyloximes were studied
(e.g. 15-keto similar fragmentation modes were
found to occur in the 3rd and 4th oxime isomers ( on
GLC retention )• These isomers are predicted as being
isomeric at C-15. The postulated fragmentation mode
for 15-keto PGE^ oxirae derivatives is shown in figure
on page 238 •
To date the proposed fragmentation modes for
the o-alkyloxime trimethylsi^ri ether derivatives of
PGE2 and 15-keto PG222 have h©en found to be applicable
to all the 2 series E prostaglandins so far studied.
One important group that appears to be essential is the
presence of a functional leaving group at C-ll. In
neither 11-deoxy, nor 11-methyl PGE„ ig the above















Figure 42. The proposed mode of fragmentation at 70 eV
for the major isomers (third and fourth) of
15-keto prostaglandin Eg bis 0-alkyl oximes
resulting in the two major ion intensities
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Prostaglandins E2 and D2 were both converted to
prostaglandin F2a (9a,11a) by an enzyme present in sheep
blood. Neither the 913,11 a epimer nor the 9a, 116 epimer
was produced from PGE2 or PGD2 respectively. The rate of
reduction was measured using isotope dilution (D4 PGF2a)
and multiple-ion detection gas chromatography-mass
spectrometry.
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The reduction of prostaglandin E2 (PGE2) to prosta¬
glandin F2Q, (PGF2a) by an enzyme present in sheep blood has
recently been reported1'2. Few other examples of this type
of conversion have been described3-7. These two prostaglan¬
dins and a third primary prostaglandin, prostaglandin D2
(PGD2) are enzymatically produced from the same 9,11-cyclic
endoperoxide8-10 . Although these three primary prosta¬
glandins (PGD2, PGE2 and PGF2a) are formed from a common
precursor and are not precursors of each other, the results
reported here indicate that some interconversion of these
three primary prostaglandins is possible. If the enzyme
concerned is widely distributed, it may be of importance in
the physiological role of prostaglandins since these three
compounds have many qualitatively and quantitatively
different pharmacological actions11.
Freshly citrated sheep blood was treated as described
previously1 to produce the six different stock enzyme
preparations (A to F) that were used to compare PGE2 and
PGD2 as substrates for the enzyme producing PGF2a. These
were incubated at 37°C and a substrate concentration of
5 pg/ml 1. In addition blank samples were also incubated
without any substrate. Aliquots (0.2 ml) were sampled from
each preparation at 1, 5, 10, 15, 30. 60 and 90 minutes and
extracted into ethyl acetate after the addition of 1 pg of
3, 3, 4, 4, tetradeutero PGF2a. The residue obtained from
the ethyl acetate was converted to the methyl ester tri-
methylsilyl ether as described previously12 and quantitative¬
ly assayed by multiple ion detection (MID), gas chromato-
graphy-mass spectrometry as reported earlier13.
The mean results for six experiments are shown in
figure 1.
It can be seen that both PGD2 and PGE2 produce PGF2a
in a time dependent fashion when incubated with sheep blood.
Although the enzyme concerned had been shown to produce
only the 9a hydroxy epimer (PGF2a) from PGE2, confirmation
that PGD2 was converted to PGF2ff only, required more
detailed chromatographic and mass spectrometric analysis
since the 9alla and the 9allG PGF2 epimers did not separate
on the gas liquid chromatography system employed.
The prostaglandin residue obtained at the end of the
incubation period (approximately 100 min) from samples D,
E and F converted to methyl esters and subjected to
straight phase gel chromatography on a lipophilic
substituted LH-20 gel using the method described previously14,
co-chromatographed with PGF2a (and not its HG-epimer). The
chromatographic separation of the 9allR PGF2 and the 9alla
PGF2 epimers gave greater than 98% purity with respect to
each other when authentic prostaglandin methyl esters were
chromatographed (Figure 2). Further evidence of identifi-
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cation of the end product obtained from PGD2 was obtained
by using the cyclic n-butyl boronate ether described
previously15. The n-butyl boronate derivative is produced
only when the hydroxyl groups at the 9 and 11 positions
are in the cis configuration. An example of the gas liquid
chromatography result obtained with this derivative is
shown in figure 3. This evidence combined with the mass
spectral evidence confirmed that the end product of the
reduction of PGD2 is PGF2a . No evidence was obtained that
suggested any of the 1KB epimer was produced.
The experiments described here were designed to
compare the reduction of PGE2 and PGD2 by an enzyme present
in sheep blood and in addition to identify conclusively
the reduced products. The enzyme concerned is believed to
be prostaglandin specific1'2 however, further substrate
specificity studies are required to confirm this and to
characterise the enzyme in more detail.
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Figure 3: Gas liquid chromatograms of authentic 9allaPGF2
and 9allGPGF2a and also the 9allaPGF2 zone from 1
liquid gel chromatography of sample E. These were
prepared as the methyl ester (diazomethane) n-butyl
boronate (n-butylboronic acid in 2,2 dimethoxy
propane) trimethyl silyl ether (BSTFA). The n-butyl
boronate on forms the 9,11 cyclic ether when the
9,11 hydroxyl are cis to the ring consequently
9allBPGF2 under these circumstances produces the
methyl ester trimethyl silyl ether derivative only.
A) Authentic 9allBPGF2. The mass spectrum of this
G.L.C. peak was characteristic of the Me TMS
derivative.
B) Authentic 9alla;PGF2 . The mass spectrum of this
peak was characteristic of the Me NBB TMS derivative.
C) 9allaPGF2 zone from the 51% LH20 gel column.
Three mass spectral scans at 8.1, 10.2 and 11.3
minutes showed that only the Me NBB TMS derivative
of 9allaPGF2 was present (11.3).
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The Vail Conference on Prostaglandins
ANNOUNCEMENT
The fourth annual conference on Recent Advances in Prosta¬
glandins Research will take place in Vail, Colorado, March 9-13th,
1975. The tentative program includes sessions on the following
topics: Analogue Chemistry; Prostaglandins and Animal Reproduction;
The Nervous System; and the Renal-Cardiovascular System.
As in previous meetings, participation and attendence will be
by invitation only. If readers of the Journal are interested in
attending the meeting, please write to the Editors of the Journal,
stating the following: area of research interest; and intention to
present new information.
Attendence will be limited to approximately 100 scientists
insuring that an air of informality with a free exchange of ideas
(even a few arguments) will prevail.
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DISTRIBUTION STUDIES ON THE REDUCTION OF PROSTAGLANDIN E2
TO PROSTAGLANDIN F2a BY TISSUE HOMOGENATES
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Summary
Liver homogenates from guinea-pig, rabbit and horse, and heart homo-
genates from the horse have been found to convert prostaglandins Ei and E2 to
prostaglandins Fla and F2a, respectively. The end products have been provi¬
sionally characterised by thin-layer chromatography, and conclusive identifica¬
tion was carried out by gas-liquid chromatography-mass spectrometry.
Introduction
The reduction of prostaglandin E2 to prostaglandin F2 a by an enzyme
present in the cellular fraction of sheep blood has recently been reported [1,2].
This type of metabolism, namely reduction of the 9-oxo group has been con¬
clusively described in only a few instances. The first example was the demon¬
stration that prostaglandin F2 a is produced from prostaglandin E2 when incu¬
bated with guinea-pig liver homogenates in vitro [3].
Many of the pharmacological actions of prostaglandin E2 and prostaglan¬
din F2a, differ both qualitatively and quantitatively an example being that
prostaglandin E2 is a bronchodilator whereas prostaglandin F2q. is a broncho-
constrictor [5]. Although these two prostaglandins are both formed enzymatic-
ally from the same precursor (arachidonic acid), there is no interconversion of
prostaglandin E and prostaglandin Fa in their biosynthesis [6,7]. The discovery
of an enzyme in sheep blood which reduces prostaglandin E to prostaglandin
Fa raised the possibility that this conversion may be widespread in occurrence
and of biological importance. It was thus felt necessary to ascertain whether
the conversion of prostaglandin E2 into prostaglandin F2 a was a widely distri¬
buted phenomenon.




Preparation of tissue homogenates. Tissues from guinea-pig, rat, dog, cat,
cow, sheep, horse, pig and rabbit of both sexes, were removed as soon as
possible after death (kept on ice if transport was required) and chopped into
small pieces approx. 1 cm3. These were then homogenised in 3 volumes (by
weight) of ice-cold 0.1 M sodium phosphate buffer (NaH2P04, 2.7 g; Na2-
HP04 12.54 g in 1 1 of distilled water) using a Polytron homogeniser at maxi¬
mum speed. The resulting homogenate was then centrifuged at 4° C for 30 min
at 2400 X g and the supernatant was carefully decanted and stored on ice until
used.
Incubation and extraction procedure. The resulting supernatant was added
to a 100 ml conical flask containing tritiated prostaglandin E2 (Radiochemical
Centre, England, [ 5,6,8,11,12,14,15-3 H] prostaglandin E2 spec, act., 36.4
Ci/mol) at a substrate concentration of 14 pM and a cofactor concentration of
NAD and NADH of 10 mM each. The samples were then incubated at 37° C for
2 h (with agitation) in a water bath.
The products of the incubation were diluted to 150 ml with distilled
water and acidified to pH 4 with 10% acetic acid. After extraction twice with
2 volumes of either diethyl ether or diethyl ether/ethyl acetate (4:1, v/v), the
pooled organic phases were washed twice with 50 ml of distilled water before
being taken to dryness under vacuum and desiccated.
The resulting residue was dissolved in 50 ml of 67% by volume aqueous
ethanol and partitioned twice with one equal volume of either benzene or
toluene, before the aqueous phase was taken to dryness and desiccated. Where
prostaglandin F2 a appeared to be a metabolite of prostaglandin E2, the experi¬
ment was repeated at a 10-fold increase of substrate concentration (140 pM)
and in addition [2-1 4 C] prostaglandin E, was compared in parallel at the same
substrate concentration.
Preparation of methyl esters. The residue from the 67% ethanol phase was
dissolved in excess diazomethane in diethyl ether/methanol (9:1, v/v) and left
at room temperature for 15 min to allow methyl esters to form. Where neces¬
sary (e.g. if material had precipitated out of solution) the resulting solution was
filtered through a glass wool plug inserted in a Pasteur pipette. The original
flask was then washed with excess methanol (5—10 ml) and this was also
filtered. The pooled solution was then taken to dryness under vacuum and
desiccated.
Straight phase gel chromatography. Glass columns (300—400 X 10 mm)
were silanized by treatment for a minimum of 2 h at room temperature with a
5% dichlorodimethylsilane (Sigma) solution in toluene (v/v). These were then
washed thoroughly with chloroform and methanol to remove excess silanizing
agent and plugged at the base with glass wool. These columns were then packed
with a lipophilic Sephadex LH-20 gel (Lipidex 5000) as described previously by
Brash and Jones [8]. This gel has been substituted with hydroxyalkyl groups
(C, 4 hydrocarbon chain lengths) to 50% by weight. Prior to packing, the gel
had previously been equilibrated with a heptane/chloroform (80 : 20, v/v)
mixture and was further equilibrated in situ before being used. A constant
pressure head at the top of the column was maintained and a flow rate of 6—12
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ml/h was obtained. Room temperature was maintained at 20 ± 1"C. The sample
to be chromatographed (as the methyl esters) was dissolved in 100—200 pi of
chloroform and then heptane was added until the solvent composition was the
same as the column eluant. The total loading volume (including washings) was
never greater than 1.5 ml.
The column effluent was led via narrow bore Teflon tubing to the drop-
counting head of an LKB Ultrorac fraction collector. Fractions, equivalent to
10% bed volume, were collected until the 2000% bed volume point was
reached.
The elution profile of the column was obtained by liquid scintillation
counting of an aliquot of each fraction. These columns have been found to be
re-usable and reproducible both for authentic standard prostaglandins and also
biological extracts. Columns which had begun to lose performance (as shown
by peak broadening) were purged by reverse flowing the column with a more
polar solvent (e.g. methanol/chloroform/heptane, 10 : 50 : 50, by vol.) before
re-equilibrating in the original solvent.
From the elution profile it was possible to bulk several fractions into
corresponding zones. These were taken to dryness and re-dissolved at 1.0 ml of
methanol and an aliquot counted by liquid scintillation counting to determine
the percent of the total recovered radioactivity.
Thin-layer chromatography. Neutral silica gel (200 mm X 200 mm X 0.25
mm) on glass plates (Merck) was used. Marker standards containing [3H]-
prostaglandins F2(3, F2a, E2, 13,14-dihydro E! and A2 methyl esters were
spotted on the plate at the side of the samples being chromatographed. The
plate was then developed in a closed equilibrated glass tank using a modified
form of a thin-layer solvent described previously [9]. The solvent was ethyl
acetate/methanol/acetic acid (110 : 5 : 1, by vol.). This system was found to
give a good resolution of many prostaglandins and their metabolites.
Liquid scintillation counting. This was performed with a Mark II Nuclear
Chicago Liquid scintillation counter.
Aliquots of either the individual column fractions or the methanol solu¬
tion containing the pooled fraction residue were counted in 5 ml of a toluene,
ethoxyethanol-based scintillant mixture (toluene/ethoxyethanol, 1500; 900,
v/v; DMPOPOP/PPO/napthalene, 0.9 : 10.5 : 112.5, by weight). Where dpm
were required these were obtained by correcting for quenching using the
automatic external standard channels ratio method and a quench-calibration
curve constructed for the scintillation mixture.
Radio gas chromatography. A Pye series 104 gas chromatograph inter¬
faced with a Panax radio detector enabled the simultaneous recording of mass
and radioactivity. The gas chromatograph stationary phase was 3% OV-1 on
Supelcoport 100—120 mesh. The oven temperature was 230—240°C, the car¬
rier gas (argon) flow rate was 35—40 ml/min and the oxidation furnaces were at
650-680° C.
Carbon values of compounds were obtained from a log retention time
versus carbon value for normal saturated fatty acid methyl esters as described
previously [10].
Combined gas-liquid chromatography — mass spectrometry. Mass spectra
were obtained using an LKB 9000 combined gas chromatograph — mass spec-
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trometer, fitted with a glass column packed with 3% OV-1 on Supelcoport
(100—120 mesh). The oven temperature was 240—260°C and the carrier gas
(helium) flow rate was 30—35 ml/min.
Preparation of derivatives for gas-liquid chromatography — mass spectro¬
metry. An aliquot of the methanol residue from the appropriate zone of the
Lipidex 5000 columns was taken to dryness and desiccated. Trimethylsilyl
ethers were prepared by treating the residue with N, N-bis (trimethylsilyl)-tri-
fluoroacetamide by the method described previously [11]. The prostaglandin
derivatives were injected into the gas chromatograph in 5—10 pi of this reagent.
Purification of /3 H]prostaglandin E2 ■ An aliquot (approx. 0.5 pCi) of the
tritiated prostaglandin E2 free acid (The Radiochemical Centre, Amersham,
England: [5,6,8,11,12,14,15-3 H] prostaglandin E2, spec. act. 167 Ci/mmol)
was found by thin-layer chromatography to be contaminated by a less polar-
compound that had a chromatographic behaviour identical to that of unlabeled
prostaglandin A2 free acid.
The total [ ' H] prostaglandin E2 (1.5 mCi, 3.5 pg) was then purified by
reversed phase partition chromatography on a graded LH-20 column (essen¬
tially as described previously [1]). The glass column used (300 X 10 mm) was
packed with graded LH-20 (50 ± 5 pM diameter size particle) previously equili¬
brated in the solvent mixture (methanol/water/chloroform/butanol/acetic acid,
50 : 50 : 5 : 5 : 0.1, by vol.) and allowed to flow at a constant pressure head
for 12 h before use. The column bed volume was 20 ml, the flow rate 7—8 ml/h
and the room temperature 23 + 1°C. Effluent fractions of 2.0 ml volume were
collected as described previously and a 5 pi aliquot counted. The chromato¬
graphic step yielded 1.0 mCi of tritiated prostaglandin E2 that was greater than
99% pure by thin-layer chromatography.
[2-14 C] Prostaglandin E, (New England Nuclear, spec. act. 40 Ci • mol"')
was found to be greater than 99% pure when tested in the above thin-layer
chromatography systems and thus was not further purified.
Solvents and chemicals. All solvents were of analytical grade or redistilled
before use. The chloroform was redistilled over anhydrous CaCl2 and 1% (by
vol.) of absolute ethanol was added to the redistillate to stabilize it.
Results
The liver of horse, rabbit and guinea-pig and horse heart have been found
in these studies to be capable of converting prostaglandin E to prostaglandin
F„. The average degree of prostaglandin E2 to prostaglandin F2 a conversion
was 14; 42; 9 and 12%, respectively, as determined by the recoveries from the
Lipidex 5000 columns. At no time has any evidence been obtained for the
conversion of prostaglandin E to prostaglandin F^,
Separation of prostaglandin metabolites by Lipidex 5000
The separation of methyl esters of authentic tritiated prostaglandins A2,
E2, F2o and F2)3 is shown in Fig. 1A. There was good separation of these
prostaglandins on the lipophilic LH-20 gel chromatography system employed.
Fig. IB shows an example of the elution profile obtained when a rabbit
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Fig. 1. (A) The upper diagram represents the chromatographic separation on Lipidex 5000 of authentic
3H-labelled prostaglandins A2, E2, F2# and F2fi methyl esters. (B) The lower trace represents the elution
profile on Lipidex 5000 (after conversion to methyl esters) of an extract from rabbit liver incubated for
2 h at 37 C with prostaglandin E2.
same column as the authentic standards shown in Fig. 1A immediately after
these standards had been chromatographed. It can be seen from Fig. IB that
rabbit liver homogenates produce several metabolites when incubated with
prostaglandin E2 at least one of which is more polar than prostaglandin E2 and
has chromatographic properties identical with prostaglandin F2 a in this system.
The majority of these metabolites have only been provisionally identified
TABLE I






15-oxo E2 0.55 2.9
15-oxo F2q. 0.49 3.9
13,14-dihydro, 15-oxo E2 0.58 1.7
13,14-dihydro, 15-oxo F2q< 0.50 1.9
13,14-dihydro Ei 0.48 —
13,14-dihydro F 0.39 —
Abbreviation: GMC, gas-liquid chromatography-mass spectrometry.
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by their retention volumes on Lipidex 5000 and their RF values on thin-layer
chromatography. These values for authentic prostaglandin standards are given
in Table I. The separation of prostaglandins E2, F2q, and F2(3 was essential
because it has been shown by Hamberg and Samuelsson [4] that in the guinea-
pig in vivo, prostaglandin E2 is reduced to the |3 isomer as indicated by a
urinary metabolite with the prostaglandin F2 p configuration. In vitro, however,
it has been shown that guinea-pig liver homogenates produce prostaglandin F2 a
as one of the metabolites of prostaglandin E2 [3]. The possibility, therefore,
existed that the 9-oxo group of prostaglandin E2 could be reduced to either the
9a or 9(3 alcohol by some of the tissues being studied. The use of these columns
have enabled the detection of approx. 1% metabolism of prostaglandin E2 to
be detected.
Thin-layer chromatography
It was suspected that the peak corresponding to fractions 51—64 on the
Lipidex 5000 column (shown in Fig. IB) contained at least two compounds.
(METHYL ESTERS)




Fig. 2. Thin-layer chromatographic separation. (A) The lower trace represents the separation of authentic
3H-labelled prostaglandins F> Fa, E, 13,14-dihydroE and prostaglandin A methyl esters. (B) The middle
and upper trace represent the separation of fractions 51—55 and 56—64, respectively, obtained from the
Lipidex 5000 elution profile represented in Fig. 1.
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Although this peak overlaps with the peak corresponding to authentic prosta¬
glandin E2 it is much broader. Thin-layer chromatography of these fractions
confirmed this was so, (Fig. 2). Fractions 51—55 mainly contained a material
that was identical with authentic 13,14-dihydro-prostaglandin E, methyl ester,
together with a smaller amount of material identical with prostaglandin E2
methyl ester. In contrast fractions 56—64 contained material most of which
was identical with prostaglandin E2 methyl ester and a smaller portion that was
identical with 13,14-dihydro-prostaglandin Ei methyl ester. The 1 and 2 series
prostaglandins do not separate on the thin-layer chromatography systems
employed.
The tissues so far studied have all been found to produce less polar com¬
pounds than prostaglandin E2 and these have provisionally been identified by
their mobilities on Lipidex 5000 and by thin-layer chromatography. The two
major metabolites produced by most tissues were provisionally identified by
the above methods as 15-oxo-prostaglandin E2 and 13,14-dihydro,15-oxo-
prostaglandin E2; where prostaglandin F2 a has been found as a metabolite the
corresponding prostaglandin F2 a metabolites have also been identified.
Both the Lipidex 5000 gel column chromatography and the thin-layer
chromatography have been found to give comparable separations of the prosta¬
glandin E! metabolites produced in parallel with the prostaglandin E2 meta¬
bolites.
Radio gas chromatography
The tissues found to convert prostaglandin E2 into prostaglandin F2 a,
namely, homogenates from guinea-pig, rabbit and horse liver and horse heart
were incubated with [2-1 4 C] prostaglandin Ej. These tissues produced several
metabolites, one of which was provisionally identified by the above methods as
prostaglandin F! a. An example of this is shown in Fig. 3. Here it can be seen
from the upper trace that the methyl ester trimethylsilyl ether of both prosta¬
glandins F1(3 and Flct separate on the gas chromatography system employed.
The lower half of Fig. 3 shows material produced by a rabbit liver homogenate
and provisionally identified by Lipidex 5000 mobility and thin-layer chroma¬
tography as prostaglandin Fj a. It can be seen that when subjected to gas-liquid
chromatography as the methyl ester trimethylsilyl ether, this material has a
retention time for both mass and radioactivity (14C) identical with that of
authentic prostaglandin F, a methyl ester trimethylsilyl ether.
Radio gas chromatography was not performed on any of the prostaglandin
E2 metabolites produced by any tissues because 1 4 C-labelled prostaglandin E2
was not available and the radio gas chromatography system employed was not
sufficiently sensitive to detect the levels of 3 H-labelled metabolites produced.
Mass spectrometry
Conclusive evidence that prostaglandins E[ and E2 were being converted
into the corresponding prostaglandin Fa compounds was obtained by com¬
bined gas chromatography-mass spectrometry. Homogenates of horse, guinea-
pig and rabbit liver and of horse heart produced material which, as the methyl
ester trimethylsilyl ether, chromatographs identically with authentic prosta¬
glandin F2a. Mass spectral scans taken at the crest of each gas chromatography
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Fig. 3. Radio gas chromatographic separation. (A) The upper trace represents the separation of authentic
14C-labelled prostaglandins and Fjq, as their methyl ester trimethylsilyl derivatives. (B) The lower
trace represents the material eluted in the prostaglandin F j q. zone from Lipidex 5000 of an extract of
rabbit liver incubated for 2 h at 37 C with prostaglandin Ej. Again the derivative is the methyl ester
trimethylsilyl derivative.
peak were identical to that of authentic prostaglandin F2a. Prominent ions
were at m/e 584 (M+); 569 (M—15); 513 (M—71); 494 (M—90); 423 (M—90 +
71); 404 (M—2 X 90); 333 (M—2 X 90 + 71) 217; 199; 191; and 173. These
ions are characteristic of prostaglandin F2 a methyl ester trimethylsilyl ether.
Similar results were obtained with the prostaglandin F, a zones produced from
incubating the tissues with [2-1 4 C] prostaglandin E! .
The corresponding prostaglandin Fj p and F2(3 compounds are separated
from the prostaglandin Fj a and F2a by the gas-liquid chromatography systems
used. No detectable levels of these /3 epimers were found.
Discussion
The purpose of the experiments described in this paper was to establish
whether the conversion of prostaglandin E2 to the corresponding prostaglandin
Fa previously found to occur in a variety of systems [1—3,12—16] was a
widely distributed phenomenon.
In the present studies in addition to confirming the presence of an enzyme
in guinea-pig liver that reduces prostaglandin E2 to prostaglandin F2q, three
other conclusive examples have been described. These are the liver of horse and
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rabbit and the horse heart. In these tissues both prostaglandins E( and E2 have
been found to be equally good substrates for the enzymes that reduce prosta¬
glandin E to prostaglandin Fa.
It is not yet established whether the enzymatic conversion of prostaglan¬
din E to Fa is reversible. However, much evidence is accumulating for the
conversion of the prostaglandin E into the corresponding prostaglandin Fa in
certain tissues.
The failure of the experiments described in this paper to detect this type
of prostaglandin E metabolism in all tissues investigated, may indicate that this
is not a widely distributed type of metabolism. Alternatively, it may be that an
excess of other prostaglandin E-metabolising enzymes makes difficult the
detection of any reduction of the 9-ketonic substituent. Further studies are
being conducted to obtain a prostaglandin E2 analogue that is a good substrate
for 9-oxo-reducing enzymes but that is not metabolised by other prostaglandin-
metabolizing enzymes. Such a substrate would have obvious advantages in the
study of the conversion of prostaglandin E2 into prostaglandin F2a. One such
analogue at present under investigation is the 15-methyl ether of prostaglandin
E2.
Other factors such as age, sex and pregnancy that may affect the conver¬
sion of prostaglandin E2 into prostaglandin F2 a by rabbit and guinea-pig liver
homogenates are at present under investigation.
The possibility that the reduction of prostaglandin E2 to prostaglandin
F2q, may be of a modulatory nature as suggested previously [15] obviously
requires further elucidation. This and further distribution studies of the 9-oxo
reductase are at present being conducted in an attempt to elucidate its possible
physiological, biochemical or pathological function.
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